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ABSTRACT OF DISSERTATION 
 
 
 
ADDRESSING PUBLIC HEALTH RISKS OF PERSISTENT POLLUTANTS 
THROUGH NUTRITIONAL MODULATION AND BIOMIMETIC 
NANOCOMPOSITE REMEDIATION PLATFORMS 
 
Due to their relative chemical stability and ubiquity in the environment, 
chlorinated organic contaminants such as polychlorinated biphenyls (PCBs) pose 
significant health risks and enduring remediation challenges. Engineered nanoparticles 
(NPs) provide a novel platform for sensing/remediation of these toxicants, in addition to 
the growing use of NPs in many industrial and biomedical applications, but there 
remains concern for their potential long-term health effects. Research highlighted herein 
also represents a transdisciplinary approach to address human health challenges 
associated with exposure to PCBs and NPs. The objectives of this dissertation research 
are two-fold, 1) to develop effective methods for capture/sensing and remediation of 
environmental toxicants, and 2) to better understand associated risks and to elucidate 
relevant protective mechanisms, such as lifestyle-related modulators of environmental 
disease. 
 
Prevalent engineered nanoparticles, including aluminum oxide and titanium 
dioxide, have been studied to better understand effective nanoparticle dispersion 
methods for in vitro nanotoxicology studies. This work has served both to effectively 
stabilize these nanoparticles under physiological conditions and to better understand the 
associated mechanisms of toxicity, which links these metal nanoparticles to endothelial 
oxidative stress and inflammation through phosphorylation of key cellular signaling 
molecules and increased DNA binding of pro-inflammatory NFκB. Surface 
functionalization, though, is being found to limit potential toxicity and has been utilized in 
subsequent research. 
 
A novel polyphenol-functionalized, NP-based system has been developed which 
combines the biomimetic binding capabilities of nutrient polyphenols with the separation 
and heating capabilities of superparamagnetic iron oxide NPs for the capture/sensing of 
organic contaminants in polluted water sources. Magnetic nanocomposite microparticles 
(MNMs) incorporating the fluorescent polyphenols quercetin and curcumin exhibit high 
affinity for model organic pollutants followed by rapid magnetic separation, addressing 
the need for sustainable pollutant remediation.    
  
	  
Further work has been performed to both better understand health concerns 
associated with environmental toxicants such as PCBs and to determine effective 
methods for modulating their toxicity. This research has shown that PCB remediation 
through dechlorination is a viable technique for decreasing endothelial inflammation, 
although complete dechlorination to biphenyl is necessary to effectively eliminate 
superoxide production, NFκB activation, and induction of inflammatory markers. 
Additionally, the nutrient polyphenol EGCG, found in green tea, has been shown to 
serve as a biomedical modulator of in vivo PCB toxicity by up-regulating a battery of 
antioxidant enzymes transcriptionally controlled by AhR and Nrf2 proteins. 
 
KEYWORDS: POP toxicity; polyphenol; oxidative stress; antioxidant response; 
sustainable remediation 
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Chapter 1. Introduction  
 
1.1 Background 
1.1.1 Combining environmental science and biomedical strategies to better 
protect against pollutant toxicity 
Contaminant remediation and biological modulation of environmentally persistent 
pollutants are two crucial means of reducing the human health risks of Superfund 
chemicals/toxicants and related hazardous materials. The Superfund program, designed 
to clean up sites contaminated with a variety of hazardous substances, was formed as 
the United States’ response to this growing environmental and public health concern1, 
but these pollutants are of worldwide concern. Although complete remediation of a 
hazardous site may continue to be an ultimate goal of human exposure risk reduction, it 
is important to design and implement other biologically relevant means of buffering 
against toxicant exposure before, during, and after remediation activities.  Of additional 
emerging concern, nanotechnology products, such as metal oxide nanoparticles (NPs), 
show much potential both for drastically improving biomedical and consumer products 
and as the basis for effective pollutant remediation strategies, but they also present 
potential physiological and toxicological concerns associated with their ability to pass 
through cell membranes and into the cytosol of cells2.  There is a clear need to develop 
the potential uses of NPs in biomedical treatments and remediation platforms while 
concomitantly understanding potential public health concerns that may arise from their 
increased use. 
Additionally, new data now implicate the importance of an individual’s nutritional 
status and the use of protective bioactive food components to decrease the overall 
toxicity of environmental pollutants to biological systems3.  Nutrition is being 
substantiated as an important modulator of inflammatory and antioxidant pathways, 
especially with regard to environmental insults. Interestingly, novel research now shows 
that bioactive food components that are environmentally friendly can also be integrated 
into remediation technologies, which in turn allow for more sustainable, inexpensive, and 
effective pollutant removal and detoxification4.  Implementing bioactive molecules in both 
biomedical and environmental science settings, together, will allow for decreased overall 
body burden and human toxicity of a multitude of pollutants (see Figure 1.1 for 
overview). Herein, the relevant literature concerning this novel paradigm is discussed, 
2 
 
which points to the possible future uses of bioactive food components in healthful 
nutrition as well as their emerging uses in environmentally friendly remediation strategies 
for ultimately reducing human risks to persistent environmental pollutants.   
  
1.1.2 Exposure to POPs, risks for non-communicable diseases, and mechanisms 
of toxicity 
 Persistent organic pollutants (POPs) consist of a long list of toxic chemicals 
designated as persistent due to their high chemical stability. POPs have been widely 
banned due to their unforeseen adverse health effects5. Of special interest herein, 
polychlorinated biphenyls (PCBs) are a diverse class of manmade POPs that have been 
outlawed in the United States since the 1970s, but still pose toxicological risks due to 
their persistence to environmental degradation6.  Marketed for their effective thermal and 
electrical properties, PCBs became commonplace in capacitors, caulking, and hydraulic 
fluids but have become notorious for their correlation to multiple human toxicities ranging 
from endocrine disruption to vascular inflammation7.  Although PCBs are detrimental to 
multiple target organ systems and tissue types8, special focus of this research has been 
placed on their role in vascular related toxicity.  Of the 209 individual congeners that 
were manufactured, dioxin-like coplanar PCBs such as PCB 77 and PCB 126, which 
lack chlorine substitutions on ortho positions of both phenyl rings, are most toxic to the 
endothelium and associated vasculature9.   
Halogenated POPs, including polychlorinated biphenyls (PCBs) and 
trichloroethylene, are highly prevalent in the environment in soil, air, and water3.  For 
example, a major source of human exposure to PCBs is through dietary intake of 
contaminated foods and through inhalation of airborne pollutants8.  Because most 
halogenated POPs, including PCBs, are lipid soluble, they easily accumulate in human 
tissues, leading to a perpetually increasing disease risk throughout a life span, especially 
in overweight populations10. Historically, epidemiological studies have been focused on 
occupational exposures such as those that occurred with Swedish capacitor workers in 
the mid 20th century, but it is becoming clearer that chronic low-dose exposure may pose 
the most risk for the general public11; 12.  For example, populations most at risk for 
chronic exposure are those that ingest high levels of fatty fish due to the fact that PCBs 
preferentially bioaccumulate in adipose tissue and thus can be transported vertically 
through the food chain13; 14.  Although Inuit populations have been observed to have 3.4-
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fold higher plasma PCB levels than Caucasians, low ppb concentrations in plasma are 
common for the general United States population15.  Importantly, according to the 
National Health and Nutrition Examination Survey (NHANES) there appears to be an 
association with plasma levels of PCBs and cardiovascular disease in women in the 
United States16.  Although these association studies are far from causative and can only 
correlate levels of PCBs with disease outcome, there are human studies that show PCB 
exposure can alter blood lipid profiles and increase total blood cholesterol and 
triglycerides, lending merit to the paradigm that environmental toxicants can promote or 
exacerbate vascular pathologies in humans13.   
Mechanistically, an increase in cellular oxidative stress often precedes an 
inflammatory response17. PCBs, and in particular coplanar PCBs, have been shown to 
cause oxidative stress primarily through a cytochrome P450 (CYP1A1)-mediated 
uncoupling mechanism18.  CYP1A1 induction allows for the detoxification of multiple 
xenobiotics, but when in the presence of PCB, can become inefficient and leaky (i.e., 
uncoupled) and produce detrimental reactive oxygen species18. A hallmark of the 
pathology of vascular diseases, including atherosclerosis, includes a change in the 
cellular redox status and a resultant increase in oxidative stress, which favors chronic 
and low level inflammation19.  Such changes in redox status and oxidative stress levels 
can be driven in part by pro-oxidative and pro-inflammatory environmental pollutants that 
are persistent and which can be easily stored in adipose tissue.  Thus, an increased 
body burden of such persistent environmental pollutants is a particular risk factor during 
obesity, a disease characterized by excessive adipose tissue10.  There is sufficient 
evidence that several POPs contribute to inflammation by activating oxidative stress-
sensitive transcription factors such as nuclear factor kappa-light-chain-enhancer of 
activated B cells (NFκB)20.  For example, our studies suggest that PCBs, and in 
particular coplanar PCBs, can increase cellular oxidative stress and induce inflammatory 
parameters such as inflammatory cytokines, chemokines, and adhesion molecules in the 
vascular endothelium, which are metabolic events that foster an inflammatory response 
and atherosclerosis20-23.  Through these pro-inflammatory mechanisms, PCBs and 
related environmental toxicants have been correlated with increased risk of multiple 
human chronic disease phenotypes including diabetes and heart disease13; 24-27.  The 
pathology of many inflammatory diseases, especially of non-communicable or chronic 
diseases, develops over a long period of time and thus can be easily modulated by 
environmental exposures, specifically to persistent organic pollutants. Since many 
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populations susceptible to toxicant-induced disease are often also afflicted by diet-
induced diseases, future human studies and integrated risk assessments are needed to 
better investigate the interaction between nutrition and toxicology28.  
 
1.1.3 Potential opportunities and risks associated with nanotechnology 
Nanotechnology and the production of nano-sized particles have emerged as 
promising areas of study due to their many applications in industry and medicine29; 30. In 
fact, it is conservatively estimated that $10 billion of industrial and governmental funding 
is directed toward nanotechnology research each year, and that the global production of 
metal oxide NPs alone, without considering engineered nanoparticles, will increase 
600% over the next 5 years to 1.6 million tons31. Nanoscale materials have several 
properties that cause them to behave differently than their bulk counterparts upon 
interacting with chemical and biological compounds, such as their size, shape, surface 
chemistry, presence of surface lattice defects, curvature of the NP surface, and the 
atomic arrangement of the crystalline facets32.  Additionally, nanomaterials have 
increased surface-to-volume ratios, which favor adsorptive phenomena.  As crystalline 
particles become smaller, their surfaces become strained; consequently they have more 
facets and surface atom steps. This results in atoms in under-coordinated states (i.e., 
"hot spots") on the surface of NPs to a greater extent than those found in mesoscale 
materials33.  These edge effects lead to differences in chemical reactivity and electronic 
properties.  Although these differences at the nanoscale provide the basis for much 
opportunity for the development of new industrial and therapeutic products, it is 
conceivable that materials considered generally bioinert could behave differently at the 
nanoscale.  This behavior may not only be a result of different NP surface properties, but 
also due to increased ability to be internalized by cell systems through receptor-
mediated endocytosis34.  Given the commercial promise of nanotechnology, it is 
necessary to establish whether exposure to manufactured nanoparticles poses 
significant health risks.    
Nanoscale metal oxides such as TiO2, ZnO, Fe3O4, SiO2, Al2O3, and CrO3 all 
have been found to have some effect on cellular viability, plasma membrane 
permeability, cell morphology, lactate dehydrogenase (LDH) membrane leakage, 
mitochondrial function, and/or increased cell apoptosis35; 36.  Some have also been 
shown to increase inflammatory markers of the endothelium, such as VCAM-1, ICAM-1, 
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and ELAM-1 and initiate the secretion of proinflammatory cytokines37.  In previous tests, 
Al2O3 and TiO2 have shown relatively low cytotoxicity as compared to ZnO and CrO3, 
although decreased mitochondrial function and increased LDH leakage occurred at 
higher NP concentrations36; 38.  Our laboratory’s recent work with TiO2, however, has 
further highlighted the ability of these NPs to induce oxidative stress and inflammation 
through increased DNA binding of NFκB and phosphorylation of multiple intracellular 
signaling pathways; physicochemical similarities between TiO2 and Al2O3 indicate the 
potential for similar health concerns39.  
 Although there are potential negative health concerns associated with 
nanomaterials, much has been done to limit these potential concerns while building upon 
the many uses for industrial and biomedical applications.  For instance, magnetic 
nanoparticles (MNPs) have found widespread applications in bioseparation, catalysis, 
environmental remediation, and magnetic resonance imaging, as well as in emerging 
medical areas for targeted drug delivery and hyperthermia40-43. Their nanoscale size is 
critical for their superparamagnetism, and thus their end applications, and much 
progress has been made in colloidal synthesis for tailoring nanoparticle size and surface 
characteristics for a wide range of applications.  Nanoparticle surface functionalization, 
and specifically magnetic nanoparticle surface functionalization, with polymer systems is 
of great emerging interest for combining the beneficial characteristics found at the 
nanoscale with biomimetic functionalities imparted through polymer science41; 42. 
 
1.2 Nutrition as a modulator of environmental chemical insults 
1.2.1 Sub-optimal or unhealthy nutrition modulates the toxicity of environmental 
pollutants  
There is a large collection of evidence pointing to the role that a person’s dietary 
makeup and eating habits can play in the promotion of chronic inflammation, metabolic 
disorders and vascular diseases44-46.  Additionally, emerging data show that exposure to 
POPs such as PCBs may work in concert with unhealthy diets to promote cumulative or 
synergistic negative effects47.  POPs and subprime nutritional status share mechanisms 
of disease development including the induction of pro-inflammatory pathways.  
Interestingly, a growing body of evidence implicates an exacerbated toxic effect of PCBs 
and other environmental pollutants when combined with an additive pro-inflammatory 
dietary environment3.  For example, our group has shown that, when combined, pro-
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inflammatory PCBs and omega-6 fatty acids create an exacerbated toxicological 
response that is not simply the sum of their individual inflammatory responses48.  
Importantly, animal fats such as those found in beef and chicken are significant sources 
of pro-inflammatory medium and long-chain omega-6 fatty acids as well as PCBs and 
other related POPs49.  Also, other groups have investigated a linkage between high 
saturated fat diets and increased toxicity of POPs such as polycyclic aromatic 
hydrocarbons and have shown an increased risk for adenomas and cancer50.  In 
addition, other environmental contaminants such as heavy metals and nanoparticles 
may work in concert with sub-optimal nutrition to promote chronic inflammation and 
disease, but studies that investigate the impacts of mixing multiple types of exposures, 
(e.g. chlorinated pollutants and heavy metals) in combination with the added variable of 
an unhealthy diet are severely lacking51; 52.  These types of comprehensive integrated 
toxicity studies will better mirror real world exposure conditions especially for people 
residing in close proximity to Superfund and other hazardous waste sites.  Newly coined 
“obesogen research,” which deals with the study of toxicants that can promote obesity 
and related syndromes, is a compound-driven area of study that is an important addition 
to the toxicological sciences, but we suggest that it does not focus enough on the 
interactions between diet and pollutant53. Although obesogen research is becoming a 
more developed area of study, work is still needed to elucidate interactions between 
nutrients, nutritional status, environmental toxicants and human health.   
 
1.2.2 Healthful nutrition decreases the toxicity of pro-inflammatory pollutants 
Polychlorinated biphenyls and related Superfund POPs induce chronic oxidative 
stress and disregulated inflammatory responses, but anti-inflammatory nutritional 
antioxidants may buffer and protect against toxicant-induced disease through multiple 
cell signaling mechanisms3.  Diets rich in bioactive food components such as 
polyphenols and omega-3 polyunsaturated fatty acids have been correlated with 
decreased toxicant-induced maladies including liver diseases, tumor formation and 
growth, and endothelial cell activation3; 54-57.  Polyphenols, for example, are an abundant 
and diverse class of bioactive compounds found in many fruits and vegetables and have 
been linked to decreased toxicity from dioxin and dioxin-like PCBs58.  These reactive 
oxygen species (ROS) scavenging compounds can also increase PCB excretion rates59, 
prevent AhR-induced inflammation60, limit body wasting61 and decrease cellular 
dysfunction62.  Resveratrol, a well-studied polyphenol, has been shown to interact with 
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the primary receptor of coplanar PCBs, AhR, and to limit its activation and subsequent 
proinflammatory signaling cascade63; 64. Diets rich in antioxidant and anti-inflammatory 
agents are well known as a part of French and Mediterranean diets65.  It should not be a 
surprise then that heart disease and related pathologies are significantly lower in these 
areas when compared to similarly industrialized western regions66.  Although it is 
extremely difficult to determine a unique causative protective agent, bioactive nutrients 
such as resveratrol, quercetin, tea catechins, and docosahexaenoic acid (DHA) may all 
work independently or synergistically to decrease oxidative stress, inflammation, and 
vascular diseases67-69.  Since the hallmark of coplanar PCB vascular toxicity is also 
increased oxidative stress and inflammation, polyphenols (e.g., flavonoids) and omega-3 
polyunsaturated fatty acids are prime nutritional candidates as biomodulators of PCB-
mediated cytotoxicity.  Our work has shown that plant-derived flavonoids such as 
epigallocatechin-3-gallate (EGCG), and long-chain omega-3 fatty acids such as 
docosahexaenoic acid (DHA) can protect cellular systems by decreasing pro-
inflammatory lipid raft signaling domains called caveolae and by simultaneously up-
regulating antioxidant defenses through increased nuclear factor (erythroid-derived 2)-
like 2 (Nrf2) activation70; 71.  Most recently we have elucidated novel cross-talk 
mechanisms between caveolae and Nrf2 pathways and have shown that nutrients 
and/or bioactive food compounds may protect against vascular dysfunction, oxidative 
stress and inflammation by down-regualting caveolae and simultaneously up-regulating 
Nrf2 target antioxidant genes3.  Other groups have shown that bioactive food 
compounds such as those found in broccoli (sulphoraphane) and red wine (resveratrol) 
can activate Nrf2 through multiple mechanisms and decrease oxidative stress levels in 
cells and in animals64; 65; 72-75.  Polyunsaturated fatty acids, and especially omega-3 fatty 
acids, as well as their anti-inflammatory breakdown metabolites can protect against 
PCB-induced disease by activating Nrf2 but interestingly also by disrupting functional 
caveolae70.  Although caveolae and Nrf2 pathways appear to be prime candidates for 
bioactive food components to work through, more research is necessary to better 
elucidate other novel pathways that can be targeted both in vitro and in vivo.  
 
1.2.3 Protective cellular signaling pathways        
Multiple signaling pathways have been attributed to nutritional modulation of 
environmental toxicants, but we have shown that caveolae and the antioxidant master 
controller Nrf2 play integral protective roles.  There is increasing evidence that lipid raft 
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membrane microdomains, i.e., caveolae, may play an important role in atherosclerosis, 
the toxicity of coplanar PCBs, and nutritional protection76-78.  Caveolae are flask shaped 
membrane invaginations that are important in cholesterol transport, nutrient and 
xenobiotic import into cells and cellular signaling79.  Due to the lipophilicity of PCBs, they 
may enter the cell through lipid raft mediated events or come into contact with caveolae-
related signaling proteins.  Interestingly, caveolae-mediated endocytosis is a leading 
mechanism for nanoparticle entry into cells as well and a focal point of nanotoxicology 
studies (see Figure 1.2)80. Caveolae are abundant in vascular endothelial cells and the 
cardiovascular system in general, which points to a highly probable role for caveolae in 
inflammation and atherosclerosis81. Our laboratory has previously reported that coplanar 
PCBs promote the up-regulation of genes related to the activation of endothelial cells 
and the initial stages of atherosclerosis, and that the loss of functional caveolae 
ameliorates these detrimental effects82.  Caveolin-1 (Cav-1), the major structural protein 
of caveolae, contains the “Cav-1 binding domain” that is known to bind multiple proteins 
including endothelial nitric oxide-synthase (eNOS), v-src sarcoma (SRC), protein kinase 
C (PKC), extracellular-signal-regulated kinase (ERk) and protein kinase B (Akt); many of 
which are involved in inflammatory pathways76.  For example, down-regulation of Cav-1 
can lead to eNOS activation and subsequent increases in diffusible nitric oxide, which 
has been shown to play a major role in healthy blood pressure and vessel tone22.  Many 
publications from our laboratory and others show down-regulation and elimination of 
Cav-1 to be anti-atherosclerotic23; 83. Importantly, eliminating Cav-1 prevents PCB-
induced cellular dysfunction82.  Our data point to Cav-1 as a possible anti-atherosclerotic 
therapeutic target, and we hypothesize that nutritional intervention can down-regulate 
Cav-1 and, in turn, protect against PCB-induced inflammation. 
Nrf2 is a transcription factor that can up-regulate cytoprotective genes in 
response to oxidative stress, xenobiotics, and bioactive food molecules84-86.  Many 
nutrients, including resveratrol, sulforaphane, and epigallocatechin gallate (EGCG), have 
been shown to activate Nrf274; 87; 88. There are multiple mechanisms of Nrf2 activation, 
including direct phosphorylation of Nrf2 by PKC delta and loss of contact between Nrf2 
and inhibitory kelch-like ECH-associated protein 1 (Keap-1)89. Upon activation, Nrf2 is 
able to evade ubiquitination, enter the nucleus, and bind cis-acting antioxidant response 
elements (ARE) in target genes such as heme-oxygenase 1 (HO-1) and 
NAD(P)H:quinoneoxidoreductase 1(NQO1)90. Importantly, Nrf2 activation leads to 
decreased inflammation, which is a hallmark of PCB toxicity86.  Activation of Nrf2 may 
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lead to vascular protection from PCB-induced toxicity, and we hypothesize that a diet 
rich in bioactive food components can activate Nrf2 and prevent PCB-induced 
inflammation. Nrf2 has been shown to cross-talk with multiple signaling partners, 
especially with the major player in PCB toxicity, AhR91.  Although it has been known for 
decades that dioxin and dioxin-like compounds activate both AhR- and Nrf2-related 
genes, it was shown only recently that Nrf2 is required for induction of AhR genes such 
as CYP1A192.  This observed cross-talk can be explained mechanistically at the genetic 
level by the fact that the promoter region for Nrf2 contains AhR binding regions and the 
gene promoter for AhR contains multiple Nrf2 binding elements91.  Our laboratory 
previously determined that AhR is a binding partner of Cav-1, so it is plausible that 
cross-talk between caveolae and Nrf2 signaling pathways also exists83. 
Little is known about the cross-talk between Nrf2 and caveolae signaling and 
how bioactive compounds such as omega-3 lipids, flavonoids and other polyphenols 
interact to protect against environmental insults.  We have shown that decreasing 
cellular Cav-1 levels results in a more intense antioxidant response.  Mechanistically, we 
attribute this to decreased AhR activity as well as increased Nrf2 activity60.  Recently, an 
intimate example of cross-talk between Cav-1 and Nrf2 was illustrated93, and our 
published and unpublished data supports this phenomenon.  We have shown that 
decreasing Cav-1 via siRNA technology or utilizing Cav-1 KO mice can result in 
decreased expression of inhibitory Keap1, which allows for increased Nrf2 activation.  
Importantly, we have shown in vitro that pretreatment with the polyphenol EGCG can 
cause decreased expression of Cav-1 and up-regulation of the Nrf2 target cytoprotective 
genes glutathione S-transferase (GST) and NQO1 (unpublished data).  We believe that 
an efficient nutritional biomodulator will work through the observed cross-talk between 
caveolae and Nrf2 and result in broad and diverse cellular protection.  These data 
support the paradigm that utilizing bioactive food components can be an effective 
strategy to combat PCB-induced vascular toxicity.  Using bioactive food components 
such as flavonoids and omega-3 polyunsaturated fatty acids (PUFAs) may be an 
economically and logistically beneficial method to counteract PCB-induced vascular 
inflammation.  Although it does appear that both caveolae and Nrf2 signaling pathways 
play an important role in nutritional modulation of vascular inflammation, other signaling 
cascades may also prove to be involved. 
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Phytochemicals may work through mechanisms that up-regulate protective 
genes, down-regulate pro-inflammatory genes and/or decrease overall oxidative stress 
(Figure 1.3).  For example, the green tea polyphenol EGCG has been shown to protect 
against inflammation via many of the previously discussed signaling mechanisms, but 
interesting new data also points to a role of the laminin receptor.  The laminin receptor is 
a cell surface receptor that has been shown to play a role in inflammation and cancer 
metastasis, and multiple groups have shown EGCG to directly bind the receptor and 
subsequently decrease basophil activation, induce apoptosis in cancer cells, inhibit 
TLR4 and down-regulate pro-inflammatory cytokines and chemokines94; 95.  Studying the 
interactions between laminin receptor, nutrients and environmental toxicants may help to 
elucidate more effective nutritional modulation strategies to prevent vascular 
inflammation and disease.  
              
1.2.4 Healthful nutrition can decrease body burden of environmental toxicants 
An emerging paradigm implicates healthful nutrition as an effective protective 
modulator of environmental toxicant-induced inflammation and human disease.  Multiple 
laboratories have investigated the decreased toxicities of environmental pollutants due 
to bioactive nutrients such as flavonoids and omega-3 polyunsaturated fatty acids, but 
many of these studies rely on in vitro assays that lack the complexity of a whole body 
organismal approach.  Importantly, emerging classes of bioactive food components such 
as polyphenols also have been shown to modulate the pro-inflammatory effects of 
environmental toxicants.  Our laboratory and others have shown that a wide array of 
phenolic compounds such as EGCG, curcumin and quercetin can decrease toxicant-
induced oxidative stress and inflammation in multiple cell types, tissues and animal 
species54; 59; 67; 71; 96; 97.  Although human studies are lacking, strong evidence in animal 
models implicates a protective role for flavonoids and other polyphenols perhaps through 
the induction of antioxidant enzyme pathways and increased fecal excretion rates59; 98.  
Along with the protective effects of healthful nutrition against biological insults induced 
by exposure to POPs (summarized in section 1.2.3)3, healthful nutrition, and specifically 
antioxidant polyphenols, is also being found to decrease body burden of PCBs and other 
POPs.  In other words, plant-derived polyphenols are being found to not only protect 
against POP-mediated oxidative stress, inflammation, and toxicity but also to bind to 
POPs and thus contribute to a decrease in body burden.  In fact, if has been proposed 
that green tea, containing high levels of polyphenols including EGCG, can inhibit the 
11 
 
intestinal absorption of lipids and highly lipophilic organic compounds and accelerate 
excretion of PCBs59; 99; 100.  
Certain foods and polluted air can be major sources of toxicant exposures8. 
Thus, altering nutritional choices may prove to effectively modulate risks associated with 
exposure to POPs.  Making informed dietary decisions such as substituting lower fat 
versions of protein sources (e.g., legumes, nuts, or lean meats and dairies) may have 
multiple health benefits including decreased exposure to detrimental pollutants such as 
dioxins and PCBs101.  For many populations it may be difficult or cost-prohibitive to 
change major dietary protein sources; thus, increasing dietary intake of other bioactive 
nutrients may buffer already exposed individuals against the negative ramifications of 
pollutant exposures.  For example, several laboratories have shown that diets high in 
fiber can alter the absorption and excretion rates of pollutants such as PCBs102-104.  
Mechanistically, multiple dietary fibers have been shown to effectively bind pollutants 
such as dioxins, which may help to explain increased fecal excretion rates, decrease in 
body burden, and observed protection102.  Increasing excretion of lipophilic toxicants 
through other nutritional compounds such as fat substitutes may also effectively 
decrease risk.  For example, much emphasis including human clinical trials has been 
placed on the interactions between the non-absorbable fat substitute olestra and 
environmental toxicants105-109.  Researchers determined that low levels of olestra 
supplementation (25 grams/day) increased the excretion of multiple PCBs and related 
contaminants upwards of 11-fold compared to normal diet109.  Interestingly, in a human 
case study, an olestra-supplemented diet completely eliminated excessive POP 
concentrations in adipose tissue and reversed POP-mediated clinical conditions such as 
diabetes and hyperlipidemia110.  Diet-derived bioactive compounds such as EGCG are 
attractive modulators of toxic exposure because they may both help to prime the 
physiological system prior to a toxic insult by up-regulating protective detoxifying 
enzymes as well as protect therapeutically after exposure by increasing the rate of 
excretion and lowering overall body burden98.  Altering diets to increase fiber and 
bioactive nutrients from fruits and vegetables is an effective and cost-efficient means of 
modulating POP toxicity, but interestingly an emerging and growing body of knowledge 
also implicates the use of bioactive nutrients such as quercetin and curcumin as 
effective components of novel environmentally friendly remediation technologies.   
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Environmental remediation not only relies on efficient pollutant degradation but 
initially on effective pollutant sensing and capture/removal from contaminated settings. 
Emerging research suggests that the utilization of polyphenols for capture and sensing 
of POPs may provide a technologically efficient and cost effective remediation platform 
that results in minimal environmental and health impacts. This work adds to the 
paradigm that nutrients or diet-derived bioactive compounds can broadly impact health 
concerns associated with POP exposure (see Figure 1.1).  
 
1.3 Utilizing polyphenols for pollutant sensing, binding, and remediation efforts 
1.3.1 Current methods and difficulties for POP sensing and remediation 
Persistent organics, and especially PCBs, have proven difficult to remove from 
contaminated sources and subsequently remediate due to their poor aqueous solubility 
and low volatility, which makes extraction from soil and water especially challenging111. 
Further, sensing of these pollutants is both difficult and cost prohibitive, relying heavily 
on GC-MS methods and complicated extraction techniques112-114.  POP remediation to 
date often involves dredging and subsequent deposition in landfills or further pollutant 
degradation through incineration or various chemical dehalogenation techniques115. 
Studies have shown, though, that dredging and deposition results in substantial leaching 
into the surrounding environment, incineration can produce even more harmful 
byproducts if insufficient temperatures are reached, and organic solvents used for 
chemical dehalogenation are often as toxic as the pollutants being remediated116; 117.  
There is a clear need for more effective pollutant remediation involving inexpensive, 
environmentally friendly, stable systems for the capture/sensing of PCBs and other 
POPs, as well as environmentally-conscious pollutant degradation.  In fact, as of 2011, 
the Ecologic Institute of the European Union’s Screening methods for the Water 
Framework Directive (SWIFT-WFD) has continued to focus on this need for discovery 
and translation of low-cost screening tools for environmental contaminants118. 
As a result, much research has been performed to determine novel technologies 
and methods to capture, sense, and remediate POPs.  One such example includes 
engineered antibodies that contain binding domains that can specifically associate with 
PCBs and other POPs, which can be utilized for specific binding and sensing 
applications119. Due to inherent cost barriers and stability issues of these antibodies, 
though, other low-cost, stable engineered materials have been sought as an alternative 
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platform to mimic this specific binding interaction; growing data are implicating the use of 
nutrient polyphenols as effective components of engineered POP capture/sensing 
platforms both due to their fluorescent detection characteristics and affinity for 
chlorinated organics120.  It has been reported that the binding domains of PCB-specific 
antibodies (e.g., the monoclonal antibody S2B1) form sterically constrained, highly 
aromatic pockets, which allow for pi-pi bond stacking interactions119.  Researchers have 
successfully mimicked these interactions in the development of synthetic materials, 
including those composed of polyphenolic moieties, for capture and sensing 
applications121-124.  For instance, by exploiting their biomimetic binding properties, 
researchers have developed porphyrin-containing compounds (highly aromatic 
compounds with similar molecular geometries to polymeric polyphenols) for the 
detection of environmental contaminants113; 125.  
 
1.3.2 Emerging methods for POP sensing and remediation utilizing polyphenol-
based nanomaterials 
There is emerging evidence that biomimetic PCB binding domains can be 
synthesized by incorporating phenolic and related moieties into polymeric coatings, 
which will greatly enhance the ability to detect and remove/remediate PCB 
contamination120.  Polyphenols such as quercetin and curcumin are of special interest 
not only because of their beneficial health effects and environmentally benign nature but 
also because of their highly aromatic structures, which may enable effective and/or 
specific binding and sensing of aromatic pollutants126. Recently, we developed a novel 
strategy to synthesize polymeric networks that incorporate these polyphenols as both 
stable coating materials and biodegradable hydrogels for use as a pollutant binding 
platform and an antioxidant release platform to combat localized cellular oxidative stress, 
respectively127-129.  These materials can have enhanced biocompatibility over their free 
compound form130 and in preliminary studies, we have shown that PCB binding is 
increased through the incorporation of phenolic moieties in a polymeric matrix4.  
Additionally, the characteristic fluorescence peaks associated with these flavonoids 
effectively have been used preliminarily to sense PCB congeners in a concentration-
dependent fashion4.  
Although, biomimetic polymeric networks have been utilized for rapid binding of 
relevant pollutants131, these pollutant-bound materials must be easily removed from 
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contaminated environments in order to be effective remediation systems.  Combining 
polyphenolic polymers with magnetic nanoparticles in nanocomposite microparticle 
systems, then, allows for rapid binding of aromatic pollutants followed by high-
throughput magnetic separation from contaminated samples.  Magnetic nanoparticles 
(MNPs) have found widespread applications in magnetic fluids, catalysis, and 
bioseparation, and are being utilized increasingly in environmental remediation, either as 
uncoated particles or polymer-functionalized particles for increased pollutant adsorption, 
sensing and degradation131-134.  Although nanoparticles in general have been studied for 
some time to elucidate their potential toxicity, magnetic iron oxide nanoparticles have 
shown minimal cytotoxicity and additionally have been used successfully in biomedical 
applications for many years in areas such as magnetic resonance imaging, targeted 
drug delivery, and hyperthermia40-43; 135. Further, recent studies in our group have shown 
that polyphenolic polymers can enhance the biocompatibility of metal nanoparticles like 
iron oxide136, thus forming the basis for a safe, environmentally-sound remediation 
platform. MNPs have found great utility in biomedical applications due to their 
superparamagnetic properties (conferred by their nanoscale size), which allow for easy 
manipulation with a magnetic field (e.g., for effective magnetic separation of captured 
molecules or for transport and immobilization at target sites) and heat generation in 
response to an alternating magnetic field (AMF) for local heating to modify properties 
(e.g., reaction rates, binding properties, thermal treatment)137.  By utilizing diet-derived 
polymeric polyphenol coatings of defined thickness and matrix structure, our work has 
shown that pollutants can be very quickly removed from contaminated water samples4.  
Further, heating of the material can result in thermal destabilization of the polymer matrix 
and subsequent release of bound pollutants for potential reuse.  This combined system, 
incorporating the binding potential of nutrient polyphenols with the separation and 
remote heating potential of magnetic nanoparticles potentially could be used for rapid 
removal of pollutants from environmental samples. The addition and implementation of 
bioactive nutrients into engineered polymers and nanoparticles allows for efficient 
remediation of contaminated sites and is worthy of increased investigation due to the 
high efficiency and specificity potential as well as the environmentally responsible 
makeup of the technology. 
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1.4 Overall research goals 
Nutrition is being further substantiated as an important modulator of inflammatory 
and antioxidant pathways, especially associated with environmental insult, and is also 
emerging as a tool to address exposure toxicity of persistent organic pollutants as both a 
sensing and remediation platform (Figure 1.1).  Evidence now shows that a person’s 
nutritional status can play a key role in determining the severity of environmental 
toxicant-induced pathologies such as diabetes and cardiovascular diseases.  People 
with subprime nutrition may be more susceptible to the toxicity of environmentally 
persistent pollutants whereas individuals that make healthy nutritional decisions and 
emphasize the importance of foods high in bioactive nutrients such as flavonoids may be 
less vulnerable to environmental insults by being able to buffer against the toxicity of 
pro-inflammatory pollutants.  Although augmenting the nutritional profiles of at-risk 
populations may prove to be an effective modulator of toxicant-induced disease in the 
long term, it is critical to discover and design novel sensing and remediation 
technologies that are effective, sustainable and environmentally friendly to address 
immediate needs.  Therefore, the novel and emerging evidence that bioactive nutrients 
may be incorporated into sensing and remediation components may lead to viable 
technologies that circumvent many of the issues concerning current-day 
decontamination platforms. Ultimately, further research into nutrient polyphenols, such 
as EGCG, quercetin, and curcumin, will highlight their potential as sustainable, 
inexpensive components both that can decrease health concerns associated with 
environmental pollutants in the short term and remediate these concerns in the long 
term.   
The following studies highlight a systematic approach to addressing concerns 
associated with POP toxicity through both environmental remediation efforts and 
biomedical intervention strategies.  PCBs 77 and 126 were selected as examples of 
coplanar persistent environmental pollutants that exhibit dioxin-like toxicity. PCB 
degradation product in vitro toxicity was evaluated following pollutant dechlorination 
using iron/palladium nanoparticles, as was in vitro toxicity attributed to other metal oxide 
nanoparticles, specifically titanium dioxide nanoparticles. Improved methods for 
nanoparticle suspension for subsequent industrial application and toxicity evaluation 
were also studied. Biomedical intervention strategies were developed using nutrient 
polyphenols to mitigate in vivo PCB toxicity and polyphenol-functionalized nanoparticles 
were developed as a biologically-inspired remediation platform for removing PCBs from 
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contaminated water sources.  Overall, this research has sought to address the 
significant public health risks and enduring remediation challenges posed by PCBs as 
model toxicants, as well as to further understand potential concerns and opportunities 
associated with nanomaterial usage.  (The information in Chapter 1 represents a 
compilation of information from published review articles3; 138.) 
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Figure 1.1. Illustration of nutrition as 1) a modulator of health risks associated with 
environmental exposure and toxicity of persistent organic pollutants (POPs) and as 2) an 
environmentally sustainable tool to capture, sense and remediate POPs.  We propose 
that nutrition, and in particular diet-derived bioactive compounds such as polyphenols, 
can protect against POP toxicity through their antioxidant and anti-inflammatory 
properties.  Polyphenols also can participate in a remediation platform that includes their 
roles in POP capture and sensing technologies, thus allowing for environmentally 
friendly and sustainable remediation of POPs. 
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Figure 1.2. Three mechanisms of endocytosis: clathrin-mediated endocytosis (CME), 
caveolae-mediated uptake (CAV), and clathrin-and caveolae-independent internalization 
(CCIE). 
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Figure 1.3.  Caveolae play a critical role in PCB-induced vascular toxicity.  Protective 
bioactive nutrients such as omega-3 PUFAs and flavonoids can utilize caveolae Nrf2 
cross-talk to decrease reactive oxygen species, limit inflammatory responses and 
ultimately prevent PCB-induced vascular toxicity. 
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Chapter 2. Optimization of alumina nanoparticle dispersion for environmental and 
toxicological studies  
 
2.1 Synopsis 
 Current dispersion techniques of nanoparticles (NPs) rely on organic solvents, 
pH extremes, or stabilizing agents, but these methods are not conducive to 
environmental and toxicological studies.  The aim of this study was to determine optimal 
dispersion characteristics for nano-sized aluminum oxide (alumina) particles in aqueous 
solutions that mimic biological systems.  Alumina NP dispersion was tested in six 
biologically relevant buffers, as well as cell culture media, and artificial pulmonary 
surfactant.  Suspension media, concentration, and pH were optimized for preparation of 
alumina NPs at or below 100 nm in size.  These NPs were suspended most stably and 
reproducibly in citrate buffer using high-sheer probe sonication (forming particle sizes of 
~68 nm), and exhibited high charge stabilization, which produced highly stable 
suspensions. Acetate buffer also served to suspend alumina at approximately 95 nm in 
size, although higher polydispersity and decreased long-term suspension stability 
hampered its use.  Alumina particles initially prepared using citrate buffer also remained 
well suspended with size near 70 nm following addition to cell culture media, indicating 
that this may be a valuable nanoparticle preparation mechanism for further toxicological 
studies examining nano-sized effects, instead of the more typical studies associated with 
micron-sized particle agglomerates. This research highlights mechanisms to stably and 
reliably disperse alumina NPs in the nano-size regime for environmental and 
toxicological studies. 
 
2.2 Introduction 
Nanotechnology has become commonplace not only in the scientific community, 
but also in industry and the consumer market139.  Nanoscale aluminum oxide (alumina) 
has become important for its wide range of uses: water- and wear-resistant coatings, 
propellants, personal care products, pharmaceuticals, air and water purification, and 
structural ceramics, to name a few140; 141.  There are approximately 50 million tons of 
alumina produced each year, which are increasingly being used in nanoparticle (NP) 
form142.  This increased use of nanoscale alumina has in turn led to increased concern 
over its safety.  Although much is known about alumina on a macroscopic level, little is 
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known about the toxicological properties of its NP form.  Most metal oxides, including 
alumina, are benign at the macroscale, and even at the microscale, but, because of 
quantum size effects and larger surface area, as the nanoscale is approached materials 
can exhibit drastically different properties143; 144. 
Nanoparticles involve a size range between 1 and 100 nm.  Nanopowders, on 
the other hand, consist of agglomerates of these NPs that can begin to exhibit properties 
of the bulk material.  Although the manufactured size of NPs is often 10-50 nm, the 
agglomerates formed from these particles can easily reach to micron sizes, limiting the 
material’s benefits found at the nanoscale145-148. Effective stabilization of alumina NPs, 
especially in aqueous environments, allows for their further utilization in biomedical 
applications but has proven difficult because most industrial NPs have not been 
developed to be compatible with physiological or environmental conditions149.  Instead, 
they rely on organic solvents, pH extremes, or stabilizing agents to remain in 
suspension147; 150-160.  In order to maintain efficient particle dispersion, the steric or 
charge barriers that cause particle-particle repulsions must be sufficient to overcome the 
attractive van der Waals forces that lead to particle adherence161; 162.  As particles 
agglomerate, these larger particles gain an increased affinity for smaller particles, 
eventually resulting in bulk material formation that sediments out of suspension163; 164.  
Dispersant layers (adlayers) surrounding the NPs of interest are often used to provide a 
steric barrier when using NPs in biologically relevant environments and are effective at 
maintaining stable NP suspensions159; 165.  In order to study the actual environmental and 
physiological effects of NPs instead of that simply attributed to their adlayers, it is 
necessary to obtain effectively stabilized NP suspensions both under near-neutral pH 
conditions in biologically relevant buffers and without surface passivation by materials 
not found in nature or in the body166; 167.  
Analysis of NPs in suspension provides another obstacle.  Transmission electron 
microscopy (TEM) is often used to provide highly accurate particle size determination, 
but cannot be used to determine overall aggregation characteristics or gather 
information about how particles behave in solution.  Dynamic light scattering (DLS), on 
the other hand, can be used to determine average hydrodynamic diameters of NPs 
interacting in solution168; 169. Laser Doppler electrophoresis (LDE) also can provide an 
indication of the stability of a suspension by measuring its zeta potential and 
electrophoretic mobility169. At high zeta potentials, either positive or negative, charge 
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stabilization occurs between the bulk solution and the nearby particles causing the 
suspension to resist aggregation.  By tailoring the suspension medium with regard to 
concentration and the types of ions in solution, it is possible to obtain a stable 
suspension of NPs that could resist aggregation170.  
Although there is much potential for NPs to drastically improve biomedical and 
consumer products, they also present potential physiological and toxicological concerns 
because, for one, they are capable of passing through cell membranes and into the 
cytosol of cells2.  Principally, their very small size, but also their shape, chemical 
composition, and surface charge, facilitates entry into the body and into cells.  It is 
thought that NPs enter cells through active transport mechanisms such as receptor-
mediated endocytosis, but are also capable of passing into cells passively via 
pinocytosis171-175.  Nanoscale metal oxides such as TiO2, ZnO, Fe3O4, SiO2, Al2O3, and 
CrO3 all have been found to have some effect on cellular viability, plasma membrane 
permeability, cell morphology, lactate dehydrogenase (LDH) membrane leakage, 
mitochondrial function, and/or increased cell apoptosis35; 36.  Some have also been 
shown to increase inflammatory markers of the endothelium, such as VCAM-1, ICAM-1, 
and ELAM-1 and initiate the secretion of proinflammatory cytokines37.  In previous tests, 
Al2O3 and TiO2 have shown relatively low cytotoxicity as compared to ZnO and CrO3, 
although decreased mitochondrial function and increased LDH leakage occurred at 
higher NP concentrations36; 38.  Our laboratory’s recent work with TiO2, however, has 
further highlighted the ability of these NPs to induce oxidative stress and inflammation 
through increased DNA binding of NFκB and phosphorylation of multiple intracellular 
signaling pathways; physicochemical similarities between TiO2 and Al2O3 indicate the 
potential for similar health concerns39.  
Recent tests performed with alumina use NPs with manufactured diameters of 
approximately 20-50 nm.  However, it is broadly known that in aqueous solutions 
manufactured NPs exist as aggregates with size of 200-500 nm and above37; 140. 
Sonication is commonly used to disperse nanopowders as smaller and smaller 
aggregates, but proper charge stabilization following dispersion is key for maintaining 
effectively dispersed NP suspensions176. Stabilization of NPs nearer to their 
manufactured size could result in greater effectiveness in pharmaceutical/consumer 
applications, but also potentially increased toxicity and additional ability of inhaled 
nanoparticulates to progress further down the respiratory tract 177-179. Tests with soot 
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samples have shown that particles ranging from approximately 100 nm to 20 µm can 
deposit in nasopharyngeal/laryngeal tissue, while particles less than 100 nm are able to 
reach alveolar tissue. At the alveoli, NPs are not only able to interact with type I and II 
alveolar cells, but there is some concern that they may be able to translocate from the 
respiratory system via the alveoli to the capillaries and bloodstream180.  It is therefore 
important to investigate the physiological impact of particles stabilized at or below 100 
nm.  These tests in biologically relevant systems are meant to shed light on improved 
methods of alumina NP dispersion not only for potential use in biomedical and consumer 
applications, but also for continued risk assessment regarding cellular interactions with 
NPs, and the nanotoxicological effects thereof. 
 
2.3 Methods and Materials 
2.3.1 Materials 
Commercial grade uncoated Al2O3 NPs were obtained from Alfa Aesar (0.01-0.02 
µm, Lot # B24Q09, Ward Hill, MA) and initially characterized, as seen in Table 2.1.  
Sodium acetate, acetic acid, sodium chloride, potassium chloride, sodium phosphate 
dibasic, potassium phosphate, tris(hydroxymethyl)aminomethane carbonate (Trizma 
base), 2-(N-morpholino)ethanesulfonic acid (MES), 4-(2-hydroxyethyl)piperazine-1-
ethanesulfonic acid (HEPES), citric acid, sodium citrate, dipalmitoylphosphatidylcholine 
(DPPC), phosphatidylglycerol (PG), and bovine serum albumin (BSA) were purchased 
from Sigma-Aldrich (St. Louis, MO).  All chemicals were reagent grade or better, and all 
aqueous solutions were prepared using 16 MΩ deionized water from a Milli-Q water 
purification system (Millipore, Bedford, MA).  Dulbecco’s Modified Eagle Medium 
(DMEM)/High Glucose and fetal bovine serum (FBS) were purchased from 
ThermoFisher Scientific (Waltham, MA) and F-12K, 1X media were obtained from 
Mediatech (Manassas, VA).  Copper Lacey Carbon TEM grids (200 mesh) were 
obtained from Electron Microscopy Services (Hatfield, PA). 
 
2.3.2 Experimental conditions and measurement techniques 
Alumina (Al2O3) nanoparticle size, surface area, and purity were initially 
evaluated in comparison to vendor specifications. Elemental analysis of Al2O3 samples 
(prepared at 100 ppm in deionized H2O and evaporated to dryness on carbon tape) was 
performed using a Hitachi S-4300 scanning electron microscope (Houston, TX) with a 
Princeton Gamma-Tech energy dispersive X-ray spectroscopy (EDS) Microanalysis 
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System (Princeton, NJ), primary and aggregate particle sizes were determined using 
scanning electron microscopy (SEM), and surface area was determined through the 
Brunauer-Emmett-Teller (BET) method using a Micromeritics TriStar 3000 surface area 
and pore size analyzer (Norcross, GA), following overnight degassing at 120 °C. Initial 
Al2O3 nanoparticle dispersion and size characteristics (suspended in deionized water at 
100 ppm) were analyzed using a Malvern ZetaSizer Nano DLS/Zeta potential system 
with DTS Nano 5.1 Dispersion Technology software (Worcestershire, United Kingdom). 
Characterization results can be found in Table 2.1 as compared to vendor supplied 
values.  
 Herein, alumina nanoparticles were initially suspended at 100 ppm in 
suspension medium of interest (n≥6). Samples were vortexed to initially suspend 
particles prior to ultrasonicating in an ultrasonic bath (model #: B3500A-MTH, rated 
output: 135W, 42 KHz, VWR, Radnor, PA) or with a sonic dismembrator probe sonicator 
(model #: XL2015, rated output: 475W, 20KHz, 1” probe immersion depth, pulsed at 
15% duty, power input: 50W, Qsonica, Newtown, CT).  Samples were sonicated in 
ice/water baths to maintain temperature and limit adverse affects from sample heating. 
Nanoparticle suspensions were filtered through 0.2 µm Anodisc 47 membrane filters 
(Whatman, Maidstone, United Kingdom) or centrifuged using a Beckman Coulter Avanti 
J-251 Ultracentrifuge (Fullerton, CA), depending on suspension mechanism, to separate 
any remaining large aggregates and sedimented particles.  Sample NP final 
concentrations were confirmed using a Thermo iCAP 6500 Duo inductively coupled 
plasma optical emission spectrometer (ICP-OES) with iTeva ICP software (Waltham, 
MA). Sample size and NP physicochemical characteristics were analyzed using a Jeol 
2010F transmission electron microscope with an Oxford EDS detector (Tokyo, Japan). 
Nanoparticle hydrodynamic diameters and suspension zeta potentials were analyzed via 
DLS analysis.  
 
2.3.3 Suspension of nanoparticles in buffers 
Various buffers and preparation conditions were tested to determine alumina NP 
dispersion conditions.  Alumina was suspended in buffers with pKa values covering a 
wide pH range from pH 4 to 9.  Acetate buffer was prepared in deionized water at 0.1, 
0.01, and 0.0001 M concentrations, pH 4, using sodium acetate and acetic acid. Acetate 
buffer was selected due to previous success suspending metal oxide NPs. Citrate buffer 
was prepared at 0.1, 0.01, and 0.0001 M concentrations, pH 4 and 6, using sodium 
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citrate and citric acid. Buffer solutions of 0.5 M MES and 1 M HEPES were tested at pH 
5.5 and 7.5, respectively.  PBS 1X was tested due to its wide use and physiological pH, 
which is conducive for cell culture studies.  One molar Tris buffers (using Trizma base) 
were prepared at pH 7.5, 8.6, and 9 in order to analyze solution stabilization 
characteristics at, above, and below the pKa of alumina’s surface hydroxyls (pKa 8.6 in 
water) 181; 182. Alumina samples were bath sonicated for 6-, 12- or 24-h increments or 
probe sonicated for 10 min. Following ultrasonication, samples were allowed to sit 
undisturbed for 30 min in order to determine buffer suspension capabilities.  In the case 
of rapid visible sedimentation, the buffer was eliminated from further studies. 
Subsequently, filtered samples were compared to unprocessed samples to determine 
the effects of vortexing and filtration on resultant concentration (determined by ICP-
OES), overall particle size (determined by DLS and TEM), and suspension stability 
(inferred visually and by zeta potential). The following suspension conditions were 
compared among the various buffers: buffer concentration, pH, dispersion method and 
duration, and suspension stability (see Table 2.2 for alumina suspension conditions). 
 
2.3.4 Suspension of nanoparticles in artificial pulmonary surfactant  
Lung surfactant was simulated using 10 mg/mL DPPC in deionized water in order 
to compare suspension characteristics between buffered systems and a more 
physiological environment.  Although this phospholipid can be solubilized in chloroform 
or 90% propanol (v/v), these dispersants can act as cell fixatives and are not appropriate 
further for cell culture studies.  A previously reported DPPC dispersion medium was also 
used as another means of forming stable alumina NP dispersions in the nano-sized 
regime183; 184.  This dispersion medium was prepared in deionized water with 0.6 mg/mL 
BSA and 0.01 mg/mL DPPC and adjusted to pH 7.4. Deionized water was used as an 
alternative to PBS, which was used in previous studies, to address potential issues with 
phosphate-induced alumina aggregation. Alumina was suspended with vortexing for 4 h 
at room temperature followed by bath sonication for 3 min.  DPPC contains two 16-
carbon chains that can be cleaved by prolonged sonication; limited sonication serves to 
solubilize the phospholipid more effectively while limiting breakdown of the molecule. 
Alumina suspensions were centrifuged at 4000 rpm for 30 min at room temperature to 
remove any remaining large agglomerates. 
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2.3.5 Suspension of nanoparticles in media  
DMEM/High Glucose media and F-12K media were tested as alumina stabilizing 
agents due to their applicability for a variety of cell types, especially alveolar cells. 
Alumina nanoparticles were initially prepared as above in biologically relevant buffer and 
subsequently added to media at approximately 30 ppm final alumina concentration, in 
line with previously published alumina toxicology study concentrations35.  
 
2.4 Results and Discussion 
2.4.1 Determination of optimal particle dispersant 
Alumina NPs, with a manufactured size of 20 nm, were suspended in six buffers 
at an initial concentration of 100 ppm (See Table 2.2).  Particle size analysis is 
contingent on Brownian motion; therefore, extensive sedimentation leads to decreased 
reliability of sizing results.  Optimal buffer dispersant was then chosen based on its 
ability to both effectively suspend alumina NPs and limit particle aggregation.  Optimal 
preparation conditions were chosen based on resultant NP size.  The stability of 
effectively dispersed samples was monitored for 2 weeks by analyzing the change in 
particle size and zeta potential. Number distribution was primarily used in our DLS 
studies in order to obtain a more reliable analysis of multimodal systems made up of a 
mixture of individual particles and small aggregates as well as larger particle 
agglomerates.  One must take into account, though, that because the number 
distribution is an estimation – as this system is not an actual particle counter – it is not 
completely reliable on its own to give information about the system.  Consequently, 
although number distribution was primarily used for analysis, data were also compared 
to intensity distribution DLS measurements and electron microscopy results.  
 Four buffers, including 0.1 M citrate (pH 6.0), 0.1 M citrate (pH 4.0), 0.1 M 
acetate (pH 4.0), and 1 M HEPES (pH 7.5), were capable of suspending alumina to 
varying extents, while 1X PBS (pH 7.4), 0.5 M MES (pH 6.0), and 1M Tris (pH 7.5, 8.6, 
and 9) buffers were unable to stabilize alumina enough to obtain reliable size 
measurements.  Initial measurements were performed following 6 h sonication in an 
ultrasonic bath at 25 °C.  Although 0.1 M citrate, pH 4, was capable of dispersing 
alumina NPs, the presence of high particle polydispersity indicated poor particle 
stabilization.  HEPES buffer stabilized particle aggregates outside the target size range 
with aggregate size being approximately 1.8 µm.  Number distribution was used to look 
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more specifically at smaller particle peaks.  Peak alumina NP sizes (hydrodynamic 
particle diameter) in citrate and acetate buffers were 90±1 nm and 101±7 nm, 
respectively.  Although acetate buffer, pH 4, produced particle aggregates in the target 
size range (~70-100 nm), it also exhibited much increased size variability between 
samples because of poor particle charge stabilization.  Use of citrate buffer, pH 6, as an 
alumina suspension medium provided small agglomerates, highly reproducible results, 
and very little formation of large aggregates.  
Inductively coupled plasma optical emission spectrometry (ICP-OES) was used 
to determine the effect of filtration on sample concentration following initial sample 
preparation.  Alumina dispersed in citrate buffer, pH 6.0, with 10 min probe sonication 
showed average alumina NP recoveries (filtered/unfiltered %) of 27%, indicating final 
sample concentrations of approximately 27 ppm alumina NPs dispersed in buffer, which 
is in line with recent concentrations used for toxicology studies35.  Contaminants due to 
the citrate buffer were assumed to be minimal in comparison to alumina NPs for the 
purpose of sample analyses. 
Although not reported, deionized water was also tested as an alumina 
suspension medium control (see initial particle characterization in Table 2.1).  A bimodal 
particle size distribution was exhibited, with both particles approximately 140 nm in size 
as well as large, micron-sized aggregates, although large aggregates heavily 
predominated. PBS does not stabilize alumina because phosphate groups bind rapidly 
and strongly to the surfaces of particle aggregates, thus limiting particle disaggregation 
during sonication185.  It is presumed that Tris buffer (pH 7.5, 8.6, and 9) is unable to 
stabilize alumina NPs because pH proximity to the pKa of alumina produces a very small 
electric potential difference between the buffer and the particles, resulting in very small 
zeta potential and diminished charge stabilization.  
 
2.4.2 Buffer concentration effects on particle dispersion 
 Acetate and citrate buffers (pH 4.0 and 6.0, respectively) were tested at 
concentrations of 0.1, 0.01, and 0.0001 M after 6 h sonication durations using both 
number and intensity distribution DLS analysis.  It was found that higher concentrations 
yielded overall lower particle sizes.  Nanoparticle suspension in acetate buffer produced 
higher sample variability as compared to citrate buffer, and, although a small proportion 
of agglomerated particles were stabilized at approximately 100 nm size, large particle 
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formation occurred below 0.1 M resulting in a majority of aggregates being 
approximately 1 µm in size.  
With alumina NPs suspended in citrate buffer, though, there is a correlation 
between concentration and particle size (see Figure 2.1).  Higher buffer concentrations 
led to both a decrease in NP aggregate size (hydrodynamic diameter) and 
polydispersity; alumina NPs suspended in 0.1 M citrate had the lowest polydispersity 
and smallest overall particle size of 109±4 nm following 6 h sonication in an ultrasonic 
bath at 25 °C.  Polydispersity increased, with a decrease in suspension stability, at lower 
buffer concentrations.  The citrate anion, with its high overall charge at pH 6, presumably 
forms a highly stable electric double layer around suspended alumina NPs that limits 
particle-particle interactions, resulting in a highly stable dispersion.    
 
2.4.3 Ultrasonication effects on particle dispersion 
It is well known that sonication conditions help to disperse nanoparticles more 
effectively, but this process can be reversed if the surface charge of newly fractured 
nanoagglomerates is not maintained to prevent reaggregation. As such, inefficient 
suspension media were removed from further optimization studies.  A concentration of 
0.1 M citrate buffer, pH 6.0, subsequently was tested under various ultrasonication 
conditions in order to further optimize particle size and dispersion stability.  Alumina NPs 
were ultrasonicated in buffer for 6, 12 and 24 h at 25 °C in an ultrasonic bath, and for 10 
min on ice with a sonic dismembrator probe sonicator.  A trend toward smaller particles 
was seen when ultrasonication duration was increased, while probe sonication yielded 
the smallest peak aggregate diameters (see Figure 2.2). Mean particle sizes ranged 
from 109±4 nm for 6-h sonication to 68±9 nm for 10-min probe sonication.  The intensity 
distribution showed the presence of aggregates, approximately 1 µm in size, which 
decreased from 9.8% of the total sample after 6 h of sonication to 0.6% after 24 h.  
Increased sonication time allows for increased disaggregation; smaller particles 
disaggregate to a lesser extent because of increased particle-particle adhesive forces 
found at small overall particle diameters186.  The sonic dismembrator instead relies on 
higher power output and proximity of the probe to the sample to produce smaller particle 
aggregates with drastically reduced ultrasonication durations. 
Samples were compared to unprocessed samples to determine the role that 
ultrasonication plays in forming stable alumina suspensions in the target size regime. 
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Data confirm findings of Oesterling et al. 2008 that unprocessed samples form 
aggregates of approximately 200-500 nm or above in aqueous systems, and our studies 
of unprocessed samples in citrate buffer, pH 6.0, exhibit approximate aggregate sizes of 
200-300 nm, which drastically decrease with limited sonication37. 
 
2.4.4 Particle suspension stability 
As seen in Figure 2.3, citrate buffer produces substantial alumina stability at 
various particle sizes.  Alumina NP stability in 0.1 M citrate buffer, pH 6.0, was tested 
over 2 weeks following sample preparation with 10 min (probe sonicator) and 6 and 24 h 
(ultrasonic bath) ultrasonication periods.  In each case, alumina aggregate size 
remained essentially constant (at least within 6.1% of the initially measured aggregate 
size), indicating that 0.1 M citrate buffer is capable of maintaining well-dispersed 
suspensions of various-sized alumina NPs based on the extent of initial ultrasonication.  
Figure 2.3 represents data analyzed as a number distribution in order to more closely 
analyze data in the target size regime.  Although the overall suspension remained stable 
during the testing period, intensity distribution results showed a small concentration of 
larger aggregates, approximately 500-1000 nm in size that increased over time from 
0.5% of the initial suspension to at most 24% of the suspension after 2 weeks.  As with 
the initial sonication duration testing, samples remained stable with specific NP sizes 
based on the extent of sonication.   
Zeta potential measurements were also used to infer particle stability, based on 
surface charge determination, in various suspension media (see Table 2.3 for results). 
Zeta potential represents the charge stabilization between the electric double layers of 
ions surrounding the suspended particles with the bulk solution, and therefore is 
indicative of the overall charge stability of the dispersion.  As zeta potential increases, in 
either the positive or negative direction, the charge repulsion between particles and the 
bulk solution also increases; thus, higher zeta potential values represent more stable 
overall suspensions.  Particles suspended in citrate buffer had the highest zeta potential 
values, and thus the highest stability based on charge, which corresponds well with NP 
stability as seen in DLS measurements.  All DLS results dealing with particle stability 
were confirmed with zeta potential analysis, indicating citrate buffer as the most stable 
suspension medium.  
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2.4.5 Transmission electron microscopy analysis 
Transmission electron microscopy (TEM) analysis of samples showed alumina 
particle aggregate sizes that correspond to aggregate diameters found using DLS 
analysis.  Alumina dispersed in citrate buffer, pH 6.0, with 10 min probe sonication 
showed average aggregate size of ~72 nm, while alumina suspended via bath 
sonication with 24 h sonication and 6 h sonication resulted in aggregate diameters of 
~84 nm and 113 nm, respectively.  High dilution samples were analyzed to minimize 
potential drying effects that result in larger aggregate formation.  Because TEM 
confirmed the sizes obtained through DLS, additional aggregation due to drying is likely 
minimal (See Supplementary Figure 2.1). 
 
2.4.6 Particle suspension in artificial pulmonary surfactant 
Alumina NP suspension characteristics were also tested in systems simulating 
physiological environments to facilitate toxicological studies.  In the case of inhalation of 
alumina NPs into the lungs, alumina will first come into contact with pulmonary 
surfactant, composed primarily of dipalmitoylphosphatidylcholine (DPPC), as well as 
phosphatidylglycerol (PG) and small quantities of surfactant proteins.  DPPC suspended 
in deionized water at 10 mg/mL was used to simulate pulmonary surfactant found in the 
respiratory tract and specifically in the alveoli.  Additionally, dispersion medium 
consisting of a lower concentration of DPPC (0.01 mg/mL) and BSA was used as an 
artificial system to mimic alveolar pulmonary surfactant while limiting adverse affects of 
high protein and phospholipid content on cellular viability NP size measurement in DLS.  
When larger particles, greater than approximately 10 µm in size, enter the respiratory 
tract they are immediately covered in mucus and removed via the mucocilliary escalator.  
Smaller particles that are approximately 1-10 µm in size are able to traverse to the lungs 
where they most likely interact with pulmonary surfactant and are cleared.  
Nanoparticles, though, have the potential to reach the alveoli and interact with alveolar 
cells as well as the alveolo-capillary barrier separating the pulmonary and circulatory 
systems instead of readily being cleared from the respiratory tract180; 187-189.  It is thought 
that if NPs aggregate in artificial lung surfactant, they will also tend to aggregate in vivo.  
These aggregates are more easily cleared from the lungs, thus limiting the adverse 
affects of nanoparticulates. In the case that alumina remains well suspended in lung 
surfactant, toxicological concern increases because of the ability of NPs to enter cells 
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and cellular organelles.  It is possible that lung surfactant can instead serve to coat and 
stabilize very small NPs.   
At concentrations above the critical micelle concentration (CMC, ~3.4×10−7 
mg/mL190), DPPC forms micelle particles in water, which leads to the presence of a 
DPPC particle peak when measured by DLS191; 192.  In our DLS studies, DPPC exhibited 
a particle diameter of 146±31 nm in the absence of alumina NPs.  In multiple tests, the 
presence of 100 ppm alumina NPs in the DPPC/H2O suspension caused a decrease in 
the observed particle diameter from 146±31 nm without alumina to 79±9 nm with 
alumina (see Figure 2.4).  It is possible that a sufficient amount of the DPPC adsorbs to 
the surface of the alumina NPs in the suspension to decrease the DPPC concentration 
below its CMC and prevent micelle formation, which would account for the absence of a 
DLS peak representing DPPC in the presence of alumina NPs.  In this case, it is 
probable that the DPPC does indeed stabilize alumina NPs at approximately 80 nm, 
although this particle size range represents only one-quarter of the overall suspension 
while larger aggregates (assessed through intensity distribution DLS analysis) 
predominate.  The presence of a high polydispersity index indicates that, although DPPC 
may have the ability to stabilize alumina as relatively small aggregates, the overall 
stability of the suspension is low. 
In contrast to the effectively dispersed titania seen previously using DPPC/BSA 
dispersion medium, alumina dispersion stability remained similar to that of DPPC alone 
in water at higher phospholipid concentrations (~200 nm alumina aggregate diameters) 
183; 184; 193. Although it would have been beneficial to test NP suspension characteristics in 
artificial pulmonary surfactant with higher energy dispersion techniques (i.e., bath or 
probe sonication), vortexing was used herein to limit DPPC phospholipid breakdown and 
subsequent unreliable sample analysis. 
Alumina NP stability was tested in DPPC/water for three weeks (data not shown); 
high particle size variability is present within the first week, which increases drastically 
after one week of suspension at which point aggregated particles predominate.  
Although number analysis indicates that some particles range from 60 to 90 nm in size, 
high polydispersity indices indicate that DPPC/water does not suspend particles reliably 
or for long-term.   
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2.4.7 Particle dispersion in cell culture media 
 Alumina dispersions in DMEM/High Glucose and F-12K media produce similar 
obstacles to DLS analysis because of interference of various proteins and 
macromolecules in the target size range of the alumina particles.  TEM analysis showed 
that, while DMEM/High Glucose and F-12K media do not serve as sufficient initial 
particle dispersants, alumina dispersed initially in 0.1 M citrate buffer, pH 6.0, remains in 
a target size range following addition to media at 30 ppm.  TEM analysis of citrate-
stabilized alumina, which was suspended in DMEM/High Glucose medium, showed 
primary particle sizes of approximately 93 nm, although larger aggregates were also 
present (~150 nm in size).  F-12K medium effectively suspended citrate-stabilized 
alumina at particle diameters of approximately 79 nm with limited aggregates of ~120 
nm in size.  Consequently, F-12K and DMEM/High Glucose media are well suited to 
suspension of citrate-stabilized nanoparticulate alumina for subsequent cell culture 
toxicology studies. 
 
2.5 Conclusion 
 This work highlights the optimization of, as well as the many difficulties 
associated with, alumina nanoparticle suspension in aqueous systems for toxicological 
evaluation of alumina effectively stabilized in the nano-sized regime (particle sizes at or 
below 100 nm). Alumina NPs were dispersed in a wide range of physiologically relevant 
buffers, cell culture media, and artificial pulmonary surfactant model systems. These 
NPs were suspended most stably and reproducibly in citrate buffer using high-sheer 
probe sonication (forming particle diameters near 70 nm), and exhibited high charge 
stabilization, which produced highly stable suspensions. Alumina particles initially 
prepared using citrate buffer also remained well suspended near 70 nm following 
addition to cell culture media, indicating that this may be a valuable nanoparticle 
preparation mechanism for further toxicological studies examining nano-sized effects, 
instead of the more typical studies associated with micron-sized particle agglomerates. 
Further toxicological studies of alumina stabilized in the nano-sized regime will be of 
ongoing importance as these particles are increasingly used in industrial, environmental, 
and personal care settings. (The data presented in Chapter 2 has been submitted for 
publication) 
 
  Copyright © Bradley J. Newsome 2014  
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1Increased concentration-related conditions were tested for citrate and acetate buffers 
due to higher dispersion efficiencies and to test ionic strength effects 
2Bath and probe ultrasonication techniques (listed as "bath" and "probe"), as well as 
vortex mixing, were used to suspend alumina NPs in suspension media  
31X PBS consisted of 137 mM NaCl, 12 mM phosphate and 2.7 mM KCl 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2.2
Al2O3 nanoparticle dispersion conditions
Suspension agent Concentration1 pH Preparation conditions2
Acetate buffer 0.0001, 0.01, 0.1 M 4 6, 12, 24 h bath
Citrate buffer 0.0001, 0.01, 0.1 M 4, 6 6, 12, 24 h bath;                      10 min probe
HEPES buffer 1.0 M 7.5 6 h bath
PBS buffer 1X3 7.4 6 h bath
Tris buffer 1 M 7.5, 8.6, 9 6 h bath
MES buffer 0.5 M 5.5 6 h bath
DPPC 10 mg/mL ~7.4 4 h vortex
DPPC/BSA dispersion medium 0.6 mg/mL  BSA        0.01 mg/mL DPPC 7.4 4 h vortex
DMEM media + 10% FBS -- ~7.4 4 h vortex
F-12K media + 10% FBS -- ~7.4 4 h vortex
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  Table 2.3
Al2O3 nanoparticle zeta potential measurements in various suspension agents
Suspension agent Concentration pH Zeta potential (mV)
0.1 M 6 -46.3±10.2
0.01 M 6 -40.8±3.2
0.0001 M 6 -13.1±3.7
0.1 M 4 19.5±0.8
0.01 M 4 22.3±0.6
0.0001 M 4 10.9±1.6
HEPES buffer 1 M 7.5 -9.89±3.0
DPPC 10 mg/mL ~7.4 9.15±0.6
dI H2O -- ~7.4 -22.7±0.4
Citrate buffer
Acetate buffer
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Figure 2.1. (A) Number and (B) intensity distributions of alumina nanoparticle dispersion 
in citrate buffer, pH 6.0, prepared using 6 h bath sonication at 25 °C.  Increasing buffer 
concentration yields an overall decrease in particle agglomerate diameter. Intensity 
distribution and undersize data of alumina NPs suspended in 0.1 M citrate buffer indicate 
minimal large aggregate formation and homology with number distribution data. 
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Figure 2.2. Number distribution of nanoparticle dispersion in 0.1 M citrate buffer, pH 6.0, 
with varying sonication conditions at room temperature.  When prepared using an 
ultrasonic bath, mean particle size decreases with increasing sonication duration from 
109±4 nm for 6 h sonication to 78±3 nm for 24 h sonication. Increasing sheer using 
probe sonication produced the smallest overall alumina aggregate diameters at 68±9 
nm. 
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Figure 2.3. Alumina nanoparticle stability in 0.1 M citrate buffer, pH 6.0, was tested for 2 
weeks after sample preparation using bath and probe sonication.  Each preparation 
condition provides relatively long-term mean sample stability, with a change in sample 
diameter of +5±4 nm (6 h bath sonication), -3±5 nm (24 h bath sonication), and +5±2 nm 
(10 min probe sonication). 
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Figure 2.4. Alumina particle stabilization in dipalmitoylphosphatidylcholine (DPPC).  Size 
analysis of alumina nanoparticles suspended in 10 mg/mL DPPC.  DPPC exhibits its 
own peak at approximately 150 nm, in the absence of alumina nanoparticles, 
corresponding to micelle formation.  
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Chapter 3.A. Titanium dioxide nanoparticles increase inflammatory responses in 
vascular endothelial cells 
 
3.A.1 Synopsis 
Atherosclerosis is a chronic inflammatory disease that remains the leading cause 
of death in the United States. Numerous risk factors for endothelial cell inflammation and 
the development of atherosclerosis have been identified, including inhalation of ultrafine 
particles. Recently, engineered nanoparticles (NPs) such as titanium (TiO2) NPs have 
attracted much attention due to their wide range of applications. However, there are also 
great concerns surrounding potential adverse health effects in vascular 
systems. Although TiO2 NPs are known to induce oxidative stress and inflammation, the 
associated signaling pathways have not been well studied. The focus of this work, 
therefore, deals with examination of the cellular signaling pathways responsible for TiO2 
NP-induced endothelial oxidative stress and inflammation. In this study, primary vascular 
endothelial cells were treated with TiO2 NPs for 2-16 h at concentrations of 0-50 µg/mL. 
TiO2 NP exposure increased cellular oxidative stress and DNA binding of NFκB. Further, 
phosphorylation of Akt, ERK, JNK and p38 was increased in cells exposed to TiO2 NPs. 
TiO2 NPs also significantly increased induction of mRNA and protein levels of vascular 
cell adhesion molecule-1 (VCAM-1) and mRNA levels of monocyte chemoattractant 
protein-1 (MCP-1). Pretreatment with inhibitors for NFκB (pyrrolidine dithiocarbamate), 
oxidative stress (epigallocatechin gallate and apocynin), Akt (LY294002), ERK 
(PD98059), JNK (SP600125) and p38 (SB203580) significantly attenuated TiO2 NP-
induced MCP-1 and VCAM-1 gene expression, as well as activation of NFκB. These 
data indicate that TiO2 NPs can induce endothelial inflammatory responses via redox-
sensitive cellular signaling pathways.  
 
3.A.2 Introduction 
Nanotechnology and the production of nano-sized particles have emerged as 
promising areas of study due to their many applications in industry and medicine29; 30. 
Particularly, TiO2 NPs are produced on a large scale and are being employed in a variety 
of consumer products, such as sunscreens, cosmetics, pharmaceutical additives and 
food colorants194; 195. Although TiO2 is considered to be a safe material, concerns have 
been raised about the potential adverse health effects in occupational and environmental 
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settings196; 197. Because of its toxic potential, TiO2 has been classified by the International 
Agency for Research on Cancer as “possibly carcinogenic to humans” by inhalation198. 
Uptake of TiO2 NPs can occur through multiple routes, including inhalation, ingestion 
and transdermal.  Transdermal exposure of TiO2 NPs is linked to the use of sunscreen 
and cosmetics, although there is no evidence demonstrating that TiO2 can penetrate into 
normal skin199. Actually, the major route of human exposure to TiO2 NPs is through its 
use as a pharmaceutical additive and through food intake, where TiO2 has been widely 
used as a coloring agent for the food industry. Additionally, studies dealing with oral 
exposure of TiO2 NPs in mice have demonstrated the presence of particles in distant 
organs such as the liver, spleen, kidneys and lungs200. These data suggest that TiO2 
particles can travel to other tissues and organs following uptake by the gastrointestinal 
tract, with blood circulation primarily implicated in its biodistribution. A number of studies 
for TiO2 toxicity in animals have focused on inhalation although potential inhalation 
exposure to TiO2 NPs occurs mostly in the workplace194; 201. Because of the 
physicochemical similarities between ambient, nanoscale particles and NPs, there is a 
strong rationale linking exposure to TiO2 NPs with adverse cardiovascular effects. Past 
studies have demonstrated that inhaled ambient ultrafine particles can reach deep into 
the lungs where they can enter the circulatory system, resulting in cardiovascular 
diseases202. Also, multiple studies reporting epidemiological animal data have 
established a link between ambient particles and the etiology of cardiovascular 
disease203; 204. Other exposure routes include surgical implant-derived wear debris and 
intravenously administered contrast agents205; 206. Although intravenous exposure cases 
are rare, there is potential concern because a direct injection of TiO2-containing contrast 
agents into the circulatory system may confer a greater impact on the vascular 
endothelium due to near-100% bioavailability. 
Vascular endothelial cells are potential targets for TiO2 NP toxicity in human 
exposure. There are several cellular events responsible for the initiation of 
atherosclerosis in the vascular endothelium, including oxidative stress, inflammation and 
activation of endothelial cells207. Previous studies have evaluated endothelial activation 
and dysfunction in endothelial cells but the intracellular signaling pathways are not fully 
identified208. The purpose of this study is to determine the intracellular signaling 
pathways by which TiO2 NPs induce inflammatory responses in vascular endothelial 
cells. Our data demonstrate that TiO2 NPs increase vascular adhesion molecules such 
as monocyte chemoattractant protein-1 (MCP-1) and vascular cell adhesion molecule-1 
42 
 
(VCAM-1), and that this is mediated by multiple intracellular signaling pathways including 
mitogen-activated protein kinases (MAPKs) and phosphatidylinositol-3 kinase 
(PI3K)/Akt. 
 
3.A.3 Materials and Methods 
3.A.3.1 Materials 
Commercial grade uncoated TiO2 NPs (anatase, metal basis, stock# 44689, 
99.9% purity, 5 nm) were purchased from Alfa Aesar (Ward Hill, MA). DMSO, apocynin, 
PD98059, SB203580, SP600125 and LY294002 were purchased from Sigma-Aldrich 
(St. Louis, MO). The NFкB inhibitor pyrrolidine dithiocarbamate (PDTC) was obtained 
from Calbiochem (Darmstadt, Germany). Epigallocatechin gallate (EGCG) was 
purchased from Cayman Chemical (Ann Arbor, MI). VCAM-1, IκBα and p-IκBα 
antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Antibodies 
for extracellular signal-regulated kinase-1/2 (ERK1/2), p42/44, p38 MAPK, c-Jun-N-
terminal kinase (JNK) and Akt were obtained from Cell Signaling Technology (Danvers, 
MA). LC3 antibody was purchased from Novus Biologicals (Littleton, CO). 
 
3.A.3.2 Nanoparticle characterization 
TiO2 nanoparticle size, surface area and purity were evaluated in comparison to 
vendor specifications. Elemental analysis of dry TiO2 samples was performed using a 
Hitachi S-4300 scanning electron microscope (Dallas, TX) and Princeton Gamma-Tech 
energy dispersive X-ray spectroscopy (EDS) Microanalysis System (Princeton, NJ), 
primary and aggregate particle sizes were determined using scanning electron 
microscopy (SEM), and surface area was determined through the Brunauer-Emmett-
Teller (BET) method using a Micromeritics TriStar 3000 surface area and pore size 
analyzer (Norcross, GA), following overnight nitrogen degassing at 120 ºC. 
Characterization results can be found in Table 3.A.1 as compared to vendor-supplied 
values. Suspensions of TiO2 NPs in cell culture media were prepared at a concentration 
of 5 mg/mL. Nanoparticle dispersion and size characteristics were analyzed by dynamic 
light scattering (DLS) using a Zetasizer Nano ZS90 particle size analyzer (Malvern 
Instruments, Westborough, MA), which measures hydrodynamic diameters of 
nanoparticles209. TiO2 NP suspensions (n=3) were suspended in deionized H2O, 
sonicated briefly using a probe sonicator (Heat Systems, Inc., Farmingdale, NY) for 15 
min to minimize particle aggregates, added to cell culture medium and analyzed via DLS 
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with five measurements per sample. The same dispersion procedure was also used prior 
to in vitro studies. Sizing data, including mean nanoparticle size (nm) and particle size 
ranges, was determined using Malvern DTS Software, v. 6.32 (Table 3.A.1). 
 
3.A.3.3 Primary cell culture and endothelial cell treatments 
Primary vascular endothelial cells were isolated from porcine pulmonary arteries 
and characterized as described previously77; 210. Cells were cultured in M199 media 
(Gibco, Grant Island, NY) supplemented with 10% fetal bovine serum (FBS) (Invitrogen, 
Carlsbad). Cells were grown to confluence and serum starved overnight in medium 
containing 1% FBS prior to initiation of cell treatments. A stock suspension of 5 mg/mL 
TiO2 NPs was prepared and dispersed by probe sonication for 15 min. Based on our 
preliminary studies, we chose to treat cells with TiO2 NPs at 10 and 50 µg/mL, which 
corresponded to 2 and 10 µg nanoparticles/cm2, respectively. Of particular relevance to 
the present study, TiO2 NPs have been suggested for use in intravenous applications as 
contrast agents205; 206. Due to near-100% bioavailability, potential intravenous 
applications could allow nanoparticles to achieve significantly higher concentrations in 
the blood circulation than that from translocation of nanoparticles following occupational 
and environmental exposure. These nanoparticle concentrations (10 and 50 µg/mL) 
were selected not only to address potential intravenous and environmental exposure 
levels but also to correspond with previous studies showing increased expression of 
inflammatory genes without cell death208; 211. Equal volumes of water (up to 1% of media; 
no hypotonic conditions were produced as shown by autophagy analysis in Figure 3.A.6) 
were used in place of NP-suspension volumes to serve as controls in cell culture. The 
TiO2 NP concentrations and treatment intervals employed in these studies did not lead to 
significant cytotoxicity, as seen by trypan blue exclusion staining (data not shown). 
 
3.A.3.4 Assessment of superoxide (O2●–) levels 
Endothelial cells were grown to confluence in 8-chamber culture slides (BD 
Biosciences, Bedford, MA). Following treatment, cells were incubated with a final 
concentration of 5 µM dihydroethidium (DHE), MitoSOXTM Red mitochondrial superoxide 
indicator (MitoSOX) or DMSO (blank) in a 5% CO2 incubator for 15 min. Cells were 
washed 3x with PBS, fixed with 4% formaldehyde, and washed again 3x with PBS. 
Slides were mounted with ProLong Gold Antifade reagent containing 4’6-diamidino-2-
phenylindole (DAPI) (Invitrogen, Carlsbad, CA) to visualize the nuclei. Slides were 
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evaluated under a Nikon ECLIPSE TE2000-U fluorescence microscope and the images 
were captured digitally using a Nikon LH-M100CB-1 camera and NIS-Elements BR 
4.00.08 software (Nikon Instruments Inc. Melville, NY).  
 
3.A.3.5 Electrophoretic mobility shift assay (EMSA) 
Nuclear extracts of endothelial cells were prepared using NE-PER nuclear 
extraction reagents (Thermo, Rockford, IL). The concentration of nuclear extract was 
determined using Bradford reagent (Bio-Rad, Richmond, CA). DNA binding activities of 
NFκB were determined using a LightShift Chemiluminescent EMSA kit (Pierce, 
Rockford, IL) according to the manufacturer’s protocol. DNA-binding reactions were 
performed with a final volume of 20 µL buffer containing 5 µg of nuclear extract, 50 
ng/µL Poly (dI·dC) and biotin end-labeled oligonucleotides. Synthetic 5’-biotinylated 
complementary oligonucleotides were purchased from Integrated DNA Technologies 
(Coralville, IA). The oligonucleotides containing the NFκB consensus sequence (5’-
AGTTGAGGGGACTTTCCCAGGC-3’) were described previously22. EMSA gels were 
quantified by Image J software (NIH, Bethesda, MD). 
 
3.A.3.6 Quantitative real-time PCR 
Cells were grown in 6-well plates, and total RNA was extracted from the cells 
using TRIzol reagent (Invitrogen, Carlsbad, CA) according to the manufacturer's 
protocol. Reverse transcription was performed using the AMV reverse transcription 
system (Promega, Madison, WI). The levels of mRNA expression were then assessed 
by quantitative real-time PCR using a 7300 Real-Time PCR System (Applied 
Biosystems, Foster City, CA) and SYBR Green master mix (Applied Biosystems). Data 
analysis was performed using the relative quantification method (∆∆Ct), in which relative 
mRNA expression for target mRNAs (i.e., VCAM-1 and MCP-1) was compared to a 
constitutively expressed gene (i.e., β-actin) in the mRNA samples from untreated and 
treated cells. Primer sequences for SYBR Green chemistry were designed using the 
Primer Express Software 3.0 for real-time PCR (Applied Biosystems) and synthesized by 
Integrated DNA Technologies, Inc. (Coralville, IA). Sequences for porcine VCAM-1, 
MCP-1 and β-actin were described in previous articles published by our laboratory60.  
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3.A.3.7 Western blot analyses 
Protein expression was determined using Western blot. Whole cells were lysed in 
RIPA lysis buffer (Cell Signaling Technology, Danvers, MA) containing protease and 
phosphatase inhibitor cocktails (Thermo, Waltham, MA). Lysed cells were centrifuged at 
12,000 x g for 10 min at 4 ˚C. Protein levels of the supernatants were determined via 
BCA assay (Pierce, Rockford, IL). Protein samples (30 µg per treatment) were separated 
using 10% SDS-PAGE and subsequently were transferred onto nitrocellulose 
membranes. Membranes were blocked with 5% non-fat milk buffer and incubated 
overnight at 4 ˚C with primary antibodies. After washing, membranes were incubated 
with secondary antibodies conjugated with horseradish peroxidase and visualized using 
ECL detection reagents (Thermo, Waltham, MA).   
 
3.A.3.8 Statistical analysis 
Data were expressed as mean ± standard error of the mean (SEM). Statistical 
significance was determined by one-way or two-way ANOVA followed by Student-
Newman-Keuls method using Sigma Stat 3.1 software (Systat Software, San Jose, CA). 
A probability value p < 0.05 was considered statistically significant. 
 
3.A.4 Results 
3.A.4.1 Characterization of TiO2 nanoparticles  
Physicochemical characteristics of TiO2 NPs are described in Table 3.A.1. TiO2 
size analysis using SEM showed average NP and aggregate diameters of 79 nm, 
ranging from 7 to 232 nm. BET analysis of TiO2 NPs showed a specific surface area of 
93.9 m2/g. DLS particle size analysis in cell culture media showed particle aggregates 
349 nm in diameter on average, with a range of 250 nm to 396 nm. EDS elemental 
analysis showed 99.7% TiO2 NP purity, in keeping with manufacturer product 
information.  
 
3.A.4.2 TiO2 NPs increase superoxide production  
Oxidative stress is a critical event of endothelial inflammation, activation and 
dysfunction. The flourescent dye DHE is sensitive to reactive oxygen species and, in 
particular, to the superoxide anion. Once this dye is oxidized by superoxide, it stains 
cells a bright flourescent red. Our results showed that TiO2 NPs at concentrations of 10-
50 µg/mL significantly increased superoxide generation at 1 h post exposure (Figure 
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3.A.1). In addition, TiO2 NP-induced superoxide production was confirmed by MitoSOX 
Red fluorescent dye which selectively detects mitochondrial superoxide production. Like 
DHE staining, 10-50 µg/mL of TiO2 NP exposure markedly increased mitochondrial 
superoxide production (Figure 3.A.1). Superoxide production was not detected in cells 
treated with TiO2 NPs (10-50 µg/mL) alone (Figure 3.A.1). No detectable fluorescence 
was seen in controls with TiO2 NPs and fluorescent dye but without cells (data not 
shown). 
 
3.A.4.3 Akt and three MAPK pathways are activated by TiO2 NPs in endothelial 
cells 
Oxidative stressors are known to activate many intracellular signaling pathways. 
In order to identity intracellular signaling pathways associated with oxidative stress and 
subsequent gene expression, we observed the phosphorylation of some key signaling 
molecules. The PI3K/Akt and MAPK signaling pathways are involved in a wide range of 
cellular processes, including NFκB activation, which subsequently can induce cell 
inflammation in response to extracellular stimuli212; 213. We examined potential 
involvement of the MAPK signaling pathways (i.e., p38, ERK and JNK) in endothelial 
cells after treatment with various concentrations of TiO2 NPs. Phosphorylation of 
endogenous p38, ERK and JNK was determined by Western blot analysis. Treatment 
with both 10 and 50 µg/mL TiO2 NPs markedly increased all three MAPK pathways 
(Figure 3.A.2). Similar to activation of MAPKs, Akt was phosphorylated at Ser473 by 
TiO2 NPs (Figure 3.A.2). Phosphorylation of Akt, JNK and ERK peaked as early as 30 
min post-TiO2 NP treatment. Phosphorylation of p38 reached a maximum at 1 h post-
TiO2 NP exposure.  
 
3.A.4.4 TiO2 NPs activate NFκB 
 Activation of three MAPKs and PI3K/Akt can lead to activation of the redox-
sensitive transcription factor NFκB that subsequently up-regulates genes including 
VCAM-1 and MCP-1. Our EMSA results showed that TiO2 NPs significantly increased 
NFκB DNA binding activity in vascular endothelial cells (Figure 3.A.3.A). Competition 
assays were conducted to ensure the specificity of NFκB DNA binding (Figure 3.A.3.A). 
Activation of NFκB was confirmed by phosphorylation of IκBα (Figure. 3.A.3.B). 
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3.A.4.5 TiO2 nanoparticles increase gene and protein expression of MCP-1 and 
VCAM-1 
Vascular endothelial cells were treated with TiO2 NPs at concentrations of 0, 10, 
and 50 µg/mL for 2, 4, 8 and 16 h to determine TiO2 NP-induced expression of 
inflammatory molecules such as MCP-1 and VCAM-1.  TiO2 NPs significantly induced 
expression of MCP-1 mRNA for all exposure times at a concentration of 50 µg/mL, 
compared to control (Figure 3.A.4.A). In contrast, MCP-1 mRNA was significantly 
increased only after a 2 h exposure at a concentration of 10 µg/mL TiO2 NPs. Similarly, 
VCAM-1 mRNA expression was significantly up-regulated after cells were treated with 
TiO2 NPs (50 µg/mL) for all exposure time points, while TiO2 NPs (at 10 µg/mL) 
significantly increased VCAM-1 mRNA only at 2 h (Figure 3.A.4.B). Further, Western blot 
analysis showed that VCAM-1 protein was markedly increased when cells were treated 
with TiO2 NPs (10 and 50 µg/mL) for 4 h (Figure 3.A.5). TiO2 NPs at 50 µg/mL 
maintained significantly higher VCAM-1 protein level up to 16 h. To ensure that the 
observed inflammatory responses were derived from the NPs and not from surface 
impurities, PBS-washed TiO2 NPs (using centrifugation, 3000 x g, for 5 min, 3 times) 
were compared with unwashed TiO2 NPs for VCAM-1 and MCP-1 gene expression. The 
results showed similar proinflammatory effects by PBS-washed NPs compared to 
unwashed TiO2 NPs (data not shown).  
 
3.A.4.6 TiO2 nanoparticles increase autophagy in endothelial cells 
Protein expression of LC3-I and LC3-II was analyzed in order to determine if TiO2 
NPs and/or suspension medium increase autophagy levels in porcine endothelial cells. 
Our data showed that the addition of water (up to 1%) as the nanoparticle suspension 
medium did not lead to increased endothelial cell autophagy (Figure 2.A.6.A). Autophagy 
was markedly increased, though, when cells were treated with TiO2 NPs (50 µg/mL), 
where a maximum expression of LC3-II was observed after an 8 h exposure (Figure 
3.A.6.A). Due to the large surface area associated with NPs, nutrients can adsorb onto 
NPs in high quantities, which can potentially lead to nutritional deprivation and ultimately 
to increased autophagy. To address this, we tested if different concentrations of FBS (0, 
1 and 5%) in TiO2 suspension media can induce varying levels of autophagy in our cell 
culture model. A similar level of autophagy was observed only in cells treated with 50 
µg/mL TiO2 NPs while other treatment groups did not display autophagy, suggesting 
nutritional deprivation was not great enough to induce autophagy in our cell culture 
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model (Figure 3.A.6.B). Comparison of water and PBS as NP-suspension media 
revealed no significant difference in the induction of autophagy (Figure 3.A.6.C). 
 
3.A.4.7 Pharmacological inhibition of NFκB, oxidative stress, PI3K/Akt and MAPK 
pathways result in the decreased expression of MCP-1 and VCAM-1 
In an effort to further identify signaling pathways associated with TiO2 NP-
induced endothelial inflammatory responses, we determined expression of adhesion 
molecules i.e., MCP-1 and VCAM-1 in cells pretreated with pharmacological inhibitors 
for three MAPKs, Akt, NFκB and oxidative stress. Pharmacological inhibitors such as 
PD98059, SB203580, SP600125 and LY294002 block phosphorylation of ERK, p38, 
JNK and Akt, respectively. Pretreatment of cells with these inhibitors significantly 
attenuated TiO2 (10 µg/mL)-induced MCP-1 and VCAM-1 gene expression (Figure 
3.A.7.A and 3.A.7.B), suggesting that all of these signaling molecules can mediate TiO2-
induced inflammatory pathways in vascular endothelial cells. Pretreatment of cells with 
the NFκB inhibitor PDTC for 30 min followed by TiO2 treatment for 2 h resulted in a 
significant attenuation of MCP-1 and VCAM-1 gene expression, compare to TiO2 NPs 
alone (Figure 3.A.7.A and 3.A.7.B), confirming that NFκB signaling is a critical mediator 
of these proinflammatory responses. Similarly, the antioxidant polyphenol EGCG and 
apocynin significantly down-regulated TiO2 NP-induced expression of these genes 
(Figure 3.A.7.A and 3.A.7.B).  Treatment with SP600125 (40 µM), LY294002 (40 µM)  
and apocynin (1 mM) significantly decreased base line MCP-1 mRNA expression but not 
in VCAM-1 expression. Overall, these data demonstrate that TiO2 NP-induced 
inflammatory gene expression is mediated by oxidative stress and increased DNA 
binding of NFκB. 
 
3.A.5 Discussion 
Engineered nanoparticles have been suggested to increase the risk and 
incidence of cardiovascular diseases, including atherosclerosis144; 214. Occupational and 
environmental exposure of TiO2 NPs may be a risk factor for increased cardiovascular 
inflammatory responses in humans. Aerosolized sunscreens may lead to higher 
inhalation absorption and subsequent translocation of TiO2 NPs into the circulatory 
system. Also, intravenous exposure of TiO2 NPs for biomedical uses is of special 
concern due to their higher bioavailability in the human vasculature. 
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As seen in the current studies and also observed by others, anatase TiO2 NPs 
tended to agglomerate to sizes ranging from 250 nm to 396 nm in diameter in cell culture 
media containing 1% fetal bovine serum.  In cultured endothelial cells, TiO2 NPs and/or 
TiO2 NP agglomerates were internalized by cells within one hour, and visualized using a 
relatively simple fluorescent microscopy method using ARS that labels TiO2 NPs215. A 
recent study also highlighted the cellular uptake of TiO2 NPs by cells where 
nanoparticles were massively internalized into cytoplasmic vacuoles in endothelial 
cells216; these findings were confirmed using transmission electron microscopy. These 
previous reports suggest that endothelial cells can internalize both agglomerated and 
non-agglomerated nanoparticles, although the underlying mechanism associated with 
nanoparticle uptake is not fully identified.  
In the present study, we tested expression of adhesion molecules, particularly 
VCAM-1 in primary vascular endothelial cells, when treated with anatase TiO2 NPs. The 
role of endothelial inflammation and expression of adhesion molecules such as MCP-1 
and VCAM-1 in early atherosclerotic lesion formation is critical, and studies have found 
that by blocking VCAM-1 expression, one can reduce monocyte adhesion by 75%217. 
Results from the current study demonstrated that MCP-1 and VCAM-1 gene expression 
was significantly higher in cells exposed to TiO2 NPs. Both 10 and 50 µg/mL of TiO2 NPs 
exhibited the highest gene expression levels after a 2 h exposure. Both MCP-1 and 
VCAM-1 gene expression were diminished for longer times points when cells were 
treated with 10 µg/mL of TiO2 NPs, while 50 µg/mL of TiO2 NPs sustained the elevated 
gene expression up to 16 h. Many mechanisms may be responsible for the decrease of 
gene expression during the extended exposure time. A recent study demonstrated that 
TiO2 NPs elicit oxidative damage that can lead to the activation of nuclear factor 
erythroid 2 related factor 2 (Nrf2) as a protective mechanism218. Nrf2-regulated genes 
include many antioxidant proteins such as NAD(P)H:quinone oxidoreductase 1 (NQO1) 
and glutathione S transferase (GST). Enhanced expression of these antioxidant proteins 
resulted in the reduction of VCAM-1 and MCP-1 gene expression in endothelial cells60. 
In the present study, the cellular defensive system is sufficient to reduce TiO2 NP-
induced inflammatory gene expression at a concentration of 10 µg/mL. In contrast, 50 
µg/mL of TiO2 NPs was able to overcome the cell’s defensive mechanisms, leading to 
extended inflammatory gene expression. VCAM-1 protein expression showed a similar 
pattern to that of mRNA but the maximum expression was observed at 4 h. These data 
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show a potential trend indicating concentration- and time-dependent inflammatory 
effects associated with TiO2 NP exposure.  
Autophagy is a cellular process involving the lysosomal degradation of 
cytoplasmic components and is essential for cell survival and homeostasis219. Our data 
showed that autophagy was increased in cells exposed to 50 µg/mL TiO2 NPs while 
treatment with 10 µg/mL TiO2 NPs did not increase autophagy. Multiple forms of cellular 
stress can induce this cellular defensive process and TiO2 NPs additionally were found 
to increase autophagy in cells220; 221. Autophagy is a complex process which is linked to 
other stress responses. Recent studies have demonstrated that autophagy can 
negatively regulate NFκB signaling and gene expression such as MCP-1222-224. In our 
study, however, MCP-1 and VCAM-1 gene expression was not significantly affected by 
autophagy, although limited decrease in expression of these genes was seen 8 h post 
TiO2 exposure, which occurs concurrently with maximal induction of autophagy. With our 
current data, it is not clear if TiO2 NP-induced autophagy is a significant factor for the 
observed gene expression, therefore further studies are needed to elucidate the 
underlying mechanism. 
We also found that TiO2 NPs can increase cardiovascular inflammation by 
activation of NFκB and subsequent up-regulation of endothelial inflammatory 
parameters, such as MCP-1 and VCAM-1. Further, mechanisms and signaling pathways 
associated with TiO2 NP-induced endothelial cell toxicity were studied. TiO2 NPs 
stimulated production of ROS (e.g., superoxide), which activated four key signaling 
molecules: three MAPKs (p38, ERK and JNK) and Akt. Activation of such signaling 
molecules and expression of endothelial inflammatory parameters were dependent on 
the concentration of TiO2 NPs (0-50 µg/mL). As stated previously, induction of adhesion 
molecules including VCAM-1 and MCP-1 is the product of NFκB activation225; 226; NFκB 
is a critical redox-sensitive transcription factor by which expression of inflammatory 
genes is regulated by extracellular stimuli in cells227; 228. In the present study, we found 
that TiO2 NPs can activate NFκB, which is demonstrated by increased DNA binding 
activity of NFκB and increased phosphorylation of IκBα. These results subsequently 
were confirmed in cells pretreated with a specific NFκB inhibitor (i.e., PDTC) where this 
inhibitor served to significantly attenuate TiO2 NP-induced VCAM-1 and MCP-1 gene 
expression. Three MAPK proteins and Akt signaling protein are known to be associated 
with activation of NFκB227. Cellular oxidative stress is closely associated with 
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phosphorylation of such signaling molecules and subsequent NFκB activation. Recent 
studies have demonstrated that ROS are produced by TiO2 NPs and play an 
inflammatory role in cells220. Another recent study also implicated ROS in the activation 
of NFκB and subsequent induction of inflammatory genes in human endothelial cells 
treated with silica nanoparticles229. Similarly, results in the current study demonstrated 
that TiO2 NPs induce ROS production; our data show a significant production of 
superoxide anion after cell exposure to TiO2 NPs.  Further, in order to confirm these 
data, we pretreated cells with antioxidants such as EGCG and apocynin, which resulted 
in a significant decrease in VCAM-1 and MCP-1 inflammatory gene expression when 
compared to treatment with TiO2 NPs alone. Mechanisms responsible for TiO2 NP-
induced ROS production are not well defined but possibly are linked to the activation of 
NADPH oxidase (NOX) because apocynin, a specific inhibitor for NOX activation, can 
attenuate TiO2 NP-induced gene expression for MCP-1 and VCAM-1230. These results 
suggest that TiO2 NPs can induce ROS production and that this is a key mechanism 
associated with TiO2 NP-induced MAPKs, Akt and NFκB activation.  
The mechanisms associated with TiO2 NP-induced inflammation are not simple 
and likely involve activation of many intracellular signaling molecules. In our studies with 
endothelial cells, treatment with TiO2 NPs phosphorylated three MAPKs and PI3K/Akt. 
Phosphorylation of these key signaling molecules can lead to the activation of redox-
sensitive transcription factors, such as NFκB227.  Indeed, TiO2 NPs increased 
phosphorylation of three MAPKs and PI3K/Akt, and DNA binding of NFκB subsequently 
led to induction of MCP-1 and VCAM-1.  The roles of these three MAPKs and PI3K/Akt 
were confirmed by pretreating cells with specific MAPK and PI3K/Akt inhibitors, which 
resulted in a significant decrease in VCAM-1 and MCP-1 gene expression compared to 
treatment with TiO2 NPs alone. These data suggest a specific role of intracellular 
signaling pathways in endothelial inflammation following TiO2 NP exposure.  
Taken together, data suggest that TiO2 NPs used in our study can increase 
inflammatory gene expression in vascular endothelial cells via redox-sensitive signaling 
pathways. This work highlights the toxic effects of anatase TiO2 NPs in the 
cardiovascular system to better understand potential overall public health concerns 
associated with metal oxide nanoparticles.  (The data presented in Chapter 3.A were 
published39.) 
 
  Copyright © Bradley J. Newsome 2014
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Figure 3.A.1. TiO2 NPs increase superoxide production in endothelial cells. Endothelial 
cells grown on 8-chamber culture slides were treated with TiO2 NPs for 2 h. Cells were 
then stained with either DHE or MitoSOX, and the intensity of red fluorescence was 
assessed using a fluorescence microscope. The red areas in the cells represent 
oxidized DHE and MitoSOX representing the generation of superoxide. The nuclei were 
stained with DAPI. The images shown here are representatives of three independent 
experiments. 
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Figure 3.A.2. TiO2 NP-induced phosphorylation of MAPKs and PI3K/Akt pathways in 
endothelial cells. Cells were treated with TiO2 NPs to observe the activation of three 
types of MAPK signaling pathways, p38, ERK and JNK, as well as the Akt signaling 
pathway. The images shown here are phosphorylated signaling molecules at the time of 
maximum induction. The Western blots shown here are representative images of three 
independent experiments. 
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Figure 3.A.3. TiO2 NPs increase activation of NFκB. (A) NFκB DNA binding determined 
by EMSA analysis. (B) Phosphorylation of IκBα analyzed in whole cell lysate by Western 
blot. Cells were treated with TiO2 NPs (0-50 µg/mL) for 2 h followed by preparation of 
nuclear extracts for EMSA or whole cell lysates for Western blot. In EMSA, unlabeled 
competitor sequences were present at a 200-fold molar excess over labeled sequences. 
Data represent the mean±SEM, with n=3. Experiments were repeated a minimum of 
three times. The EMSA and Western blot shown here is a representative image. 
*Significantly different compared to control (p<0.05). 
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Figure 3.A.4.  TiO2 NPs increase expression of MCP-1 (A) and VCAM-1 (B) genes. 
Gene expression levels were measured using quantitative real-time PCR. Primary 
endothelial cells were treated with 0-50 µg/mL of TiO2 NPs for the indicated times (2-16 
h). Results represent the mean±SEM, with n=3. Experiments were repeated a minimum 
of three times. *Significantly different compared to control (p<0.05). 
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Figure 3.A.5. TiO2 NPs increase VCAM-1 protein expression in primary endothelial 
cells. Primary endothelial cells were treated with 0-50 µg/mL of TiO2 NPs for different 
time points (2-16 h). Western blots show a dose-dependent increase of VCAM-1 by TiO2 
NPs. Western blots shown here are representative images of three independent blots. 
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Figure 3.A.6. Expression of LC3-I/II, an autophagy marker, by endothelial cells. (A) 
Endothelial cells were treated with 0-50 µg/mL TiO2 NPs at different time points (2-16 h). 
(B) Endothelial cells were treated with 0-50 µg/mL TiO2 NPs for 8 h using three different 
NP suspension media: water only, water with 1% FBS and water with 5% FBS. (C) 
Endothelial cells were treated with 0-50 µg/mL TiO2 NPs for 8 h using two different NP 
suspension media: water and PBS. Western blots shown here are representative images 
of three independent blots. 
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Figure 3.A.7. Pharmacological inhibition of NFκB, oxidative stress, PI3K/Akt and MAPK 
pathways result in the decreased expression of MCP-1 and VCAM-1. Expression of 
MCP-1 (A) and VCAM-1 (B) mRNA in endothelial cells. Cells were exposed to TiO2 NPs 
(10 µg/mL) for 2 h after a 30 min pretreatment with pharmacological inhibitors, i.e., 
PD98059 (40 µM, ERK inhibitor), SB203580 (40 µM, p38 inhibitor), SP600125 (40 µM, 
JNK inhibitor) and LY294002 (40 µM, Akt inhibitor). Also, cells were pretreated with the 
NFκB inhibitor (PDTC, 10 µM, for 1 h) and antioxidants (EGCG, 50 µM for 3 h and 
apocynin, 1 mM for 1 h) followed by TiO2 NP (10 µg/mL) exposure for 2 h. mRNA 
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expression levels were measured using quantitative real-time PCR. Results represent 
the mean±SEM, with n=3. Different letters correspond to significant differences (p<0.05) 
between treatment groups. 
  
61 
 
Chapter 3.B. PCB 77 dechlorination products modulate pro-inflammatory events in 
vascular endothelial cells 
 
3.B.1 Synopsis 
 Persistent organic pollutants such as polychlorinated biphenyls (PCBs) are 
associated with detrimental health outcomes including cardiovascular diseases. 
Remediation of these compounds is a critical component of environmental policy. 
Although remediation efforts aim to completely remove toxicants, little is known about 
the effects of potential remediation byproducts. We previously published that Fe/Pd 
nanoparticles effectively dechlorinate PCB 77 to biphenyl, thus eliminating PCB-induced 
endothelial dysfunction using primary vascular endothelial cells. Herein, we analyzed the 
toxic effects of PCB congener mixtures (representative mixtures of commercial PCBs 
based on previous dechlorination data) produced at multiple time points during the 
dechlorination of PCB 77 to biphenyl. Compared to pure PCB 77, exposing endothelial 
cells to lower chlorinated PCB byproducts led to improved cellular viability, decreased 
superoxide production, and decreased nuclear factor kappa B (NFкB) activation based 
on duration of remediation. Presence of the parent compound, PCB 77, led to significant 
increases in mRNA and protein inflammatory marker expression. These data implicate 
that PCB dechlorination reduces biological toxicity to vascular endothelial cells. 
 
3.B.2 Introduction  
Polychlorinated biphenyls (PCBs) are a class of organic pollutants that were 
used heavily as dielectric fluids in industrial and electrical applications until evidence 
surfaced linking PCBs to cancer and cardiovascular disease.  Remediation efforts for 
these highly persistent pollutants have proven difficult, expensive and slow.  Our 
laboratories have developed new fast, low-cost techniques that employ Pd/Fe 
nanoparticles for reductive PCB dechlorination, which systematically dechlorinate higher 
congener PCBs to biphenyl, with lower chlorinated congeners produced as byproducts 
prior to complete degradation.  The goal of this work is to better understand the 
toxicological effects of these byproducts and to further validate the importance of PCB 
dechlorination for reducing cardiovascular risk factors and for improving overall public 
health.  
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Even though PCB production has been banned in the US since the late 1970s, 
PCBs remain concentrated in many waterways and Superfund sites, as well as in 
electrical devices such as transformers and light ballasts.  Additionally, recent research 
has indicated that a variety of PCB congeners are still being generated as industrial 
byproducts from pigment production and certain paper manufacturing231; 232.  PCBs 
exhibit unique properties, such as high environmental persistence and resistance to 
metabolism in organisms, which lead to difficulties for remediation.  Additionally, the 
costs associated with large-scale clean-up and removal of these and other chemical 
pollutants is great, and thus the development of more efficient, cost effective 
technologies continues to be important. Current remediation techniques rely on 
expensive dredging followed by incineration or bioremediation techniques. Although 
PCBs can be degraded through some natural processes such as bacterial 
degradation233; 234 and photolysis235; 236, these processes are prohibitively slow for 
remediation of larger scale contaminations. Our research group recently developed a 
Pd/Fe nanoparticle system that catalyzes the dechlorination of PCBs to form biphenyl in 
order to address this need for low cost, high throughput chlorinated aromatic 
degradation237; 238.  During chlorinated aromatic degradation, hydrogen ions are used to 
displace chlorine on biphenyl rings in stages, resulting in the production of lower 
chlorinated PCB congeners prior to complete degradation to biphenyl. It is generally 
believed that less-chlorinated congeners are more water soluble, more volatile, and 
more likely to biodegrade further239.  In a previous study, we compared the biological 
activity of the parent compound (PCB 77) with the dechlorination end product (biphenyl), 
and found that complete dechlorination markedly reduced the pro-inflammatory activity 
of PCB 77240. 
Many environmental contaminants, and especially persistent organic pollutants, 
are risk factors for cardiovascular diseases such as atherosclerosis because they can 
initiate or exacerbate the underlying disease by altering gene expression patterns and 
subsequent vascular inflammation57; 241.  Because the endothelium is in immediate 
contact with the blood, endothelial cells are particularly susceptible to the effect of 
environmental contaminants.  The lining of blood vessels is protected by the 
endothelium, and endothelial cells play an active role in physiological processes such as 
regulation of vessel tone, blood coagulation, and vascular permeability.  In turn, 
endothelial cell activation or dysfunction is a critical marker of the pathology of 
cardiovascular diseases such as atherosclerosis. 
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Activated endothelial cells produce chemokines such as monocyte 
chemoattractant protein 1 (MCP-1) and inflammatory cytokines, which attract monocytes 
from the blood stream to the site of injury.  Part of the resulting inflammatory process 
includes the endothelial cell expression of adhesion molecules, like vascular adhesion 
molecule-1 (VCAM-1), which allow the monocytes to attach to the endothelial layer and 
infiltrate this barrier into the intimal space.  We have demonstrated previously that 
coplanar PCBs (e.g., PCB 77) can induce DNA-binding activity of the oxidative stress-
sensitive transcription factor nuclear factor kappa B (NFкB) and expression of VCAM-1, 
which is dependent on functional aryl hydrocarbon receptor (AhR) activity20.  Recently, 
we have reported the mechanisms of PCB 77-mediated up-regulation of MCP-123.  
Little is known about vascular toxicity of PCBs, and especially about the toxicity 
of dechlorination or remediation products.  There is a clear need to evaluate products of 
remediation (e.g., dechlorination products) for biological activity in mammalian 
systems242.  It is important to know to what degree remediation processes of persistent 
organic pollutants have to occur before toxicity and any vascular injury becomes 
negligible.  Thus, the present study was designed to test the effects of PCB 77 
dechlorination products on pro-inflammatory parameters in a vascular endothelial cell 
model system.  Data from this study suggest that the presence of the parent compound 
(e.g., PCB 77) is necessary for maximal endothelial cell dysfunction and inflammation.  
These data also suggest that dechlorination is a successful method for decreasing 
biological toxicity, with overall toxicity linked to the level of degradation of the parent 
compound.  Herein, dechlorination is demonstrated to be an effective platform for 
addressing public health concerns associated with these persistent chlorinated 
pollutants. 
 
3.B.3 Materials and Methods 
3.B.3.1 Materials 
Biphenyl, 3-chlorobiphenyl (PCB 2), 4-chlorobiphenyl (PCB 3), 3,3’-
dichlorobiphenyl (PCB 11), 3,4-dichlorobiphenyl (PCB 12), 3,4’-dichlorobiphenyl (PCB 
13), 4,4’-dichlorobiphenyl (PCB 15), 3, 3’,4-trichlorobiphenyl (PCB 35), 3,4,4’-
trichlorobiphenyl (PCB 37) and 3, 3’, 4, 4’-tetrachlorobiphenyl (PCB 77) were purchased 
from AccuStandard, Inc. (New Haven, CT).  Experiments that included hazardous 
materials such as PCBs were performed in accordance with institutional and federal 
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guidelines243.  All cell culture reagents, including ProLong Gold antifade reagent with 
4',6-diamidino-2-phenylindole (DAPI), were purchased from Life Technologies (Carlsbad, 
CA).  All other chemicals were purchased from Sigma-Aldrich Corporation (St. Louis, 
MO), unless otherwise specified. 
 
3.B.3.2 Description of PCB 77 dechlorination treatment mixtures 
Treatment mixtures were based on the composition of PCB 77 and its 
dechlorination products at 0, 10, 24, and 48 hours of remediation as derived from GC-
MS data comparing the reductive efficiencies of 0.1 mg/mL 400 nm Pd/Fe nanotubes 
and 1 mg/mL Pd/Fe nanoparticles237; 240. Dechlorination product compositions were 
determined from these data (Table 3.B.1); treatments from each stage of the 
dechlorination are described as percent by weight and as molarity. Stocks of individual 
PCB commercial congeners were solubilized in fresh dimethyl sulfoxide (DMSO) at a 
concentration of 10 mM. Treatment mixtures were developed to delineate between the 
effects of the parent compound and dechlorination products including treatments 
representing product mixtures without PCB 77, treatments representing only the 
concentration of PCB 77 at a particular stage of dechlorination, and a treatment 
representing the 24 h dechlorination products with the higher PCB 77 concentration 
found following 10 h dechlorination, to emphasize the role of PCB 77 in overall toxicity 
(Table 3.B.2). Stock treatment mixtures were prepared in DMSO at a 5 mM total 
concentration and diluted 1:1000 in cell culture medium for 5 µM final cell culture 
treatments.  
 
3.B.3.3 Cell culture 
Primary endothelial cells (ECs) were isolated from porcine pulmonary arteries as 
described previously210. Cell culture media consisted of medium 199 (M199) containing 
10% fetal bovine serum (FBS).  At 70-80% confluence, cells were incubated overnight 
with treatment media (M199 with 1% FBS), followed by exposure to PCB 77 or 
respective treatment mixtures for 24 h.  Treatment mixtures were added to cell culture at 
a final concentration of 5 µM, which represented a maximum concentration of 0.1%v/v 
DMSO/media (see Tables 3.B.1 and 3.B.2 for PCB treatment concentrations). Cell 
viability was tested in the presence of dechlorination products using the Vybrant MTT 
Cell Proliferation Assay Kit (Invitrogen, Eugene, OR) according to manufacturer 
guidelines.  
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3.B.3.4 Assessment of superoxide (O2●–) levels 
Superoxide levels were assessed as recently reported70.  Cells were grown to 
confluence in 4-chamber culture slides (BD Biosciences, Bedford, MA). After 4 h 
exposure to PCB treatments (5 µM total concentrations; Table 3.B.1), the cells were 
rinsed 2x with Krebs-Ringer buffer (KRB) and incubated with 5 µM dihydroethidium 
(DHE) or KRB (blank) at 37oC for 30 min. Cells were rinsed with KRB, fixed with 10% 
buffered formalin, and washed with PBS. Slides were mounted with ProLong Gold 
antifade reagent with DAPI for nuclei staining. Slides were evaluated with an Olympus 
BX61W1 fluorescence microscope. Mean fluorescence intensity was quantified using 
ImageJ 1.42q (NIH, Bethesda, MD). 
 
3.B.3.5 Assessment of NFкB activation 
Nuclear extracts were prepared from endothelial cells cultured as described 
above in 10 cm dishes and treated with PCB 77 or dechlorination mixtures for 4 h.  The 
nuclear extraction was performed as described previously22.  EMSA (electrophoretic 
mobility shift assay) of nuclear factor kappa B (NFкB) binding was kindly performed by 
Dr. Seong-Su Han of the University of Iowa College of Medicine using the DNA-protein 
binding detection kit (Gibco-BRL, Grand Island, NY) with radio-labeled 
oligonucleotides60; 77. 
 
3.B.3.6 Measurement of CYP1A1, MCP-1 and VCAM-1 mRNA  
CYP1A1, MCP-1 and VCAM-1 mRNA expression was assessed using real-time 
PCR (RT-PCR), as described previously23; 77.  Briefly, mRNA was isolated using TRIzol 
Reagent (Life Technologies, Carlsbad, CA) and quantified using a SmartSpec Plus 
Spectrophotometer (BIO-RAD, Philadelphia, PA). cDNA was then generated using 
Promega AMV reverse transcriptase (Fisher Scientific, Waltham, MA) and  RT-PCR was 
performed using Power SYBR Green PCR Master Mix (Life Technologies, Carlsbad, CA) 
and the following porcine primer sequences: β-actin sense 5′-TCA TCA CCA TCG GCA 
ACG-3′ and antisense, 5′-TTC CTG ATG TCC ACG TCG-3′; CYP1A1 sense 5’- TGG 
AGA GGC AAG AGT AGT TGG-3’and anti-sense 5’-GGC ACA ACG GAG TAG CTC 
ATA-3’; MCP-1 sense 5′-CGG CTG ATG AGC TAC AGA AGA GT-3′and antisense, 5′-
GCT TGG GTT CTG CAC AGA TCT-3′; and VCAM-1 sense 5′-TGG AAA GAC ATG 
GCT GCC TAT-3′ and antisense, 5′-ACA CCA CCC CAG TCA CCA TAT-3′.  Assays 
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were run using the Applied Biosystems 7300 Real time PCR System (Life Technologies, 
Carlsbad, CA) using absolute quantification. The raw data were quantified using a 
standard curve and analyzed with a manual CT threshold of 0.200. Sample data were 
normalized to individual β-actin values.  
 
3.B.3.7 Measurement of CYP1A1, MCP-1 and VCAM-1 protein 
CYP1A1 and VCAM-1 protein levels were assessed by Western blotting, as 
described previously240.  After semi-dry transfer, nitrocellulose membranes were 
incubated for 2 h in blocking buffer (5% non-fat milk in Tris-buffered saline containing 
0.05% Tween 20).  Rabbit polyclonal CYP1A1 (H-70) and VCAM1 (C-19)-R (Santa Cruz 
Biotechnology, Inc., Santa Cruz, CA) primary antibodies were diluted 1:1000 in blocking 
buffer and incubated overnight at 4 °C, and the secondary antibody was diluted 1:4000.  
β-actin primary and secondary antibodies were diluted 1:10,00023. MCP-1 protein levels 
were measured in cell culture media diluted 1:7 using an OptEIA Human MCP-1 ELISA 
Kit (BD Biosciences, San Diego, CA) according to manufacturer guidelines.   
 
3.B.3.8 Statistical analysis 
Values are reported as means ± SEM obtained from a representative sample set 
of a minimum of three independent experiments, unless otherwise stated. Comparisons 
were made by one-way analysis of variance (ANOVA) with Tukeys test for post-hoc 
analysis, using SigmaPlot 12.0 software (Systat Software, San Jose, CA). Statistical 
probability of pvalue < 0.05 was considered significant. Similar statistical marker letters 
between treatments indicate no statistical difference. 
 
3.B.4 Results 
3.B.4.1 Dechlorination alters cellular oxidative stress and viability  
PCB-induced cellular dysfunction is characterized by increased oxidative stress 
and subsequent activation of inflammatory pathways including NFкB.  The uncoupling of 
CYP1A1 leads to the generation of reactive oxygen species (ROS), such as superoxide.  
Endothelial cell monolayers were exposed to representative dechlorination product 
mixtures (Table 3.B.1) for 4 h before ROS were visualized with DHE fluorescence 
(Figure 3.B.1.A).  Strong staining was observed in cells exposed to 0 h (pure PCB 77) 
and 10 h dechlorination products, whereas mixtures representing longer periods of 
dechlorination showed decreased superoxide production. When DHE fluorescence was 
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quantified and normalized to DAPI nuclear staining, fluorescence from initial 
dechlorination mixtures (0 and 10 h of dechlorination) indicated higher ROS production 
which decreased to control levels with further dechlorination (differences between 
groups approached significance, p=0.052; See Figure 3.B.1.B).  A similar trend was 
observed with regard to viability, where no changes were observed in cells treated with 
PCB vehicle (DMSO) and the 48 h dechlorination product, although cell viability was 
decreased in 0 h (parent compound, PCB 77), 10 h and 24 h dechlorination product 
treatments to 69±1%, 61±3%, 87±2% of control, respectively.  
 
3.B.4.2 NFкB activation is attenuated by dechlorination   
Data from an NFкB EMSA showed that cells treated for 4 h with the 
dechlorination products exhibited a prominent increase in NFкB activation when treated 
with the 0 h product, or pure PCB 77. Intermediate activation by the 10 and 24 h 
products was observed; NFĸB:DNA binding for these treatments was significantly 
decreased compared to exposure to the 0 h product but remained increased relative to 
the vehicle control and biphenyl (48 h product; see Figure 3.B.2).  Biphenyl was 
consistently within control expression levels for superoxide fluorescence, viability, and 
NFкB:DNA binding. The 10 and 24 h dechlorination products were increased from 
control but did not exhibit a consistent linear change from parent PCB 77, 0 h of 
dechlorination, expression levels. We, therefore, tested a series of treatment mixtures to 
delineate between the effects of the dechlorination products and the residual PCB 77.  
 
3.B.4.3 Dechlorination products alter CYP1A1, MCP-1 and VCAM-1 mRNA 
expression  
CYP1A1, VCAM-1 and MCP-1 levels were assessed in mRNA using treatment 
groups 1-10 (Figure 3.B.3, Table 3.B.2).  CYP1A1 expression is a sensitive marker of 
coplanar PCB-mediated cellular activation and toxicity.  Thus, significant response from 
all treatments containing PCB 77 was expected (Figure 3.B.3.A).  Indeed, all treatments 
that contained pure or some PCB 77 (treatments 2, 3, 5, 7, 9 and 10) exhibited almost 
maximal CYP1A1 expression.  There was no difference in CYP1A1 expression among 
the pure PCB 77 (treatment 2) and both 10 h (treatment 3) and 24 h (treatment 5) 
dechlorination mixtures.  Interestingly, when 10 h and 24 h dechlorination treatments 
lacked PCB 77 (treatments 4 and 6, respectively), induction of CYP1A1 was reduced 
linearly.  Both MCP-1 and VCAM-1 mRNA expression patterns (Figures 3.B.3.B and 
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3.B.3.C, respectively) followed approximately the CYP1A1 treatment patterns, 
suggesting some correlation between CYP1A1 induction and inflammatory markers in 
these dechlorination experiments.  As with CYP1A1 expression, MCP-1 and VCAM-1 
expression exhibited a linear decrease to control levels when treated with mixtures 
representing 10, 24 and 48 h dechlorination products without PCB 77 (treatments 4, 6 
and 8), indicating that any byproduct contribution to the inflammatory response was 
eliminated by further dechlorination. Total dechlorination to biphenyl (48 h product) 
showed no statistical difference from control, indicating that it was relatively benign in 
our EC model.  The presence of residual parent PCB dominated the inflammatory 
response in product mixtures, but mRNA expression levels of PCB 77 alone were 
moderately attenuated at the lower concentrations.  
 
3.B.4.4 Degree of dechlorination affects CYP1A1, MCP-1 and VCAM-1 protein 
expression 
Endothelial cells were treated with the dechlorination mixtures mentioned above 
(Table 3.B.2) in order to determine the effects of PCB 77 dechlorination on endothelial 
cell inflammatory response expressed in protein markers (Figure 3.B.4).  Treatments 
containing the parent compound showed strong correlations in both mRNA and protein. 
Similar to the mRNA expression levels, CYP1A1 protein levels were highest for 
treatments containing PCB 77 (Figure 3.B.4.A).  However, treatments that did not 
contain PCB 77 showed a marked decrease in CYP1A1 and MCP-1 protein expression, 
correlated to the degree of dechlorination. Significant increases in MCP-1 expression 
were observed with the 0 h product (PCB 77, treatment 2) and, to a lesser degree, with 
dechlorination products containing decreasing concentrations of PCB 77 (treatments 3, 
5, and 8). VCAM-1 protein expression of dechlorination product mixtures without PCB 77 
(treatments 4 and 6) and biphenyl (treatment 8) were not significantly different from 
control. The presence of PCB 77 in all treatment groups corresponded to significant 
increases in VCAM-1 protein expression above control levels.  These data suggest a 
complicated interplay between inflammatory parameters in response to PCB 77 
dechlorination product exposure.  Nevertheless, the presence of PCB 77 in the individual 
treatments markedly induced vascular inflammation.     
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3.B.5 Discussion 
PCBs are man-made chemicals that were used in hundreds of industrial and 
commercial applications244 and are byproducts of certain industries today232. Even 
though their mass production has been banned, PCBs are chemically stable, persistent 
environmental toxicants that can cause harmful health effects.  Remediation or 
detoxification of contaminated sites is difficult and expensive, and it is not clear to what 
extent these remediation processes have to occur before their disease potential is 
mitigated.  The present study was designed to test the hypothesis that dechlorination of 
coplanar PCB 77 diminishes its pro-inflammatory potential in vascular endothelial cells.  
This is an important issue because PCBs can damage vascular tissues and thus 
contribute to cardiovascular diseases such as atherosclerosis.  In fact, a recent study 
reported increased hospitalization rates for acute myocardial infarction and diabetes 
mellitus in populations residing near areas contaminated with persistent organic 
pollutants245; 246.  Furthermore, the administration of PCB 77 to male apolipoprotein E 
(ApoE) -/- mice has been shown to promote atherosclerosis247.   
The lining of blood vessels is protected by the endothelium, and endothelial cells 
play an active role in physiological processes such as regulation of vessel tone, blood 
coagulation, and vascular permeability.  Dysfunction of endothelial cells is a critical 
underlying cause of the initiation of cardiovascular diseases such as atherosclerosis. 
Coplanar PCBs are initiators of endothelial dysfunction and exert their toxicity through 
binding to the AhR. AhR target genes, including CYP1A1, are considered a source of 
oxidative stress in endothelial cells and subsequent vascular dysfunction248; 249.  We 
confirmed in the present study the oxidative stress potential of coplanar PCBs.  In fact, 
CYP1A1 induction was maximal in cells exposed to pure PCB 77 and remained elevated 
in all dechlorination mixtures that contained PCB 77, independent of its relative 
concentration.  When residual amounts of PCB 77 were excluded from the 
dechlorination mixtures, CYP1A1 induction was markedly reduced, suggesting that the 
presence of the parent coplanar PCB is necessary for maximal CYP1A1 expression.  
Furthermore, we have previously shown that coplanar PCBs 77, 126 and 169 increased 
expression of the CYP1A1 gene, oxidative stress (DCF fluorescence), and the DNA-
binding activity of NFкB20.  In the current study, oxidative stress and DNA-binding of 
NFкB decreased with increasing dechlorination.  In fact, when PCB 77 was completely 
dechlorinated to biphenyl, oxidative stress and NFкB levels approached control levels. 
70 
 
This suggests that effective dechlorination should be as complete as possible to avoid 
oxidative stress-mediated tissue toxicity.   
Oxidative stress-induced transcription factors such as NFкB, which regulate 
inflammatory cytokine and adhesion molecule production, play critical roles in the 
induction of inflammatory responses and subsequent atherosclerotic lesion formation.  
We have demonstrated previously that coplanar PCBs can cause endothelial cell 
dysfunction as determined by inflammatory markers, such as expression of inflammatory 
cytokines and adhesion molecules, i.e. MCP-1 and VCAM-1, respectively23; 56; 77. In our 
analysis of the dechlorination product mixtures, we found that inflammatory patterns of 
MCP-1 and VCAM-1 were similar to CYP1A1 patterns induced by pure PCB 77 and the 
dechlorination mixtures that contained residual PCB 77, suggesting that the parent 
compound is necessary for an endothelial inflammatory response.  The 10 h 
dechlorination byproducts also induced an MCP-1 and VCAM-1 response that was 
alleviated by further dechlorination. Again, as was found with CYP1A1, total 
dechlorination to biphenyl did not induce MCP-1 and VCAM-1 inflammatory parameters 
in our endothelial cell model system. 
The dechlorination process decreased the parent PCB 77 but contributed to 
various lower-chlorinated PCBs.  Furthermore, the ratio and proportion of these lower-
chlorinated PCBs changes with degree of dechlorination.  Even though their level of 
interaction with the AhR is not well characterized, lower-chlorinated PCBs may 
contribute to cellular dysfunction.  For example, PCB 15, which was found in relatively 
high concentrations in the dechlorination mixtures, can contribute to liver 
carcinogenesis250.  PCB 11, another common PCB in our dechlorination mixtures, 
recently has been discovered in relatively large amounts in commercial paint 
pigments232.  Furthermore, other lower chlorinated PCBs generated during 
dechlorination have been shown to be metabolically activated by electrophilic quinoid 
species, which can bind to DNA251.  Our data suggest that the temporary formation of 
lower chlorinated PCBs during dechlorination can contribute in part to induction of 
inflammatory parameters.  
In addition, the lipophilic nature of PCBs enables them to perturb membrane 
structures. We have evidence that membrane domains like caveolae are critically 
involved in endothelial inflammation induced by exposure to PCBs.  For example, PCB 
77 can accumulate in caveolae-rich fractions of endothelial cells83, and up-regulation of 
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endothelial MCP-1 by PCB 77 is caveolin-1-dependent23.  Evidence from our laboratory 
implicates caveolae as a regulatory platform involved in endothelial activation and 
inflammation by environmental contaminants (Figure 3.B.5). As a regulatory platform, 
caveolae facilitate the interaction of PCBs with the AhR, which in turn promotes the up-
regulation of CYP1A1, a phase I detoxifying enzyme. CYP1A1 metabolism of coplanar 
PCBs, like PCB 77, is inefficient, leading to protein uncoupling and release of 
superoxide, which promotes the formation of reactive oxygen species (ROS) in the cell18.  
The cell responds to this change in redox status by activating the transcription factor 
NFкB, which regulates enzymes and inflammatory parameters associated with 
endothelial dysfunction and cell injury such as MCP1 and VCAM1252.  Further studies 
are needed to understand whether caveolae have differential selectivity for various PCB 
species such as those present in dechlorination mixtures and to determine if the 
interaction of these congeners with caveolae has potential to induce endothelial cell 
dysfunction.   
In summary, our study provides evidence that dechlorination of highly chlorinated 
PCBs is beneficial for protecting the vasculature from oxidative stress-induced 
inflammation and subsequent pathologies like atherosclerosis. Highly chlorinated PCBs 
are persistent and cytotoxic and a significant risk factor to endothelial injury and 
associated vasculature pathologies.  The pro-inflammatory potential of the dechlorination 
mixtures that we observed appears to depend largely on the presence of the parent 
compound (e.g., PCB 77).  Clearly, cytotoxicity decreased relative to degree of 
dechlorination, and the final dechlorination product, biphenyl, was nontoxic in our 
endothelial cell model system.  More studies are needed to understand threshold 
concentrations of dechlorination mixtures that are required to prevent or mitigate 
compromised health associated with exposure to environmentally toxic chlorinated 
biphenyls.  (The data presented in Chapter 3.B were published21.) 
 
 
 
 
 
 
 
 
 
 
  Copyright © Bradley J. Newsome 2014
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Figure 3.B.1. Dechlorination of PCB 77 alters cellular oxidative stress.  Cells grown on 
chamber slides were treated with DMSO (vehicle control) or dechlorination products with 
a total concentration of 5 µM total concentrations and were incubated for 4 h. Cells were 
then treated with N,N'-(1,2-dihydroxyethylene) bisacrylamide, (DHE, in red) for 
superoxide detection. Slides were fixed with DAPI (in blue) for nuclear staining, (A) 
fluorescent images were recorded at 40X and (B) DHE fluorescence was quantified and 
normalized to DAPI.  
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Figure 3.B.2. Dechlorination of PCB 77 attenuates NFкB activation.  Cells were treated 
with vehicle control (DMSO), 0 h (PCB 77, 5 µM) 10 h, 24 h and 48 h dechlorination 
mixtures (5 µM), and incubated for 4 h. Both PCB 77 and dechlorination products (10 
and 24 h product treatments) significantly increased DNA binding of NFкB over DMSO 
and biphenyl (48 h treatment). Results are given as mean±SEM. Different statistical 
marker letters represent significant differences among treatment groups (determined by 
Pvalue≤0.05).  
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Figure 3.B.3. Dechlorination products alter CYP1A1 (A), MCP-1 (B) and VCAM-1 (C) 
mRNA expression. The presence of PCB 77 significantly up-regulated mRNA 
inflammatory markers in ECs; inflammation decreased with further dechlorination of the 
parent compound. Please see Table 3.B.2 for detailed treatment descriptions.  The 
vehicle, DMSO (treatment 1), was applied at 0.1%v/v for all treatments.  Treatments 
representing the dechlorination products at 0 h (treatment 2), 10 h (treatment 3), 24 h 
(treatment 5), and 48 h (treatment 8) are the same as those tested previously for NFкB, 
superoxide production and viability. Treatments 4 and 6 excluded PCB 77 while 
maintaining the representative concentrations of the dechlorination products found at 10 
h and 24 h, respectively.  In contrast, treatments 9 and 10 contained only PCB 77 at the 
concentrations found in the 10 h and 24 h mixtures, respectively.  Treatment 7 consisted 
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of the 24 h dechlorination mixture with the level of PCB 77 found in the 10 h mixture.  
Different statistical marker letters represent significant differences among treatment 
groups (determined by Pvalue≤0.05).  For example, in CYP1A1, treatment 2 (statistical 
marker “b”) is significantly different from treatment 1 (“a”) and treatment 4 (“c”).  
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Figure 3.B.4. Dechlorination mixtures alter CYP1A1 (A), MCP-1 (B) and VCAM-1 (C) 
protein expression.  The presence of PCB 77 significantly up-regulated protein 
inflammatory markers in ECs; inflammation decreased with further dechlorination of the 
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parent compound.  Treatments are the same as described in Figure 3.B.3 (please see 
Table 3.B.2 for detailed treatment descriptions). Statistical differences among treatment 
groups (determined by Pvalue≤0.05) are represented by marker letters, as stated 
previously.  
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Figure 3.B.5. PCB 77 increases ROS production and downstream cellular dysfunction. 
PCB 77 interacts with caveolae in the plasma membrane, is endocytosed into the cell, 
and interacts with the AhR and its chaperone ARNT (aryl hydrocarbon receptor nuclear 
translocater), leading to nuclear translocation, XRE (xenobiotic response element) 
binding and CYP1A1 up-regulation. CYP1A1 protein uncoupling occurs during PCB 77 
metabolism and leads to an increase in cellular ROS. NFкB is activated in response to 
the change in cellular redox status and translocates to the nucleus where it acts as a 
transcription factor to up-regulate adhesion molecules and cytokines.  
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Chapter 4. Nutritional modulation of environmental pollutant in vivo toxicity 
 
 4.1 Synopsis 
Superfund chemicals such as polychlorinated biphenyls pose a serious human 
health risk due to their environmental persistence and link to multiple diseases. Selective 
bioactive food components such as flavonoids have been shown to ameliorate PCB 
toxicity, but primarily in an in vitro setting. Here, we show that mice fed a green tea-
enriched diet and subsequently exposed to environmentally relevant doses of coplanar 
PCB exhibit decreased overall oxidative stress primarily due to the up-regulation of a 
battery of antioxidant enzymes. C57BL/6 mice were fed a low fat diet supplemented with 
green tea extract (GTE) for 12 weeks and exposed to 5 µmol PCB 126/kg mouse weight 
(1.63 mg/kg-day) on weeks 10, 11 and 12 (total body burden: 4.9 mg/kg). F2-Isoprostane 
and its metabolites, established markers of in vivo oxidative stress, measured in plasma 
via HPLC-MS/MS exhibited five-fold decreased levels in mice supplemented with GTE 
and subsequently exposed to PCB compared to animals on a control diet exposed to 
PCB. Livers were collected and harvested for both mRNA and protein analyses, and it 
was determined that many genes transcriptionally controlled by AhR and Nrf2 proteins 
were up-regulated in PCB-exposed mice fed the green tea supplemented diet. An 
increased induction of genes such as SOD1, GSR, NQO1 and GST, key antioxidant 
enzymes, in these mice (green tea plus PCB) may explain the observed decrease in 
overall oxidative stress. A diet supplemented with green tea allows for an efficient 
antioxidant response in the presence of PCB 126 which supports the emerging paradigm 
that healthful nutrition may be able to bolster and buffer a physiological system against 
the toxicities of environmental pollutants. 
 
4.2 Introduction 
The contamination of soil and groundwater aquifers by toxic chlorinated organic 
compounds at Superfund sites, e.g., polychlorinated biphenyls (PCBs) and 
trichloroethylene (TCE), is a pervasive environmental problem with serious public health 
consequences253. PCBs are persistent organic pollutants found in soil, air, and water, 
and a major source of human exposure to PCBs is dietary intake of contaminated 
foods254. Because PCBs are lipid soluble, they readily accumulate in human tissues, thus 
increasing human health concerns15. For example, the recent Aniston Community Health 
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Survey reported a significant correlation between PCB levels and risk of developing 
diabetes25, and circulating levels of PCBs have also been associated with cardiovascular 
disease risk255. Prenatal exposure to PCBs also may be associated with increased 
weight in children256. The liver is particularly vulnerable to PCB-induced toxicity because 
it is the primary organ associated with detoxification, and there is strong evidence from 
NHANES data that exposure to PCBs is associated with liver disease in humans257.   
There is evidence from cell culture and animal models that nutrition can modulate 
the toxicity of environmental pollutants258 and thus affect vulnerability to environmental 
insults and compromised health. For example, PCBs can act as diet-dependent 
obesogens when administered with a high-fat diet, and thus worsen nonalcoholic fatty 
liver disease259. We have previously shown that PCB exposure can modify lipid 
metabolism while dietary fat supplementation can ameliorate these negative effects260. 
For example, we have shown that PCB exposure increases neutral lipid staining in LDL-
R−/− mice fed a corn oil-enriched diet (i.e., a diet rich in omega-6 fatty acids), which 
could indicate increased inflammation, while inflammation was decreased in mice fed an 
olive oil-enriched diet. Omega-3 fatty acids derived from fish oil are protective and 
reduce PCB-induced toxicity in endothelial cells48; 70. Similarly, antioxidant nutrients such 
as dietary flavonoids can protect against endothelial cell damage mediated by these 
persistent organic pollutants60; 67. This is important since coplanar PCBs (e.g., PCB 126) 
exert their toxicity primarily through activation of the aryl hydrocarbon receptor (AhR) 
and subsequent uncoupling of cytochrome P450 1A1 (CYP1A1), which can be a source 
of oxidative stress261; 262.  
Mammalian cells are constantly exposed to endogenous and exogenous sources 
of free radicals which tip the cellular balance towards an overall oxidative stress 
condition.  To counteract the ubiquitous nature of reactive oxygen species (ROS), 
mammalian cells have evolved intricate and interrelated protein defenses that can work 
efficiently to limit the detrimental effects of these toxic molecules.  PCBs have been 
shown to cause oxidative stress primarily through a CYP1A1 uncoupling mediated 
mechanism3.  Production of superoxide and related ROS triggers an up-regulation of a 
battery of antioxidant enzymes such as superoxide dismutase (SOD), catalase, 
glutathione reductase (GSR), glutathione transferases (GST), thioredoxins (Trx) and 
thioredoxin reductases (TrxR)263; 264.  These proteins work in concert to either catalyze 
the transformation of ROS to benign molecules such as water and molecular oxygen or 
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to reactivate enzymes, usually by catalytic reductions (e.g. TrxR reduces oxidized Trx to 
its active form265).  Such an interconnected system requires the crosstalk of multiple 
regulatory pathways including the aryl hydrocarbon receptor (AhR) and nuclear factor 
(erythroid-derived 2)-like 2 (Nrf2) transcription factors, which work together to detoxify 
xenobiotics and to up-regulate the antioxidant response (see Figure 4.1). 
Upon activation via endogenous ligands, such as arachidonic acid metabolites, 
or xenobiotics, such as dioxin (TCDD) or coplanar PCB 126, the AhR translocates to the 
nucleus, binds consensus cis-acting sequences known as dioxin or xenobiotic response 
elements (DRE or XRE) and facilitates the up-regulation of multiple genes, especially 
those related to phase I detoxification (e.g. CYP1A1 and UDP-glucuronosyl S-
transferases)266.  Certain environmental toxicants with relatively long half-lives, such as 
TCDD and PCB 126, can promote sustained AhR activation resulting in chronic low 
levels of oxidative stress and inflammation248.  The Nrf2 pathway shares many target 
genes with AhR, but is generally regarded as a redox sensor, because its dissociation 
with inhibitory proteins (e.g. Keap1) and subsequent transactivation is promoted by ROS 
and electrophiles90.  Binding of Nrf2 to consensus antioxidant response elements (ARE) 
up-regulates a battery of protective genes including cytochrome P450s, GSTs and 
NAD(P)H dehydrogenase [quinone] 1 (NQO1)84.  Nrf2 is a critical mediator of oxidative 
stress and xenobiotic toxicity as evidenced by multiple studies involving Nrf2 KO mice267; 
268.  It appears that the interrelatedness of Nrf2 and AhR pathways is not a coincidental 
occurrence as recently intimate cross-talk between the two xenobiotic related proteins 
has been illustrated91.  In fact, AhR and Nrf2 promoter gene sequences contain binding 
sites for one another and in instances where either is absent (e.g., KO) a decreased 
protective response occurs92.  Importantly, bioactive nutrients such as tea catechins may 
work through both Nrf2- and AhR-mediated mechanisms to prevent toxicant-induced 
global inflammation60.   
We have demonstrated previously that the tea catechin epigallocatechin-3-
gallate (EGCG) can protect against vascular endothelial cell activation by coplanar 
PCBs60; 126, and that EGCG can inhibit expression of AhR-regulated genes and induce 
Nrf2-regulated antioxidant enzymes, thus providing protection against PCB-induced 
inflammatory responses in cultured endothelial cells60.  EGCG also can inhibit oxidative 
damage and attenuate carbon tetrachloride-induced hepatic fibrosis269.  Mechanisms 
responsible for EGCG-induced protection against environmental pollutants are not fully 
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understood.  In the current study we provide evidence that green tea extract, composed 
primarily of EGCG (Supplementary Table 4.1), can decrease oxidative stress in livers of 
mice exposed to PCB 126 by a mechanism that, at least in part, is due to induction of 
antioxidant genes. Thus, diet supplementation with green tea may allow for an efficient 
antioxidant response to buffer against toxicities of environmental pollutants in humans 
and protect against PCB-induced liver damage257.   
 
4.3 Materials and Methods 
4.3.1 Animals, diets, and dosing treatments 
Forty C57BL/6 mice were purchased from Jackson Laboratory (Bar Harbor, ME) 
at 2 months of age and evenly assigned to the following experimental groups: control 
diet (10% kcal as fat) + vehicle, control+1% green tea extract (GTE) + vehicle, control + 
PCB 126, control+1% GTE + PCB 126. The control diet was purchased from Research 
Diets, Inc. (New Brunswick, NJ, catalog number D12450B). Sunphenon 30S-O organic 
green tea extract (lot number: 105131, containing 37.4% total polyphenols, 32.0% total 
catechins, and 5.3% caffeine) was obtained from Taiyo International Inc. (Minneapolis, 
MN) and incorporated into the control diet formulation, as described in Supplementary 
Table 4.1. Green tea extract treatment amounts per body weight coincide with 
approximately 4 cups of tea (~200 ml/cup) per day in humans270. Mice were fed the 
control and GTE-supplemented diets for 12 weeks and were gavaged with PCB 126 (5 
µmol/kg mouse) or vehicle (stripped safflower oil; Acros Chemical Company, Pittsburgh, 
PA) in weeks 10, 11, and 12. The PCB 126 gavage concentration was chosen based on 
observations in preliminary studies where gavage of 5 µmol PCB 126/kg mouse weight 
(1.63 mg/kg-day, total body burden: 4.9 mg/kg) showed pro-inflammatory responses in 
C57/BL6 mice but not wasting syndrome.  
 
4.3.2 Blood and tissue harvesting 
 In this study, we examined the role that green tea extract catechins play in 
altering oxidative stress and inflammation following insult with environmental pollutants 
(i.e., PCB 126). 24 h after week 12 treatment, mice were euthanized with CO2 and 
quickly exsanguinated. Ethylenediaminetetraacetic acid (EDTA) was added to collected 
blood samples, briefly mixed, and centrifuged at 5000 g for 5 min at 4 °C to separate 
blood plasma. Plasma samples were frozen in liquid nitrogen and stored at -80 °C until 
processing. Livers were harvested, weighed, divided in half, and frozen in liquid nitrogen 
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for protein studies or stored in RNAlater solution (Life Technologies, Grand Island, NY) 
at 4 °C for 24 h then -80 °C prior to mRNA analysis.  
  
4.3.3 Plasma PCB and isoprostane analysis 
PCB 126 and its metabolites were extracted from plasma samples to determine 
systemic PCB and metabolite concentrations and correlate these findings to potential 
PCB-induced oxidative stress as well as the role of green tea extract in mitigating these 
effects. PCB 126 and its hydroxy metabolites were isolated from plasma samples (plus 
10 µM 13C12-labeled PCB 126 internal standard (IS), Cambridge Isotope Laboratories, 
Tewksbury, MA) through extraction with acetonitrile and subsequent sonication and 
centrifugation at 15,000 rpm for 5 min to pellet plasma debris. Supernatants were dried 
under N2 and reconstituted in 99:1 methanol:dI H2O solvent mixture with 0.5% formic 
acid and 0.1% 5 M ammonium formate. 
Measurement of F2-Isoprostanes (F2-IsoPs) provides one of the most reliable 
assessment methods for oxidative stress in vivo271. For F2-IsoP analysis, plasma 
samples were added to 5:1 ethyl acetate: methanol + 0.5% acetic acid (v/v) + 10 µM 8-
iso-PGF2α-D4 (internal standard, Cayman Chemical, Ann Arbor, MI), vortexed briefly, 
and centrifuged to pellet plasma debris. Supernatants were transferred and dried under 
N2 prior to reconstitution in methanol and addition of acetic acid for subsequent solid 
phase extraction (SPE).  
Reconstituted F2-IsoP samples were loaded onto pre-conditioned Supel-Select 
HLB SPE columns (Sigma-Aldrich, St. Louis, MO) and washed with 0.5% acetic acid 
followed by washing with 0.5% acetic acid containing 20% methanol. Columns were 
eluted with methanol, eluent was evaporated to dryness with N2, and samples were 
reconstituted with 50:50 methanol:dI H2O.  
Plasma PCB 126 and a hydroxy metabolite as well as extracted plasma F2-IsoPs 
were analyzed using a Shimadzu ultra fast liquid chromatography (UFLC) system 
coupled with an AB Sciex 4000-Qtrap hybrid linear ion trap quadrupole mass 
spectrometer in multiple reaction monitoring (MRM) mode. MRM transitions monitored: 
325.9/256.1, 325.9/254.1, and 325.9/184 for PCB 126; 338/268.1, 338/196.1, and 
338/265.7 for 13C12 PCB126. In the MRM ion transition, the precursor ion represents 
the M+· and the product ion represents either [M-Cl]+ or [M-2Cl]+. MRM transitions 
monitored with regard to hydroxy PCB metabolites: 340.8/340.9 for hydroxy PCB126 
86 
 
and 386.8/340.9 for dihydroxy PCB126. The precursor ion of the ion transition is a formic 
acid adduct: [M+FA-H]- and product ion is [M-H]-. F2-IsoP were analyzed by integrating 
peak area (area under the curve, AUC) with regard to known internal standard 
concentrations (AUC/IS). All values were subsequently normalized for sample volume 
and compared to ion transitions of internal standard (13C12 PCB 126) with known 
concentration to determine PCB parent and metabolite concentrations (pmol/µL plasma). 
 
4.3.4 RNA isolation and polymerase chain reaction (PCR) amplification 
Liver samples used to analyze oxidative stress and inflammatory mRNA markers 
were homogenized and mRNA was isolated with TRIzol reagent (Invitrogen, Carlsbad, 
CA) according to the manufacturer’s protocol. mRNA concentrations were then 
determined using a NanoDrop 2000 spectrophotometer (Thermo Scientific, Waltham, 
MA). Reverse transcription was performed using the AMV reverse transcription system 
(Promega, Madison, MI). mRNA levels were determined by quantitative real-time PCR 
using a 7300 Real-Time PCR system (Applied Biosystems, Foster City, CA) and SYBR 
Green master mix (Applied Biosystems) as compared to constitutively expressed β-actin 
(forward primer: 5’-TGTCCACCTTCCAGCAGATGT-3’; reverse primer: 5’-
GCTCAGTAACAGTCCGCCTAGAA-3’) using the relative quantification method (ΔΔCt). 
Primer sequences (see Table 4.1) for SYBR Green reactions were designed using the 
Primer Express Software 3.0 for real-time PCR (Applied Biosystems) and synthesized by 
Integrated DNA Technologies, Inc. (Coralville, IA). 
 
4.3.5 Immunoblotting  
Liver samples used for protein analysis were homogenized in extraction RIPA 
buffer containing protease inhibitors (Pierce, Rockford, IL). Lysed tissue was centrifuged 
at 10,000 g for 30 min at 4 ºC followed by Bradford protein assay (Pierce). Protein 
samples were separated using 10% SDS-PAGE and subsequently were transferred onto 
nitrocellulose membranes. Membranes were blocked with 5% non-fat milk buffer and 
incubated overnight at 4 ºC with the following primary antibodies: β-actin (product 
#A2066, ~42 kD, Sigma, St. Louis, MO), GAPDH (product #sc-20357, ~37 kD, Santa 
Cruz Biotechnology, Dallas, TX), GSR (product #ab16801, ~58 kD, Abcam, Cambridge, 
MA), and NQO1 (product #ab34173, ~31 kD, Abcam). After washing, membranes were 
incubated with secondary antibodies conjugated with horseradish peroxidase and 
visualized using ECL detection reagents (Thermo, Waltham, MA). 
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Liver samples used for nuclear translocation assays were prepared and 
cytoplasmic and nuclear proteins were extracted according to manufacturer protocol 
(NE-PER® Nuclear and Cytoplasmic Extraction Method, Thermo). Translocation 
samples subsequently were processed for Western blotting as described above, and 
probed with the following primary antibodies:  lamin (product #sc-7292, ~69 kD, Santa 
Cruz Biotechnology) and Nrf2 (product #sc-722, ~59 kD, Santa Cruz Biotechnology).   
 
4.3.6 Data analyses 
Data were analyzed using SigmaStat software (Systat Software, Point Richmond, 
CA). Comparisons between treatments were made by one-way or two-way ANOVA with 
post-hoc comparisons of the means. Overall, few statistical differences were exhibited 
between vehicle control diet groups, thus in most cases Student’s t-test was used to 
analyze differences between PCB treatment groups. qRT-PCR mRNA analysis (n=8-10), 
Western blot protein analysis (n=8), and nuclear translocation analysis (n=4) represent 
three experimental replicates. A probability value of p≤0.05 was considered statistically 
significant. 
 
4.4 Results 
4.4.1 Systemic toxicity associated with PCBs 
PCB 126 levels in mouse plasma were examined as a measure of systemic PCB 
body burden and to determine the possible effect of green tea extract (GTE) diet 
supplementation on PCB metabolism/excretion. As seen in Figure 4.2, plasma PCB 126 
was found almost completely as its hydroxylated metabolite, OH-PCB 126, with 
concentrations of approx. 0.04 pmol PCB 126/µL plasma versus approx. 30 pmol OH-
PCB 126/µL, respectively. GTE diet supplementation did not modulate PCB metabolism 
or plasma concentrations 24 h following PCB exposure, indicating that it plays a minimal 
role in pollutant clearance from the body. Additionally, Supplementary Figure 4.1 shows 
that while PCB treatment led to a significant increase in liver/body weight ratio 
(hepatosomatic index, p<0.001), in both control and GTE-supplemented diets, GTE 
supplementation did not significantly mitigate this PCB-induced increase.  
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4.4.2 F2-isoprostane levels are significantly reduced in green tea extract-
supplemented, PCB-exposed mice 
Analysis of F2-isoprostanes (F2-IsoPs), prostaglandin-like eicosanoids formed 
during fatty acid peroxidation, has emerged as the most reliable method for assessing in 
vivo oxidative stress271. Plasma samples from mice fed control and GTE-supplemented 
diets and subsequently treated with vehicle or PCB 126 (n=8-10) were analyzed to 
determine GTE’s role in modulating environmental toxicant-induced oxidative stress. 
Plasma F2-IsoP (including PGF2α, 8-iso-PGF2α, iPF2α-III, 8-epiPGF2α, 8-isoprostane, 
and 15-F2t isoprostanes) and F2-IsoP metabolite (13,14-dihydro-15-ketoPGF2α) 
concentrations were determined. As seen in Figure 4.3, GTE diet supplementation led to 
drastically decreased F2-IsoP levels (approximately a five-fold reduction, p<0.05) in mice 
treated with PCB 126, indicating that GTE acts as a strong antioxidant to modulate 
against environmental toxicant insult. Additionally, GTE drastically decreased PCB-
induced F2-IsoP metabolite production (greater than a five-fold reduction, p<0.05); F2-
IsoP metabolite analysis is developing as an even more sensitive measure of in vivo 
oxidative stress because the metabolites do not undergo autoxidation and artificial 
production as has been seen with parent F2-IsoP272. Interestingly, GTE supplementation 
led to no significant modulation of F2-IsoP parent or metabolite levels under control 
situations, indicating that antioxidant modulation occurs primarily when a system is 
under a secondary stressor. 
 
4.4.3 Green tea extract increases antioxidant gene expression   
Antioxidant enzyme levels were measured in mouse liver to further develop the 
role of GTE diet supplementation in modulating environmental insults in vivo. Table 4.2 
highlights antioxidant mRNA markers tested and overall results. qRT-PCR analysis (n=8-
10) shows a significant up-regulation in catalase, glutathione peroxidase (Gpx3), 
glutaredoxin (Grx2), glutathione reductase (GSR), glutathione S-transferases (GSTa1, 
GSTa4, GSTm1, GSTm2, and GSTm3), NAD(P)H dehydrogenase [quinone] 1 (NQO1), 
superoxide dismutase 1 (SOD1), thioredoxin 2 (Trx2), and thioredoxin reductase 1 
(TrxR1) during the concomitant treatment of PCB 126 and GTE diet supplementation.  
As before, in most cases GTE supplementation did not significantly modulate antioxidant 
response in the absence of PCBs. NQO1 and GSTm3, enzymes associated with 
detoxification, exhibited significantly increased mRNA levels above vehicle control diet 
levels in the presence of PCB 126, while GTE diet supplementation drastically induced 
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antioxidant mRNA expression following PCB insult. mRNA levels of SOD1, critical for 
modulating harmful superoxide radicals produced during toxicant insult, were 
significantly decreased following PCB gavage, while GTE supplementation returned 
mRNA expression to vehicle control diet levels. While PCB administration did not 
modulate GSR (an important cellular antioxidant) mRNA levels in mice fed vehicle 
control diets, GTE diet supplementation led to a significantly increased antioxidant 
response (see Figure 4.4, p<0.01). Additional data shown in Supplementary Figure 4.2 
is also consistent with these trends observed in response to GTE supplementation. For 
example, thioredoxin 2 (Trx2, an important redox protein) mRNA levels are significantly 
up-regulated in the concomitant presence of GTE and PCB 126 although GTE does not 
induce increased antioxidant activity without the addition of secondary external insult.  
 
4.4.4 Green tea extract increases NQO1 and GSR antioxidant protein response 
against PCB 126 
Antioxidant marker protein analysis was performed in order to better understand 
the role that GTE diet supplementation plays in increasing the body’s defensive 
mechanisms against toxicant insult. Proteins of interest were normalized to multiple 
housekeeping genes, β-actin and GAPDH. In PCB 126-treated mouse liver samples, 
NQO1 protein was significantly up-regulated when fed a GTE supplemented diet, as 
shown in Figure 4.5 when quantified against GAPDH (p<0.01). The associated 
representative blot continues trends seen in mRNA with a large increase in antioxidant 
protein activity in GTE supplemented mice exposed to PCB insult. GSR protein 
expression was also statistically increased in response to diet supplementation and 
continues the trend seen in mRNA analysis in which neither GTE supplementation nor 
PCB treatment led to modulation of antioxidant response while their concomitant 
treatment led to significant up-regulation (p≤0.05). 
 
4.4.5 Green tea extract drives Nrf2 nuclear translocation in the presence of PCB 
126 
Nuclear translocation assays are commonly used techniques that serve as a 
representation of cellular transcriptional activation. Nuclear factor (erythroid-derived 2)-
like 2 (Nrf2) nuclear translocation was analyzed in comparison to lamin, a nuclear 
fraction housekeeping gene; liver samples from GTE-supplemented mice exposed to 
PCB 126 showed a trend toward increased nuclear abundance of Nrf2 (p=0.1, n=4). As 
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in antioxidant mRNA and protein studies, GTE without a concomitant insult from PCB did 
not modulate Nrf2 activity and translocation. The Nrf2 antioxidant pathway plays a 
pivotal role in modulating oxidative stress, and therefore its up-regulation by GTE diet 
supplementation, as seen in Figure 4.6, is an important indicator of GTE’s ability to 
increase the body’s responsiveness toward environmental stressors. 
 
4.4.6 Green tea extract modulates inflammatory and xenobiotic-related markers in 
the presence of PCB 126  
Cytochrome P450 (e.g., CYP1A1 and CYP1B1), a family of enzymes controlled 
by the aryl hydrocarbon receptor (AhR) and Nrf2 proteins that are vital for the 
metabolism of xenobiotic substances, including toxicants, was analyzed from liver 
samples to determine potential modulation of its activity in response to GTE diet 
supplementation. Substantial CYP up-regulation was seen in the presence of PCB insult, 
as has been shown previously67, while concurrent GTE supplementation causes a 
significant up-regulation in CYP1B1 mRNA analysis (as seen in Figure 4.7). In mice fed 
GTE-supplemented diets and exposed to PCB, major indicators of inflammation 
including monocyte chemoattractant protein-1 (MCP-1, also referred to as chemokine 
(C-C motif) ligand 2, CCL2) and CCL3 (also referred to as macrophage inflammatory 
protein-1α, MIP-1α) were significantly decreased back to vehicle control levels. 
Interestingly, GTE supplementation alone led to significant increases in inflammatory 
marker mRNA levels, although these levels returned to vehicle control levels with 
concomitant treatment (p<0.05).    
 
4.4.7 The AhR is implicated as a control mechanism both in PCB 126 toxicity and 
antioxidant response   
As seen in Figure 4.8, GTE diet supplementation led to significant up-regulation 
of AhR mRNA levels in liver in the presence of PCB 126, a dioxin-like AhR ligand. PCB 
126 insult did not induce AhR mRNA in vehicle control, vehicle + GTE control, and PCB 
control settings, but, interestingly, concomitant treatment led to a two-fold up-regulation, 
similarly to that seen in mRNA and protein antioxidant and inflammatory markers, thus 
allowing for increased in vivo toxicant clearance (p<0.01). Nrf2 mRNA levels were also 
significantly increased during PCB 126 insult, although GTE supplementation did not 
cause significant modulation of PCB toxicity. AhR and Nrf2 signaling pathways control 
both xenobiotic responses and inflammatory cascades, therefore their modulation by 
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GTE diet supplementation implicates further GTE’s role in strengthening antioxidant 
response toward insult by environmental pollutants.  
 
4.5 Discussion 
 Healthy nutrition can positively influence, or lessen, the human health risks 
associated with exposure to mixtures of environmental chemicals273.  The liver is one 
tissue particularly vulnerable to environmental pollutants, and especially PCB-induced 
toxicity257.  One type of liver disease that affects more than 20% of Americans is 
nonalcoholic fatty liver disease, which can lead to nonalcoholic steatohepatitis274.  
Industrial toxicants also have been linked to secondary insults that can lead to 
steatohepatitis274. Our laboratory and others have shown that PCB exposure increases 
liver/body weight ratio (hepatosomatic index, HSI; see Supplementary Figure 4.1), which 
is generally accepted as indicative of an adverse hepatic response to chemical 
exposure275. Mechanisms defining the involvement of environmental pollutants in the 
pathology of liver diseases may include a compromised redox status or toxicant-induced 
increase in oxidative stress.   
 Lifestyle modifications that include healthful nutrition have been suggested as a 
powerful means of reducing the vulnerability to environmental insults273 and in reducing 
the risk to environmental toxicant-induced liver disease274. For example, green tea 
extract has been shown to protect against hepatic steatosis in obese mice by reducing 
oxidative stress and enhancing hepatic antioxidant defenses276; 277. In the present study 
we observed significant protection against PCB 126-induced oxidative stress by dietary 
supplementation with green tea extract. In fact, mice supplemented with green tea 
extract and subsequently exposed to PCB displayed a decrease in overall F2-
isoprostane and metabolite levels compared to animals on a control diet exposed to 
PCB. We did not see a large increase in oxidative stress as evidenced by an increase in 
F2-isoprostane levels in mice fed a control diet and subsequently gavaged with PCB.  
This may have been due to the fact that the amount of administered PCB 126 reflects 
more relevant environmental PCB exposure concentrations in humans than previous 
studies using high concentrations of PCB congeners (e.g., 150 µmol/kg in previous 
studies versus 5 µmol/kg used herein)278; 279. We hypothesize that levels of PCBs 
encountered by humans today initiate low levels of chronic oxidative stress and 
inflammation that, together with multiple other factors including poor diet and exposures 
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to other environmental stressors, leads to augmented or exacerbated human disease. 
The protective properties of green tea have been studied extensively, and recent human 
studies suggest that consumption of green tea may protect against cardiovascular 
disease and some forms of cancer, have anti-hypertensive and anti-obesity effects, and 
contribute to antibacterial and antiviral activity280. 
 Certain environmental pollutants, and in particular ligands for the AhR, induce 
oxidative stress, in part via induction and uncoupling of cytochrome P450 enzymes18. 
Hepatic changes in lipid composition, altered membrane structure and membrane 
functions are well-described phenomena of PCB-induced liver damage281-284. The 
protective properties of green tea extracts against PCB-induced pathologies, and in 
particular liver damage, may be numerous. For example, green tea may normalize the 
formation of lipid peroxide products induced by exposure to toxicants to prevent hepatic 
fibrosis269, or green tea may favorably regulate intestinal tight junction proteins or overall 
intestinal barrier function285. It has been proposed that green tea can inhibit the intestinal 
absorption of lipids and highly lipophilic organic compounds99; 100. Induction of antioxidant 
enzymes by green tea also may contribute to its tissue protective properties286. Our 
current study supports this concept, and we observed an increased induction of 
antioxidant genes such as SOD1, GSR, NQO1 and GST in mice that were fed a green 
tea-supplemented diet and subsequently challenged with PCB, compared to animals 
exposed to the control diet plus PCB. This may explain in part the observed decrease in 
overall oxidative stress due to green tea supplementation. Of particular interest is our 
observed induction of NQO1, a Nrf2 target gene, which suggests that green tea protects 
in part by modulation of the Nrf2/ARE pathway. In fact, it has been shown that food 
polyphenols, including the green tea polyphenol EGCG, the primary component of GTE 
tested herein, can modulate Nrf2-mediated antioxidant and detoxifying enzyme 
induction287; 288. Our own work with vascular endothelial cells further suggests that 
multiple pathways including lipid raft caveolae and the antioxidant defense controller 
Nrf2 play a role in nutritional modulation of PCB-induced vascular toxicity3 and that 
cross-talk between caveolae-related proteins and cellular Nrf2 may be required for 
optimal cytoprotection by green tea catechins and other diet-derived polyphenols. 
 Many groups, including ours, have shown that green tea catechins such as 
EGCG can up-regulate basal levels of antioxidant enzymes in vitro71; 280; 289. Interestingly, 
our overall results show that green tea extract supplemented in the diet acts as an 
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antioxidant only in the presence of a secondary stressor, in this case, the pro-
inflammatory coplanar PCB 126. The inconsistencies between in vitro and in vivo studies 
may be explained by the relatively high doses of tea catechins usually employed in cell 
culture or the fact that most tea catechins are quickly biotransformed in vivo to 
metabolites that exhibit differential physiological effects286.  There are many other 
examples of instances where supplementation with GTE or specific catechins is 
protective in in vivo models of inflammation and oxidative stress. For many of our 
investigated antioxidant enzymes we saw decreased expression in the presence of PCB 
when fed a control diet, but levels were up-regulated, many returning to control vehicle 
levels in PCB groups fed a GTE-rich diet (e.g., SOD1 in Figure 4.4). These observations 
are in line with other groups who investigated GTE effects on other stressors including 
ethanol toxicity and bacterial infection290; 291. 
 Our past work in cell culture points to the antioxidant controller Nrf2 as a major 
player in nutritional modulation of PCB toxicity. Many nutrients other than green tea 
catechins, including resveratrol, found in the skins of grapes, and sulforaphane, which is 
found in broccoli, have been shown to activate Nrf274; 87; 88; 290; 291. Nrf2 can become 
transcriptionally active through multiple mechanisms including direct phosphorylation by 
PKC delta and loss of contact between Nrf2 and inhibitory kelch-like ECH-associated 
protein 1 (Keap1)89. Upon activation, Nrf2 is able to evade ubiquitination, enter the 
nucleus, and bind cis-acting antioxidant response elements in target genes such as 
NQO190. Nrf2 activation leads to decreased overall oxidative stress and inflammation, 
which is a hallmark of PCB toxicity86. In this work we observed a relatively significant 
trend toward increased NRF2 translocation to the nucleus in animals supplemented with 
GTE and subsequently exposed to PCB (Figure 4.6). More interestingly and novel, we 
also saw a drastic increase in AhR mRNA expression in this same treatment group 
(Figure 4.8). This up-regulation was mirrored in increases in both CYP1A1 and CYP1B1 
mRNA levels in mice fed a GTE rich diet and subsequently exposed to PCB. An 
increase in AhR may help to detoxify the acute exposure to PCB by increasing 
metabolism-assisted excretion. Although a consistent, steady up-regulation of AhR may 
create a negatively imbalanced redox situation, the GTE’s ability to up-regulate AhR only 
in the presence of a toxicant may in some cases be a protective and positive 
mechanism. Other groups have shown that different catechins within GTE display either 
antagonistic or agonist activities against CYP1A1292, but to our knowledge no group has 
reported the mRNA up-regulation as seen in Figure 4.7. In our analysis of PCB 
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concentrations in plasma we observed a very slight trend towards decreased levels of 
parent PCB 126 in the plasma of mice supplemented with GTE (Figure 4.2). Although 
plasma levels may be a good overall picture of body-burden of PCBs, in the future, 
collecting urine and feces may paint a clearer picture of GTE’s involvement with 
detoxification and excretion. Also, we may have been able to see a more significant 
decrease in PCB levels and or a modulation of PCB hydroxy metabolite in mice 
supplemented with GTE if we sacrificed the mice more than 24 hours after the final PCB 
dose99.       
 PCBs can induce vascular inflammation by up-regulating pro-inflammatory 
mediators such as MCP-1 and CCL3. We hypothesized that GTE would down-regulate 
basal levels of these inflammatory markers in vehicle treated mice as well as decrease 
PCB-mediated up-regulation in PCB 126 treated mice. Interestingly however, for both of 
our inflammatory markers we saw a significant increase in mRNA levels in vehicle 
treated mice supplemented with GTE (Figure 4.7).  This observation would suggest that 
the dose of GTE used in this study may not be optimal, and perhaps toxic to some 
degree, in basal levels of oxidative stress and inflammation. Other groups have shown 
GTE toxicities at certain doses in vivo293; 294, and interestingly, data illustrating protection 
seems to be more conclusive in animal models of oxidative stress and inflammation.  
Importantly, for our study, both MCP-1 and CCL3 mRNA levels return to vehicle treated 
control diet levels in mice fed GTE and subsequently exposed to PCB. This may point to 
GTE as exhibiting possible hormetic activity by inducing a slight response by the 
organism that ultimately primes the protective antioxidant system for a future stressor, 
i.e., Superfund pollutant exposure. Understanding hormesis and the role that nutrients 
can play is an extremely interesting scientific discipline and demands much more future 
investigation295.            
In summary, our current study supports our in vitro data that green tea catechins 
can protect against PCB 126-induced cytotoxicity by reducing oxidative stress60. Our 
current in vivo data contributes to the overall hypothesis that nutrition can modulate 
environmental insults. More studies are needed to further understand detailed 
mechanisms of protective benefits to consume diets high in protective and healthful 
nutrients such as plant-derived polyphenols and other bioactive compounds. (The data 
presented in Chapter 4 were published98.) 
   
Copyright © Bradley J. Newsome 2014 
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Table 4.1
Primers used for qRT-PCR
Gene name Forward primer 5'-3' Reverse primer 5'-3' Fragment size
Inflammatory and xenobiotic-related markers
AhR GACCAAACACAAGCTAGACTTCACACC CAAGAAGCCGGAAAACTGTCATGC 200 bp
CCL3 CACCCTCTGTCACCTGCTCAA TGGCGCTGAGAAGACTTGGT 100 bp
CYP1A1 TGGAGCTTCCCCGATCCT CATACATGGAAGGCATGATCTAGGT 100 bp
CYP1B1 TGCATCGGTGAGGAACTGTCT CTCATGTTTGAGGACTCATTTTGG 104 bp
MCP-1 GCAGTTAACGCCCCACTCA CCTACTCATTGGGATCATCTTGCT 63 bp
Nrf2 GAGTCGCTTGCCCTGGATATC TCATGGCTGCCTCCAGAGAA 100 bp
Antioxidant markers
Catalase CAGAGAGCGGATTCCTGAGAGA CTTTGCCTTGGAGTATCTGGTGAT 100 bp
Gpx2 GTGGCGTCACTCTGAGGAACA CAGTTCTCCTGATGTCCGAACTG 125 bp
Gpx3 CATACCGGTTATGCGCTGGTA CCTGCCGCCTCATGTAAGAC 80 bp
Grx2 CATCCTGCTCTTACTGTTCCATGGCCAA TCATCTTGTGAAGCGCATCTTGAAACTGG 123 bp
GSR TCGGAATTCATGCACGATCA GGCTCACATAGGCATCCCTTT 100 bp
GSTa1 AAGCCCGTGCTTCACTACTTC GGGCACTTGGTCAAACATCAAA 159 bp
GSTa4 TACCTCGCTGCCAAGTACAAC GAGCCACGGCAATCATCATCA 109 bp
GSTm1 ATACTGGGATACTGGAACGTCC AGTCAGGGTTGTAACAGAGCAT 349 bp
GSTm2 ACACCCGCATACAGTTGGC TGCTTGCCCAGAAACTCAGAG 118 bp
GSTm3 CCCCAACTTTGACCGAAGC GGTGTCCATAACTTGGTTCTCCA 208 bp
NQO1 GGCATCCAGTCCTCCATCAA GTTAGTCCCTCGGCCATTGTT 100 bp
SOD1 GAAACAAGATGACTTGGGCAAAG TTACTGCGCAATCCCAATCA 100 bp
Trx2 GCTAGAGAAGATGGTCGCCAAGCAGCA TCCTCGTCCTTGATCCCCACAAACTTG 168 bp
TrxR1 GGCCAAAATCGGTGAACACATGGAAG CGCCAGCAACACTGTGTTAAATTCGCCCT 175 bp
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Table 4.2
5 µmol PCB 126/kg mouse (fold change)
Control diet Control + 1% GTE p-value
Inflammatory and xenobiotic-related markers
AhR 0.771±0.096 1.506±0.131 <0.001
CCL3 2.051±0.224 0.945±0.116 <0.001
CYP1A1 915.208±136.510 1169.338±78.900 N.S.
CYP1B1 87.504±7.694 146.998±12.329 <0.001
MCP-1 1.909±0.478 0.745±0.235 0.012
Nrf2 3.088±0.307 3.212±0.234 N.S.
Antioxidant markers
Catalase 0.495±0.057 0.817±0.071 0.003
Gpx2 0.339±0.161 0.682±0.098 0.08
Gpx3 0.925±0.167 1.411±0.159 0.004
Grx2 0.213±0.015 0.486±0.078 0.003
GSR 0.702±0.074 1.245±0.097 0.001
GSTa1 14.771±2.911 22.955±3.975 0.034
GSTa4 0.896±0.117 2.222±0.245 <0.001
GSTm1 2.306±0.450 4.024±0.301 0.006
GSTm2 0.868±0.097 1.366±0.114 0.004
GSTm3 4.469±0.664 18.596±1.819 <0.001
NQO1 1.980±0.051 6.138±0.031 0.006
SOD1 0.311±0.041 0.684±0.063 <0.001
Trx2 0.731±0.050 1.556±0.152 <0.001
TrxR1 1.522±0.143 2.673±0.276 0.002
Gene name
The effect of green tea extract (GTE) diet supplementation on 
PCB 126-induced mRNA Inflammatory, xenobiotic-related and 
antioxidant markers
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Figure 4.1. Proposed signaling pathway for PCB detoxification in vivo. PCB 126, an 
AHR ligand and activator of NRF2, causes CYP1A1 up-regulation, which leads to 
superoxide production. Green tea extract (GTE) diet supplementation effectively up-
regulates redox-related enzymes in the presence of PCB 126 which allows for a more 
efficient antioxidant response to environmental insult. 
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Figure 4.2. The effect of green tea extract (GTE) diet supplementation on systemic PCB 
126 concentration and metabolism. PCB 126 and its hydroxy metabolites were 
measured in mouse plasma by UFLC/MS MS and normalized to sample volume and 
internal standard recovery. PCB 126 is heavily metabolized in vivo, as seen by very low 
levels of parent PCB 126 remaining in plasma samples while its hydroxylated 
metabolites predominate. GTE supplementation did not significantly modulate systemic 
PCB or metabolite concentrations. Data are presented as mean±S.E.M (n=5). 
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Figure 4.3. PCB 126-induced oxidative stress is modulated by green tea extract (GTE) 
diet supplementation. Plasma F2-isoprostane (A) and metabolite (B) levels were 
measured by HPLC/MS MS to assess in vivo oxidative stress induced by PCB 126 that 
is potentially mitigated by GTE supplementation. Relative levels of combined F-2 IsoPs, 
including PGF2α, 8-iso-PGF2α, iPF2α-III, 8-epiPGF2α, 8-isoprostane, and 15-F2t 
isoprostanes, were determined by averaging the AUC integration values from retention 
times of 8 and 11.3 minutes (Q1 = 353.144, Q2 =193.1). Additionally, the level of 13,14-
dihydro-15-ketoPGF2α, an F-2 IsoP metabolite, was determined by integrating its peak 
at 11.3 minutes (Q1 = 355.2, Q2 = 311.4). Data are presented as mean±S.E.M. (n=8-
10). GTE supplementation significantly decreased oxidative stress induced by PCB 126 
treatment (*p<0.05).  
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Figure 4.4. Relative mRNA levels of representative antioxidant enzyme markers, NQO1 
(A), GSTm3 (B), SOD1 (C) and GSR (D) in mouse liver samples. Overall GTE 
supplementation did not significantly increase antioxidant mRNA levels in control diets, 
but, in the presence of environmental perturbation (i.e. PCB 126 gavage), significantly 
higher antioxidant levels were seen in mouse liver above non-supplemented diet. All 
values were determined using the relative quantification method (ΔΔCt) as a fold change 
from control. Data are presented as mean±S.E.M (*p<0.01, n=8-10). See Table 4.2 and 
Supplementary Figure 4.1 for more information concerning all antioxidant markers 
tested.  
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Figure 4.5. GTE supplementation leads to increased antioxidant protein expression in 
the presence of PCB 126. Protein expression of NQO1 (A) and GSR (B) in mouse liver 
samples was assessed by Western blot analysis. Protein samples were separated 
through gel electrophoresis and probed with NQO1 and GSR primary antioxidant-related 
antibodies. Statistically significant increases in antioxidant protein activity were seen in 
PCB 126-treated mice that were fed a GTE-supplemented diet. In addition to visualized 
Western blot comparison to β-actin housekeeping gene, samples were compared to 
GAPDH housekeeping gene for densitometry quantification to further substantiate 
findings. GTE supplemented mice exposed to PCB showed a significant increase in 
protein expression, indicating a strengthened antioxidant response due to GTE 
supplementation (*p<0.01,**p≤0.05, N=8).  
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Figure 4.6. Nuclear translocation of Nrf2 in mouse liver samples. Mice fed a 1% GTE-
supplemented diet and subsequently exposed to PCB 126 displayed increased Nrf2 
activation, as evidenced by increased Nrf2 translocation to the nucleus, compared to 
mice fed 10% fat control diet and exposed to PCB. Lamin was used as a nuclear fraction 
housekeeping gene for densitometry quantifications. GTE supplemented mice exposed 
to PCB showed a trend toward increased nuclear abundance of Nrf2 (*p=0.1, n=4).    
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Figure 4.7. Relative mRNA levels of inflammatory and xenobiotic-related markers, 
Cyp1A1 (A), Cyp1B1 (B), MCP-1 (C) and CCL3 (D) in mouse liver samples. GTE 
supplementation led to increased cytochrome P450 (CYP1A1 and CYP1B1) mRNA 
expression in the presence of both GTE and environmental toxicant (i.e., PCB 126), 
indicating increased activity for toxicant degradation and/or excretion. MCP-1 and CCL3 
inflammatory markers were statistically increased in GTE-supplemented mice liver 
samples but toxicant-induced inflammatory markers returned to control levels due to 
GTE supplementation. All values were determined using the relative quantification 
method (ΔΔCt) as a fold change from control. Data are presented as mean±S.E.M. 
(*p<0.01, **p<0.05, n=8-10).   
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Figure 4.8. mRNA expression for AhR (A) and Nrf2 (B) genes in mouse liver samples. 
GTE diet supplementation leads to significant up-regulation of AhR mRNA levels in the 
presence of PCB 126, thus increasing in vivo toxicant clearance. Nrf2 mRNA levels are 
significantly increased during PCB 126 insult, although GTE supplementation does not 
cause statistically significant modulation of PCB toxicity. All values were determined 
using the relative quantification method (ΔΔCt) as a fold change from control. Data are 
presented as mean±S.E.M (n=8-10). GTE supplementation significantly increased AhR 
in the presence of PCB 126 treatment (*p<0.01).  
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Chapter 5. Conclusions 
 
5.1 Overall outcomes 
 In conclusion, we have demonstrated that aluminum oxide nanoparticles can be 
effectively stabilized under biologically relevant conditions by optimizing charge 
stabilization based on buffer characteristics and pH, and by tailoring ultrasonic sheer to 
initially disperse aggregated particles as single nanoparticles or small agglomerates.  
Citrate buffer, pH 6.0, with high sheer probe ultrasonication produces alumina 
nanoparticle suspensions in the nanosize regime (below 100 nm) that are stable for 
extended periods of time in buffer or when added to relevant biological media for 
eventual in vitro toxicity studies. 
  Nanotoxicology studies were performed to study potential concerns associated 
with increased nanoparticle usage in industrial and biomedical settings.  Titanium 
dioxide nanoparticles, another highly relevant metal oxide particle system used heavily 
in industrial and commercial applications, were tested to determine overall in vitro effects 
in vascular endothelial cells and to further understand the cellular signaling pathways 
involved in TiO2-linked oxidative stress and inflammation. TiO2 NP exposure was shown 
to increase cellular oxidative stress and DNA binding of NFκB, significantly increase 
induction of mRNA and protein levels of VCAM-1 and MCP-1 inflammatory markers, and 
increase phosphorylation of key signaling pathways linked to NFκB activation and 
subsequent inflammation. These data indicate that TiO2 NPs can induce endothelial 
inflammatory responses via redox-sensitive cellular signaling pathways. 
 The toxicity of PCB 77, a coplanar persistent environmental pollutant that exhibits 
dioxin-like toxicity, was studied at various stages of iron/palladium nanoparticle-induced 
dechlorination to determine the effectiveness of PCB degradation for decreasing 
associated public health risk. Although complete PCB 77 degradation to biphenyl was 
shown to eliminate PCB-induced endothelial dysfunction, degradation product mixtures 
showed significant in vitro toxicity in vascular endothelial cell systems in the presence of 
any concentration of parent PCB 77.  As the concentration of parent PCB 77 decreased 
with increased remediation duration, though, cellular viability improved and superoxide 
production decreased, as did NFκB activation and mRNA and protein inflammatory 
marker expression. These data implicate PCB dechlorination as a beneficial tool for 
decreasing biological toxicity to the vascular endothelium.     
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 Nutrient polyphenol-functionalized nanomaterials were developed to address the 
need for efficient, environmentally friendly POP remediation. Capitalizing on the 
previously determined binding affinity of PCBs to aromatic polyphenols, quercetin and 
curcumin multiacrylates were synthesized and were both surface functionalized onto 
magnetic iron oxide nanoparticles and incorporated into magnetic nanocomposite 
microparticle systems. Preliminary results show rapid PCB binding in both MNP and 
MNM systems, with increased binding contingent on higher polyphenolic polymer 
content, as seen primarily in MNM binding systems. Additionally, curcumin-based 
systems exhibited higher PCB binding affinity and higher binding capacity when 
incorporated into MNM systems. Future work will further substantiate the use of these 
polyphenolic systems for fluorescence-based, concentration-dependent pollutant 
sensing. 
 Finally, green tea extract, comprised primarily of the potent antioxidant 
polyphenol EGCG, was tested as a nutritional intervention mechanism for PCB-induced 
in vivo toxicity.  Mice fed a green tea-enriched diet and subsequently exposed to 
environmentally relevant doses of coplanar PCB 126 exhibited decreased overall 
oxidative stress primarily due to the up-regulation of a battery of antioxidant enzymes.  
F2-isoprostane and its metabolites, established markers of in vivo oxidative stress, 
exhibited fivefold decreased levels in mice fed green tea-supplemented diets. In addition 
to data indicating increased induction of key antioxidant enzymes, liver mRNA and 
protein analysis showed that many genes transcriptionally controlled by the aryl 
hydrocarbon receptor and nuclear factor (erythroid-derived 2)-like 2 proteins were up-
regulated in PCB-exposed mice fed the green tea-supplemented diet, which indicates 
both higher pollutant degradation/excretion and a more efficient antioxidant response to 
environmental insult. These data support the emerging paradigm that healthful nutrition 
may be able to bolster and buffer a physiological system against the toxicities of 
environmental pollutants. 
 
 5.2 Broad approach to addressing a public health concern 
 Overall, this research has sought to address the significant public health risks 
and enduring remediation challenges posed by PCBs, as well as to further understand 
potential concerns and opportunities associated with nanomaterial usage.  Nutrition is 
being further substantiated as an important modulator of inflammatory and antioxidant 
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pathways, especially associated with environmental insult, and is also emerging as a 
tool to address exposure toxicity of persistent organic pollutants as both a sensing and 
remediation platform. Evidence now shows that a person’s nutritional status can play a 
key role in determining the severity of environmental toxicant-induced pathologies such 
as diabetes and cardiovascular diseases.  People with subprime nutrition may be more 
susceptible to the toxicity of environmentally persistent pollutants, whereas individuals 
that make healthy nutritional decisions and emphasize the importance of foods high in 
bioactive nutrients such as flavonoids may be less vulnerable to environmental insults by 
being able to buffer against the toxicity of pro-inflammatory pollutants.  This research 
has highlighted that while PCBs have been shown to cause vascular toxicity through 
ROS-initiated inflammation, the detrimental effects can be counteracted by nutritional 
modulation via bioactive food components, such as EGCG found in green tea, that have 
potent antioxidant and anti-inflammatory properties. Thus, the use of healthy nutrition as 
a tool against the toxicity of environmental pollutants may be an economically and 
socially viable alternative to expensive and logistically challenging ecological 
remediation.  
 Although augmenting the nutritional profiles of at-risk populations may prove to 
be an effective modulator of toxicant-induced disease in the long term, it is critical to 
discover and design novel sensing and remediation technologies that are effective, 
sustainable and environmentally friendly to address immediate needs.  To this end, 
nanoparticle-based remediation systems have been studied to determine new methods 
for binding and removing organic pollutants from contaminated water sources, 
biologically-relevant nanoparticle suspension methods have been optimized, and 
nanotoxicological tests have been performed to understand potential causes of concern. 
Novel and emerging evidence indicates that bioactive nutrients may be incorporated into 
nanomaterial-based sensing and remediation platforms for the development of viable 
technologies that circumvent many of the issues concerning current-day 
decontamination systems. Ultimately, further research into nutrient polyphenols, such as 
EGCG, quercetin, and curcumin, will highlight their potential as sustainable, inexpensive 
components that can both decrease health concerns associated with environmental 
pollutants in the short term and remediate these concerns in the long term.   
 
  Copyright © Bradley J. Newsome 2014  
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Appendices 
 
Appendix A. Biomimetic nanocomposite-mediated removal of chlorinated organic 
pollutants from contaminated water sources 
 
A.1 Synopsis 
 Polychlorinated biphenyls (PCBs), organic pollutants prevalent in multiple 
Superfund sites, have proven difficult to remediate due to their high structural stability 
and their broad environmental presence. Endothelial dysfunction attributed to exposure 
to PCB contamination may lead to atherosclerosis and steatohepatitis. There is a need 
to not only address toxicological implications of PCB contamination, but also to detect 
and remediate contamination sites. Currently, though, there remains an unmet need in 
the ability to rapidly detect and remove PCBs from a variety of environmental water 
sources. Ongoing research indicates that polyphenol-functionalized magnetic 
nanomaterials can serve as a platform for rapid binding of PCBs from contaminated 
water sources, with eventual use as a combined detection and remediation platform. 
Quercetin and curcumin antioxidant polyphenols with binding affinities for PCBs were 
acrylated (producing quercetin multiacrylate (QMA) and curcumin diacrylate (CDA)) and 
either surface-functionalized onto or polymerized with magnetic iron oxide nanoparticles 
using PEG200DMA as a co-macromer crosslinker. Polyphenol-functionalized magnetic 
nanoparticles (MNPs) and magnetic nanocomposite microparticles (MNMs) were 
characterized for proper functional groups using FTIR (addition of C=O peak at 1740 cm-
1), for size using TEM/SEM and DLS (MNPs: approx. 15nm individual particles, 200-
400nm aggregates; MNMs: approx. 10µm individual particles, 20 µm aggregates), and 
for overall composition using TGA (MNPs: approx. 10 wt% polymer; MNMs: approx. 90 
wt% polymer). CDA- and QMA-functionalized MNP and MNM PCB binding affinities and 
capacities were analyzed in 50:50 ethanol:DI H2O or contaminated groundwater and 
quantified using LC-MS/MS. PCB binding to materials as a function of binding material 
concentration, binding time, and as a ratio of polyphenolic polymer mass to bound PCB 
indicated that MNMs, containing higher percentages of polyphenolic polymer, exhibit 
higher PCB binding capacities (approx. 80% of initial PCB (5 ppm initial concentration) 
bound to CDA-MNMs (5 mg/mL)), while optimal PCB binding for all systems occurs 
within minutes of addition to contaminated water samples. Studies in complex 
groundwater samples showed that polyphenol-functionalized materials have increased 
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affinity in comparison to suspended particulate matter (QMA-MNPs captured 87% of 
PCBs). Initial pollutant release studies indicate a release of 12% bound PCB 126 
following AMF heating, which indicates the potential for material regeneration following 
binding. Overall, quercetin and curcumin incorporation into biomimetic pollutant binding 
systems significantly increased PCB 126 binding from contaminated water samples and 
may serve as an effective fluorescence-based pollutant detection system.  
 
A.2 Introduction 
More than 30 years after passage of the initial Superfund legislation, risk 
managers continue to confront high concentrations of persistent chlorinated organic 
compounds at Superfund sites296 despite decades of remediation effort297. Soil and 
groundwater aquifer contamination by toxic chlorinated organic compounds at Superfund 
sites across the country and throughout the world is a pervasive environmental problem 
which has been studied extensively to further understand associated health 
consequences as well as to develop effective means of pollutant decontamination and 
mitigation of negative health effects296; 298. For instance, polychlorinated biphenyls 
(PCBs), persistent organic chemicals heavily used as dielectric and heat transfer fluids 
prior to their production ban in 1979, have been shown to play a contributory role in a 
wide variety of chronic diseases such as atherosclerosis, diabetes and obesity. A recent 
population study by Silverstone et al. identified PCB exposure as a risk factor for 
development of type 2 diabetes independent of other risk factors25, while other studies 
have shown that circulating levels of PCBs are associated with atherosclerotic plaque 
formation247; 255.  PCBs, particularly dioxin-like congeners that are ligands of the aryl 
hydrocarbon receptor (AhR)(i.e., PCB 77 and 126), have been shown to promote 
expression of proinflammatory cytokines and to effect changes in redox status, events 
which act as precursors to these disorders21.  In addition to highly toxic dioxin-like 
congeners and despite a total production ban, though, studies have shown that many 
lesser-known PCBs continue to be produced as unintentional byproducts of pigment 
manufacturing processes, further increasing exposure risk299. The result is that 
environmentally persistent chlorinated organics present a 21st century challenge. 
Biomedical intervention strategies and environmental remediation techniques 
both have been employed to address environmental pollutant-induced public health 
concerns. For example, a recently published case study of the residents of Anniston, AL, 
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a community affected by 30 years of PCB contamination, showed that nutritional 
intervention with the fat substitute olestra effectively decreased body burden of PCBs300. 
Additionally, green tea extract, primarily composed of the antioxidant polyphenol 
epigallocatechin gallate (EGCG), has been shown to significantly decrease PCB-induced 
proinflammatory protein and mRNA markers in vivo by up-regulating a battery of 
antioxidant enzymes as well as the AhR and nuclear factor (erythroid-derived 2)-like 2 
(Nrf2) pollutant clearance and antioxidant response mechanisms (see Chapter 5)98. 
Other antioxidant polyphenols, i.e., quercetin and curcumin, also have been shown to 
protect against in vivo and in vitro PCB-induced oxidative stress126; 301 and have been 
studied extensively for their use as overall free radical scavengers and as the basis for 
biodegradable antioxidant polymer systems128. While environmental remediation 
provides a more long-term answer to pollutant-induced public health concerns, this large 
goal has proven difficult and costly. Traditional treatment strategies, e.g., dredging/soil 
removal, reactive barriers, six phase heating, microbial transformation, carbon 
adsorption, etc. for remediation/reclamation of contaminated areas require extensive use 
of chemicals and/or energy or post-treatment due to formation of undesirable 
byproducts302-307. Thus, complete remediation has been technically unattainable and 
economically impractical.  
Affinity-based methods (i.e., antibody-based detection systems) are emerging as 
effective binding and detection platforms for pollutant remediation due to their refined 
specificity and reduced need for sample purity308-310. Although antibody affinity in the 
form of enzyme-linked immunoassays currently serves as the most commonly applied 
immunoassay for environmental PCB detection, antibodies are prone to long-term 
stability concerns and are expensive to produce118; 309; 311. Instead, biomimetic polymeric 
systems can be tailored that exploit the binding domains of pollutant-specific antibodies 
while addressing these stability and cost concerns. Studies have shown that binding 
domains of PCB-specific antibodies (e.g., S2B1) form sterically constrained, highly 
aromatic pockets that allow for pi-pi bond stacking interactions312. This binding 
relationship is also seen in tests of PCB soil distribution (e.g., humic containing matter) 
and biodistribution (e.g., lipid rafts, PCB-binding proteins)312-316. We hypothesize that 
synthetic, biomimetic PCB binding domains can be synthesized by incorporating 
phenolic moieties into polymeric coatings for high PCB binding affinity and capacity as 
an effective means of pollutant removal from contaminated sites. As with biomedical 
intervention strategies, polyphenols (e.g., plant derived flavonoids) offer an intriguing 
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mechanism to address PCB-related public health concerns through their use as 
precursors for creating biomimetic affinity domains. Similar to the ability of antibodies 
and natural humic matter to bind PCBs, we hypothesize that nutrient polyphenols (i.e., 
curcumin and quercetin) can be used as monomeric starting materials to mimic PCB 
binding microdomains, allowing for the synthesis of PCB binding pockets that enable 
environmentally-benign pollutant capture/removal systems.   
Additionally, the development of magnetic iron-based nanomaterials has brought 
important and promising new opportunities to the field of contaminant detection and 
environmental remediation in addition to its wide use for biomedical applications (i.e., 
magnetic resonance imaging, targeted drug delivery, and hyperthermia)40-43. Beyond 
their growing use as a platform for PCB dechlorination/remediation21; 237; 240; 302; 317-320, 
magnetic nanoscale iron particles have attracted growing attention for their easy 
manipulation with a magnetic field (e.g. for magnetic separation of captured molecules or 
transport and immobilization at target sites) and response to an alternating magnetic 
field (AMF) for targeted heating to modify properties (e.g. binding/release properties, 
reaction rates, etc.). By tailoring nanoparticle surface characteristics through 
functionalization it is possible to combine the pollutant binding capabilities of biomimetic 
polymer systems with the separation and heating characteristics of magnetic 
nanoparticles for effective and environmentally benign pollutant capture/removal from 
contaminated sites41; 42. 
This research employs plant polyphenol-derived polymers incorporated into 
magnetic nanocomposite platforms that allows for the selective capture and removal of 
PCB congeners from contaminated water samples (see Figure A.1).  This work provides 
a potential means of environmentally sound pollutant remediation by combining 
biomedical treatment strategies with materials-based remediation platforms for the 
creation of biomimetic binding systems with the potential for future use not only in 
pollutant capture but also detection and release for material reuse.  
 
A.3 Materials and Methods 
A.3.1 Materials 
 Quercetin, curcumin, acryloyl chloride, 2-bromo2-methylpropionic acid (BMPA), 
iron(II) chloride tetrahydrate, iron(III) chloride hexahydrate, dimethyl sulfoxide (DMSO), 
2,2’-bipyridine (BPY), ammonium persulfate (APS), and tetramethylethylenediamine 
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(TEMED) were purchased from Sigma-Aldrich (St. Louis, MO). Triethylamine (TEA), 
tetrahydrofuran (anhydrous) (THF), acetonitrile (ACN), dichloromethane (DCM), and 
potassium carbonate (K2CO3) were purchased from Thermo Fisher Scientific (Waltham, 
MA). Poly(ethylene glycol) (200) dimethacrylate (PEG200DMA) was purchased from 
Polysciences (Warrington, PA).  3,3’,4,4’,5-pentachlorobiphenyl (PCB 126) was 
purchased from Accustandard (New Haven, CT). All other organic solvents, acids, and 
salts were obtained from Sigma-Aldrich or Thermo Fisher Scientific and used as 
received.   
 
A.3.2 Synthesis of magnetic iron oxide nanoparticles 
 Magnetic iron oxide nanoparticles were synthesized by a coprecipitation method 
as previously reported by our laboratory40; 321. Briefly, Fe(II) and Fe(III) salts were 
dissolved in deionized water via sonication at a 1:2 molar ratio, respectively, stirred 
under N2, and heated to 85 °C. Ammonium hydroxide was added dropwise when the 
reaction mixture reached 85 °C and was stirred for 1 h to precipitate the nanoparticles. 
Subsequently, magnetic iron oxide nanoparticles were washed and dialyzed for 24 h in 
deionized (DI) water. Nanoparticles were characterized for size and suspension stability 
using dynamic light scattering (DLS, Zetasizer Nano ZS90, Malvern, Worcestershire, 
United Kingdom) (See Table A.1). Particles were stored in DI water until further use.     
 
A.3.3 Synthesis and purification of quercetin multiacrylate and curcumin 
diacrylate 
 Acrylated antioxidant polyphenols were synthesized by reacting the polyphenols 
quercetin and curcumin with acryloyl chloride in tetrahydrofuran (THF) and potassium 
carbonate (K2CO3) or triethylamine (TEA), similar to work previously reported by our 
laboratory128, to enable their subsequent polymerization (See Supplementary Figure A.1 
for synthesis overview). Quercetin and curcumin polyphenols were dissolved in THF at a 
concentration of 100 mg/mL. K2CO3 was added to the quercetin solution at a 6:1 
K2CO3:quercetin molar ratio while TEA was added to the curcumin solution at a 3:1 
TEA:curcumin molar ratio, followed by purging with N2. Acryloyl chloride was added 
dropwise to the reaction mixtures with stirring on an ice bath at initial molar ratios 
(acryloyl chloride:antioxidant) of 6:1 and 3:1 for quercetin and curcumin, respectively. 
The reactions were allowed to proceed for 18 h at room temperature, protected from 
light.  
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 Subsequently, THF was removed from acrylated products by vacuum distillation 
using a liquid N2 trap, and precipitated salts and potassium bicarbonate were separated 
by vacuum filtration. In order to remove unreacted acryloyl chloride from the products, 
dried quercetin multiacrylate (QMA) and curcumin diacrylate (CDA) powders were then 
redissolved in dichloromethane (DCM) (80 mL) and QMA and CDA were extracted using 
0.1 M K2CO3 (3 x 150 mL) and DI water (3 x 120 mL) with centrifugation at 10,000 rpm 
for 5 min. Residual water was then removed using anhydrous MgSO4, solutions were 
filtered using vacuum filtration, and DCM solvent was removed from purified products 
under vacuum using a roto-evaporator (Rotovapor R II, Buchi, Switzerland). Synthesized 
polyphenol multiacrylates were then characterized using high performance liquid 
chromatography (HPLC, Shimadzu, Kyoto, Japan). Products were stored at -20 °C until 
further use. 
 
A.3.4 Synthesis of polyphenol-functionalized magnetic nanoparticles (MNPs) 
 Polyphenol-functionalized magnetic iron oxide nanoparticles (QMA- and CDA-
MNPs) were synthesized using atom transfer radical polymerization (ATRP) to 
functionalize acrylates (PEG200DMA and antioxidant multiacrylates) onto BMPA-surface 
initiated nanoparticles, similar to that reported previously322.  Uncoated MNPs were 
mixed with BMPA initiator at a 1:4 molar ratio in 75:25 water:ethanol (v/v) and stirred for 
24 h at RT. The particles were then washed 3x with ethanol, retrieved by magnetic 
decanting, and suspended at 10 mg/mL in ethanol. Surface initiated magnetic 
nanoparticles (5 mL in ethanol) were then combined with BPY and CuBr catalysts, along 
with 2-3 Cu0 crystals, at 1:0.01 and 1:0.04 PEG200DMA:catalyst molar ratios, 
respectively. PEG200DMA was used herein as the primary macromer and QMA/CDA as 
secondary functional monomer. Catalyst solution was stirred and heated to 50 °C with 
N2 bubbling. At 50 °C, 8 mmol macromer (99:1, 95:5, and 90:10 molar ratios of 
PEG200DMA to QMA or CDA) was injected into the catalyzed mixture and allowed to 
react for 24 h, protected from light. Functionalized nanoparticles were then magnetically 
decanted, washed 3x with ethanol to remove excess catalyst, and further washed with 
50:50 ACN/DCN, followed by DI water to determine potential macromer leaching. 
Functionalized MNPs were characterized to determine accurate synthesis characteristics 
using Fourier transform infrared spectroscopy (FTIR, 7000e, Varian, Palo Alto, CA), for 
size using DLS and transmission electron microscopy (TEM, 2010F, Jeol, Tokyo, 
Japan), for polymer weight loss using thermogravimetric analysis (TGA), and for 
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potential macromer leaching rates using UV-vis spectrophotometry (50 Bio, Varian). 
Nanoparticles were stored at 4 °C in DI water until further use.   
 
A.3.5 Synthesis of polyphenolic magnetic nanocomposite microparticles (MNMs) 
 Polyphenolic magnetic nanocomposite microparticles (QMA- and CDA-MNMs) 
were synthesized by polymerizing primary and secondary macromers in the presence of 
suspended uncoated magnetic nanoparticles, followed by gel cryomilling to produce 
particles in micron size regime. PEG200DMA and QMA or CDA were mixed at 99:1, 
95:5, and 90:10 molar ratios and polymerized in the presence of 1 wt% magnetic 
nanoparticles via free radical polymerization with 3 wt% APS and 1.5 wt% TEMED. 
Following polymer formation in glass templates, gels were cut into small pieces, washed 
5x with 50/50 anhydrous ACN/DCN with stirring for 30 min each wash. Solvent was then 
removed, microparticles were frozen at -20 °C overnight, and subsequently lyophilized 
overnight. Dried gels were then cryomilled for 10 min using a SPEX 6770 Freezer/Mill 
(Metuchen, NJ). Polyphenolic MNMs were characterized for size using laser diffraction 
particle size analysis (SALD-7101, Shimadzu) and scanning electron microscopy (SEM, 
S-4300, Hitachi, Houston, TX), for polymer weight loss using TGA, and for potential 
macromer leaching using UV-vis spectrophotometry. Dry MNM powders were stored at -
20 °C until further use. 
 
A.3.6 Polyphenol MNP- and MNM-mediated binding of polychlorinated biphenyls 
from contaminated water samples 
 PCB 126 was added to 50:50 ethanol:water at 5 ppm to mimic an aqueous 
environment while the addition of ethanol increases the overall solubility of PCB to 
enable higher test concentrations. QMA/CDA-MNPs and MNMs were added to PCB-
contaminated samples at varying particle concentrations (0.5, 1, and 5 mg/mL) and 
incubated with shaking at RT for times ranging from 1 min to 2 h to optimize binding 
conditions. Uncoated magnetic nanoparticles and PEG200DMA-coated MNPs/MNMs 
served as pollutant binding controls. MNPs/MNMs with bound PCB were magnetically 
separated and supernatants were removed. Pollutant binding ability and efficiency of the 
materials were analyzed by measuring remaining PCB in supernatants using a 
Shimadzu ultra fast liquid chromatography system coupled with an AB Sciex 4000-Qtrap 
hybrid linear ion trap quadrupole mass spectrometer (LC-MS/MS) in multiple reaction 
monitoring (MRM) mode using atmospheric pressure chemical ionization (APCI). MRM 
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transitions monitored: 325.9/256.1, 325.9/254.1, and 325.9/184 for PCB 126. Unbound 
PCB 126 was analyzed by integrating peak area (area under the curve, AUC) and 
comparing to that of a concentration curve of known PCB 126 values. 
 
A.3.7 AMF heating for PCB removal from particles 
 The efficiency of PCB 126 release from particle systems following PCB binding 
was tested to determine the viability of material reuse. An alternating magnetic field 
(AMF) was applied to heat the polyphenolic MNPs and MNMs for controlled 
destabilization of the polymer matrix and subsequent release from the particles back in 
to 50:50 ethanol:water. LC-MS/MS was used as reported in Section A.3.6 to determine 
PCB leachate concentrations following heating and PCB release.  
 
A.4 Results and Discussion 
A.4.1 Material development and characterization 
Polyphenol-functionalized magnetic nanoparticle (MNP) and nanocomposite 
microparticle (MNM) binding systems were successfully synthesized with quercetin and 
curcumin multiacrylate polymers (QMA and CDA, respectively) to create biomimetic 
binding systems for chlorinated organic pollutants (i.e., PCBs). First, magnetic iron oxide 
nanoparticles were produced through a one-pot coprecipitation method as the core 
material to impart controlled heating and separation functionality. QMA and CDA were 
then synthesized by incorporating acrylate groups onto the native quercetin and 
curcumin structures to enable polymerization with poly(ethylene glycol) (PEG), while 
maintaining original monomer functionality (see reaction scheme, Supplementary Figure 
A.1). Magnetic nanoparticles were surface-functionalized with QMA and CDA polymers 
using atom transfer radical polymerization or incorporated within the polyphenolic 
polymer matrix at 1 wt% and cryomilled to the micron size regime.  
In these studies, PEG was used as a crosslinker and co-macromer along with 
QMA and CDA functional monomers in order to tune the polymer network structure of 
the polymer coating for tailored PCB binding affinities and matrix porosity. PEG-based 
systems were selected due to their low non-specific interactions with hydrophobic 
systems and wide variety of commercially available systems with various molecular 
weights, allowing for the tuning of polymeric network structures. Following 
polymerization of CDA or QMA with PEG200DMA to form MNPs and MNMs, FTIR 
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analysis was used to confirm successful incorporation of desired polyphenolic functional 
groups, as indicated by the C=O peak observed at 1740 cm-1 (see Figure A.2).  
Size analysis of both polyphenolic binding systems (i.e., MNPs and MNMs) was 
performed using light scattering and electron microscopy methods, as seen in Table A.1 
and Figure A.3. TEM analysis of MNPs showed individual particle sizes of 10-20 nm 
(CDA-MNPs: 11 nm; QMA-MNPs: 15 nm) while DLS showed MNP aggregate 
hydrodynamic diameters ranging from 240 (CDA-MNPs) to 400 nm (QMA-MNPs). This 
large increase in particle size is primarily due to the slightly hydrophobic nature of the 
particles that enables both a higher affinity binding environment for lipophilic PCBs and 
faster magnetic decantation from contaminated water. Size analysis of cryomilled MNMs 
showed much larger particle sizes (approx. 10 µm particle sizes via SEM), as expected, 
and less particle aggregation (aggregate particle diameters of approx. 20 µm via laser 
diffraction particle sizing).  
While nanoparticles exhibit much higher overall surface area than microparticles, 
with increasing surface area potentially leading to increased total pollutant binding, 
microparticles are composed of a higher percentage of functional polymer in comparison 
to the magnetic nanoparticle core material. TGA was used to analyze overall particle 
composition based on particle mass loss at increased temperatures. As seen in Figure 
A.4, MNP system mass was attributed primarily to the magnetic nanoparticle core (90 
wt% NP core, 10 wt% polymer) while polymeric material predominated in MNM systems 
(10 wt% NPs, 90 wt% polymer).  Leaching studies were also performed to further clarify 
overall material composition and determine QMA and CDA incorporation rates into the 
polymeric matrix. MNPs and MNMs were washed following synthesis to remove 
uncrosslinked macromer and washes were analyzed via UV-vis spectroscopy. 
Absorbance measured at 370 nm (QMA) or 380 nm (CDA) indicated that CDA was 
incorporated into both MNP and MNM systems at approx. 90% of initial macromer 
content while QMA was incorporated at approx. 60-70%. 
 
A.4.2 Preliminary studies of fluorescence modulation for pollutant detection  
Curcumin and quercetin nutrient polyphenols are of interest not only due to their 
wide use as natural antioxidant supplements and expected affinity for chlorinated 
organics, but also due to their inherent fluorescence characteristics that form the basis 
for future pollutant detection systems and are a key functionality to be exploited with 
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future experimentation. Preliminary solution phased fluorescence interaction studies 
were performed to evaluate the potential of quercetin and curcumin esters as 
fluorescence indicators for PCB interaction. Heterocyclic rings under high concentrations 
can exhibit pi-pi bond stacking. When the ringed molecules also have fluorescence 
activity, pi-bond stacking can lead to resonance energy transfer, which shifts the 
emission spectra into the red323; 324. Initially, QMA was tested for potential fluorescence 
modulation in the presence of PCB 126; when excited at 350 nm, QMA exhibited a 
fluorescence peak at 390 nm. However, as the concentration of PCB 126 increased from 
0.04 to 20 ppm, a second peak emerged at 535 nm, with the ratio between these peaks 
increasing proportionally over the observed range (see preliminary data in Figure A.5A). 
Additionally, by characterizing both Kd and potential fluorescence shifts, it is possible to 
develop a calibration curve for identification of PCB concentration. A Langmuir binding 
interaction model was used to approximate QMA/PCB binding affinities, indicating a 
preliminary Kd of the interaction of 2.2 ppm.  
While QMA was found to exhibit a PCB-induced fluorescence shift, it was not 
clear if this capability would remain following incorporation into magnetic nanocomposite 
binding platforms. Further studies involving QMA-functionalized MNPs were then 
performed to substantiate the viability of this platform. Surface functionalized MNPs 
containing 20% QMA were incubated with and without PCB 126 and fluorescence 
analysis indicated that 6 ppm of PCB resulted in an intense fluorescent peak at 535 nm. 
This fluorescence shift corresponds directly to that of QMA alone in solution and 
indicates that QMA incorporation into nanocomposite binding systems does not inhibit 
binding/sensing activity (see Figure A.5B). 
 
A.4.3 PCB 126 binding to polyphenol-functionalized nanomaterials 
 Capture materials are designed for high affinity of the analyte (i.e., PCB) to the 
material, the number of available binding sites (binding capacity), and selectivity of the 
material for the analyte of interest.  These binding interactions are the result of multiple 
weak molecular forces (e.g., pi-pi stacking, electrostatics, hydrogen bonding), which are 
dictated by the localized environment of the binding pocket. Following substantiation of 
CDA and QMA affinity for PCBs, CDA- and QMA-functionalized MNPs and MNMs were 
optimized for binding capacity using a variety of polyphenolic polymer compositions and 
binding conditions. The magnetic core material of these binding systems enables 
manipulation with both static and alternating magnetic fields (AMF) for decantation or 
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remote heating, respectively. As seen in Figure A.6A, MNPs and MNMs well dispersed 
in medium of interest were completely collected within 5 min following exposure to a 
static magnetic field. Although the primary purpose of the magnetic core material is to 
enable simple separation of bound pollutant from contaminated samples, its ability to be 
manipulated (i.e., remotely heated) with an AMF is key for polymer destabilization for 
pollutant release. Initial studies performed with magnetic iron oxide nanoparticles at 5 
mg/mL showed that temperature increased from 23 °C to 65 °C within 10 min when 
exposed to an AMF at 300 kHz and 30 kA/m (Figure 4.6B).  
  Pollutant binding studies were conducted to determine PCB 126 affinity for CDA- 
and QMA-functionalized MNPs and MNMs as a function of binding material 
concentration, PCB binding time, and as a ratio of polyphenolic polymer mass to bound 
PCB.  MNPs and MNMs (1 or 5 mg/mL) were added to 50:50 ethanol:water (v/v) 
containing 5 ppm PCB 126 and incubated with shaking for a variety of time points from 1 
min to 2 h. LC-MS/MS analysis was then performed using supernatants following 
magnetic separation of PCB-bound materials.  As seen in Figure A.7A, a five-fold 
increase in polyphenolic material concentration led to increased PCB binding, although 
total PCB binding only increased by approx. 20% at higher material concentrations. This 
indicates that the availability of binding sites plays some role in increased pollutant 
binding, although equilibrium effects with the 50:50 ethanol:water medium also play 
some role in incomplete PCB binding. When normalized for polymeric content instead of 
total particle mass (Figure A.7B), MNPs were shown to bind PCB 126 at much lower 
rates over the entire study time span. This is both indicative of the primary role that the 
polyphenolic polymer plays in PCB binding (much increased polymer content in the 
MNMs yielded significantly higher pollutant binding rates) as well as the role of increased 
NP surface area in compensating for decreased polymeric content (when comparing 
PCB binding as a function of total particle mass as opposed to polymeric content). 
Equilibrium time studies indicated that high pollutant binding is seen within minutes of 
exposure to functionalized nanomaterials while decreasing pollutant binding, primarily 
seen with CDA-functionalized MNMs, may be due to excessive vortex-based sheer force 
during pollutant binding. 
 When transitioning to real-world settings dealing with contaminated groundwater 
sources, soluble humic acid components (found in sediment and soil samples) have 
been found to negatively impact PCB sorbent performance. Both competitive binding for 
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sites on the sorbent material and preferential PCB-humic acid interactions, which may 
favor the suspension of PCB in the aqueous environment, can lead to decreased binding 
efficiencies for capture platforms325-327. Herein, preliminary studies were performed to 
test the viability of polyphenol-functionalized nanomaterials as PCB binding systems in 
complex media. Groundwater from the Paducah Gaseous Diffusion Plant, Kentucky’s 
largest Superfund site and the sight of initially significant PCB contamination, (a 50:50 
mixture of ethanol to groundwater) was spiked with 5 ppm PCB 126, 1 mg/mL QMA-
MNPs were introduced and allowed to bind PCB for 1 h, and bound PCB was 
magnetically decanted, followed by removal of supernatant. LC-MS/MS analysis 
indicated that QMA-MNPs captured 87% of PCB 126 in complex media samples, 
indicating that these polyphenolic functionalities may have higher affinity for PCBs than 
humic containing matter suspended in water samples (see Figure A.8). This suggests 
that further development of this system is warranted. 
 
A.4.4 Reversible capture of PCBs using controlled heating 
Currently, capture materials used for PCB extraction and detection require 
extensive post processing with large amounts of organic solvents and complex 
extraction methods. Materials that exhibit switchable affinities for PCBs and other 
pollutants, though, could provide a means for material reuse without extensive 
processing with chemicals that also pose health hazards, thus forming a low energy, 
“greener” approach to pollutant remediation. As highlighted in section A.4.3, magnetic 
nanomaterials can be heated remotely by applying an AMF to destabilize the polymeric 
coating material and release PCBs back into the medium of interest. As seen in Figure 
A.9, QMA-MNPs were used to remove PCB 126 from contaminated water samples, 
which, following magnetic separation, were resuspended and exposed to an AMF 
(amplitude of 60 kA/m and frequency of 293 kHz). AMF heating for 10 min led to a 12% 
PCB 126 release back in to the medium (M±SE, n=3) from the MNPs. While it is 
necessary to further optimize this release system, this ability to remotely impact affinity 
substantiates further studies for the development of capture/release systems that can 
easily cycle from low to high affinity binding states.  
 
A.5 Conclusions 
 This research provides a framework for continued experimentation in the 
development of environmentally benign, biomimetic PCB capture systems. Polyphenolic 
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macromers based on quercetin and curcumin antioxidant polyphenols with notable 
affinity for persistent organic pollutants were surface-polymerized onto or polymerized in 
the presence of magnetic iron oxide nanoparticles to create nanocomposite materials 
that can be manipulated with a magnetic field. The potential of these systems for 
fluorescence-based detection of PCBs and as a capture/release platform for material 
reuse was substantiated.  Further, QMA- and CDA-functionalized MNPs and MNMs 
were shown to bind PCB 126 in both control and real-world contaminated groundwater 
settings (see Figure A.10 for overall schematic of PCB capture/release platform).  
Ongoing experimentation is focused on optimizing material affinities and binding 
characteristics for a wide variety of PCB congeners, as well as PCB release and material 
reuse. Future experimentation is needed to further substantiate the use of these 
materials in fluorescence-based pollutant detection, especially in complex mixtures of 
organic pollutants, and in higher throughput settings for rapid pollutant binding and 
contaminated material separation. Overall, this work highlights the use of novel 
biologically inspired materials for pollutant removal from contaminated water sources 
and its potential use as a capture/detection/release platform for addressing public health 
concerns associated with PCBs.    
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aSize analysis performed using dynamic light scattering to determine nanoparticle 
aggregate hydrodynamic diameters  
bSize analysis performed using laser diffraction particle analysis to determine 
microparticle hydrodynamic diameters   
Table A.1
Particle system size analysis
Particle system Analyzed hydrodynamic 
aggregate size
Analyzed TEM 
average size (nm)
Analyzed SEM 
average size (µm)
Uncoated MNPs 162±4 nma -- --
PEG-coated MNPs 203±3 nma -- --
CDA-coated MNPs 241±11 nma 11 --
QMA-coated MNPs 401±6 nma 15 --
PEG MNMs 16.2±0.5 µmb -- 8
CDA MNMs 19.6±0.3 µmb -- 10
QMA MNMs 22.1±0.3 µmb -- 11
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Figure A.1. Overall illustration of composite magnetic nanomaterial platforms for the 
capture, sensing, and release of chlorinated organic pollutants from contaminated water 
sources.  
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Figure A.2. FTIR transmittance showing steps of MNP synthesis. 1) Core magnetic 
particles are 2) surface initiated by coating with BMPA and 3) functionalized with 
polyphenolic polymers (i.e., CDA and QMA crosslinked with PEG200DMA). FTIR 
analysis confirms successful functionalization with the desired polyphenolic polymers via 
the C=O peak observed at 1740 cm-1, which confirms in this case the presence of 
quercetin functionality in the polymer coating. 
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Figure A.3. Electron microscopy particle size determination. SEM analysis of MNMs 
indicates average particle sizes of A) QMA MNMs, B) CDA MNMs, and C) PEG MNMs 
as 11, 10, and 8 µm, respectively. TEM analysis of MNPs indicates average particle 
sizes of D) QMA MNPs and E) CDA MNPs as 11 and 15 nm, respectively.  
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Figure A.4. Thermogravimetric analysis of functionalized nanomaterial systems. Weight- 
loss profiles were analyzed to determine average polymer content of MNP and MNM 
binding systems, indicating that MNMs were composed of approximately 90% polymeric 
material and 10% magnetic nanoparticles. Conversely, approximately 90% of the mass 
of MNPs is due to the core magnetic nanoparticles while polyphenolic polymer surface 
coating comprises 10% overall particle mass.  
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Figure A.5. Fluorescence-based sensing of PCB 126. QMA and PCB demonstrate a 
concentration dependent fluorescence shift. A) When excited at 350 nm, QMA exhibits a 
fluorescence peak at 390 nm. As PCB 126 increased from 0.04 to 20 ppm, a second 
peak emerged at 535 nm, with the ratio between these peaks increasing proportionally 
over the observed range. Using a Langmuir binding interaction model to approximate 
QMA/PCB binding affinities it was found the Kd of this interaction as 2.2 ppm. B) Studies 
involving QMA-functionalized MNPs also showed a concentration specific fluorescence 
peak at 535 nm upon QMA-MNP/PCB binding.  
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Figure A.6. Material response to static and alternating magnetic fields.  A) MNPs and 
MNMs can be completely separated from PCB-contaminated water samples within 5 min 
after exposure to a static magnetic field. B) Illustration of the heating of Blank MNPs in 
an alternating magnetic field (Amp = 60 kA/m, Freq = 293 kHz)(M±SE, n=3). 
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Figure A.7.  PCB 126 capture by polyphenolic MNPs and MNMs. CDA- and QMA- 
functionalized MNP and MNM binding affinities for PCB 126 (5 ppm) were analyzed as a 
function of binding material concentration, PCB binding time, and as a ratio of 
polyphenolic polymer mass to bound PCB. A) a five-fold increase in polyphenolic 
material concentration leads to increased PCB binding, although total PCB binding only 
increased by approx. 20% at higher material concentrations. B) When normalized for 
polymeric content instead of total particle mass, MNPs were shown to bind PCB 126 at 
much lower rates over the entire study time span (M±SE, n=3). This is both indicative of 
the primary role that the polyphenolic polymer plays in PCB binding (increased polymer 
content yields higher pollutant binding) as well as the role of increased NP surface area 
in compensating for decreased polymeric content. Equilibrium time studies indicate that 
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high pollutant binding is seen within minutes of exposure to functionalized nanomaterials 
while decreasing pollutant binding, primarily seen with CDA-functionalized MNMs, may 
be due to excessive vortex-based sheer force during pollutant binding.  
130 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A.8. QMA-MNP capture of PCB 126 from contaminated groundwater samples.  
Contaminated water samples from the Paducah Gaseous Diffusion Plant were spiked 
with 5 ppm PCB 126, 1 mg/mL QMA-MNPs with varying QMA content was introduced 
into samples, and remaining PCB 126 in supernatant following magnetic separation was 
analyzed with LC-MS/MS.  Functionalized particles capture 87% of PCB in complex 
media samples, indicating that material binding affinities are higher than that of the 
particulate matter suspended in the water samples (M±SE, n=3).  
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Figure A.9. Temperature-induced PCB 126 release from MNPs. QMA-MNPs were 
heated with AMF (amplitude of 60 kA/m and frequency of 293 kHz), which led to a 12% 
PCB 126 release back in to supernatant (M±SE, n=3).  
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Figure A.10. Overall schematic of PCB capture and material regeneration. Polyphenol-
functionalized materials (MNPs or MNMs) can be introduced into PCB-contaminated 
water sources within a closed system where PCBs bind within biomimetic binding 
pockets. The application of a static magnetic field can then be used to magnetically 
decant PCB-bound MNPs and MNMs, leaving decontaminated groundwater, while 
exposure to an alternating magnetic field can serve to destabilize the polymer matrix, 
releasing bound PCB to be further remediated while also regenerating the polyphenolic 
material for reuse.    
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Appendix B. Additional data 
 
 
 
Supplementary Figure 2.1. Transmission electron microscopy images of characteristic 
alumina aggregates under various conditions.  (A) Alumina dispersed in citrate buffer, 
pH 6.0, with 10 min sonication using a probe sonicator showed mean aggregate 
diameter of ~72 nm, while alumina suspended using ultrasonic bath with (B) 24-h 
sonication and (C) 6-h sonication resulted in aggregate diameters of ~84 nm and 113 
nm, respectively.  Average aggregate sizes of citrate-stabilized alumina suspended in 
(D) DMEM/High Glucose medium and (E) F-12K medium remain relatively the same, 
with average particle diameters of ~93 nm and ~79 nm, respectively.  Although primarily 
suspended at sizes below 100 nm, some alumina particle agglomeration was seen when 
suspended in media that resulted in particle diameters of ~150 nm.  Mean aggregate 
diameter represents n≥5 TEM data. 
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Supplementary Table 4.1
Experimental diets
g/kg kcal g/kg kcal
Protein 19 (20%) 19 (20%)
Carbohydrate 67 (70%) 67 (70%)
Fat 4 (10%) 4 (10%)
Casein 190 800 190 800
L-Cystine 3 12 3 12
Corn Starch 299 1260 299 1260
Maltodextrin 10 33 140 33 140
Sucrose 332 1400 332 1400
Cellulose, BW200 47 0 47 0
Soybean Oil 24 225 24 225
Lard 19 180 19 180
Mineral Mix S10026 9 0 9 0
Vitamin Mix V10001 9 40 9 40
Green Tea Extract 10 !! 0 !!
Total 1065 4057 1055 4057
1% GTE-supplemented diet Control diet
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Supplementary Figure 4.1. PCB 126 exposure leads to a significant increase in 
liver/body weight ratio (hepatosomatic index, HSI) in both control and GTE-
supplemented diets, although GTE supplementation did not significantly mitigate this 
PCB-induced increase. Statistical analysis was performed using two-way ANOVA 
followed by Tukey test with *p<0.001. A trend toward a statistically significant interaction 
between diet and PCB 126 treatment (p=0.06) was also seen. 
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Supplementary Figure 4.2. Relative mRNA levels of antioxidant enzyme markers. 
Overall, GTE supplementation did not significantly increase antioxidant mRNA levels in 
control diets, but, in the presence of environmental perturbation (i.e., PCB 126 gavage), 
significantly higher antioxidant levels were seen in mouse liver above non-supplemented 
diet. All values were determined using the relative quantification method (ΔΔCt) as a fold 
change from control. Vehicle and PCB 126-treated mice with 10% fat control and GTE-
supplemented diets: n=8-10. Data are presented as mean±S.E.M (*p<0.01, **p<0.05). 
See Table 5.2 and Figure 5.3 for more information concerning antioxidant markers 
tested. 
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Supplementary Figure A.1. Curcumin diacrylate (CDA) and quercetin multiacrylate 
(QMA) synthesis schemes. To enable crosslinking with PEG200DMA, A) curcumin and 
B) quercetin were first acrylated to form CDA and QMA, respectively, as seen in the 
above reaction mechanisms. These polyphenols were reacted with acryloyl chloride to 
form ester bonds between the acid chloride (–OCl) of acryloyl chloride and the 
polyphenol hydroxyls (–OH), with the release of HCl byproduct that is neutralized with 
K2CO3.  
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